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Abstract
In recent years, substituted 2-arylbenzothiazoles have emerged as an important 
pharmacophore with a number of possible diagnostic and therapeutic 
applications. An example of this is provided by the simple 2-(4- 
aminophenyl)benzothiazole series which has shown both exquisite antitumour 
activity and potential as a PET tracer in non-invasive imaging o f Alzheimer’s 
disease. Although there are documented procedures for their synthesis, the 
majority refer to those benzothiazoles unsubstituted in the benzothiazole ring 
and involve the use of harsh reaction conditions, and chromatographic 
purification.
In this work a simple method for the rapid access to a range of 2- 
phenylbenzothiazoles both substituted and unsubstituted in the benzothiazole 
ring is reported, importantly the method described requires no chromatographic 
purification.
A simple one-step synthesis to 2-phenylbenzothiazoles unsubstituted in the 
benzothiazole ring is described whereby the desired product was made in high 
yield and with a short reaction time under either thermal or microwave 
irradiation o f a variety of benzaldehydes and 2-aminothiophenol using sodium 
metabisulfite as a mild oxidant in DMSO.
The methodology was extended to the synthesis o f biologically relevant 2- 
phenylbenzothiazoles substituted on the benzothiazole ring, starting from the 
appropriately substituted 2-aminophenyldisulfIde. Under thermal conditions, a 
small diverse library o f compounds was obtained in short reaction times with 
no chromatographic purification necessary.
The synthesis o f a number of 2-phenylbenzothiazoles either substituted or 
unsubstituted in the benzothiazole ring is also reported by polymer-supported 
synthesis, utilising polymer-supported triphenylphosphine and p- 
toluenesulfonic acid as catalysts for the reaction.
Biological evaluation was undertaken on four cancer cell lines, namely, A549, 
LoVo, MCF-7, and PC3, with A549 and MCF-7 the most active. Although no 
exquisite activity was found, as these compounds contain either or both a 
carbon and fluorine atom they have the possibility to be labelled with either a 
n C or 18F label and therefore have potential use in PET imaging.
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1 Introduction
1.1 Benzothiazole as an Important Pharmacophore
Although a simple bicyclic ring system, benzothiazoles, 1, have emerged in recent 
years as an important pharmacophore in a number of therapeutic and diagnostic 
settings. In this chapter a number of these areas will be illustrated and those that 
are of the greatest importance are highlighted. Once their therapeutic applicability 
has been demonstrated, the shortcomings of their synthetic accessibility will be 
discussed and possible solutions to overcome a number o f these problems will be 
shown. A simple synthetic procedure for a number of benzothiazole containing 
compounds with both known and potential therapeutic use will be illustrated.
In particular this thesis will focus on 2-arylbenzothiazoles, 2, with promising 
therapeutic potential in cancer therapy and Alzheimer’s diagnosis.
Figure 1: Benzothiazole and 2-arylbenzothiazole
1.2 Benzothiazoles in Non-invasive Disease Diagnosis
Arguably one o f the most promising biological applications of 2- 
arylbenzothiazoles to date has come from the development of substituted 2- 
arylbenzothiazoles as potential non-invasive diagnostic imaging agents in 
progressive neurodegenerative conditions such as Alzheimer’s disease (AD). 
Discoveries in the laboratory can now be seen translated into their first stages of 
clinical evaluation in this area.
Dementia is a term used to describe various different brain disorders that all have 
in common the loss o f brain function. Alzheimer’s disease is the most common 
cause of dementia and in the UK it is estimated that dementia currently affects
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around 417,000 people, with numbers increasing every year. One in 14 people 
over the age of 65 and one in six over the age of 80 are affected by this disorder1. 
Given the association of dementia with old age and the fact that we are an ageing 
society with an ever increasing average lifespan Alzheimer’s disease is a major 
healthcare issue.
The presence and abundance of senile plaques of P-amyloid protein (Ap) 
aggregates are one of the earliest and most relevant pathological features of 
Alzheimer’s disease and provide the basis for definitive diagnosis of the disease2. 
Ap plaques in particular have provided a focus for the development of potential 
molecular diagnostic tools for early detection of the disease and also to identify 
those patients at risk from the disease. At present there are numerous groups 
developing radiolabelled small molecules for possible detection of p-amyloid 
plaques and tangles through non-invasive imaging techniques. The majority of the 
developmental work has focused on using positron emission tomography (PET), 
single photon emission computed tomography (SPECT) or magnetic resonance 
imaging spectroscopy (MRI)3,4. The most successful radiotracers to date have been 
small molecules which display optimal in vivo pharmacokinetics for crossing the 
blood-brain barrier. Neutral and lipophillic derivatives are needed to achieve 
sufficient quantities o f the radiotracer in the brain for subsequent PET or SPECT 
images5,6.
Among the potential radiolabelled small molecules being developed for PET and 
SPECT imaging, 2-arylbenzothiazoles have shown great potential as imaging 
agents. One important discovery was a series of n C labelled 6-substituted 2-(4- 
aminophenyl)benzothiazoles that showed high affinity for aggregated amyloid and 
more importantly also showed high in vivo brain entry and rapid clearance from 
normal brain tissue7. The lead compound from this series [n C]6-OH-BTA-l 
otherwise known as PiB, 3, became the first compound of its class to enter clinical 
evaluation for the detection of Alzheimer’s disease8,9.
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Figure 2: PiB
Results of the first human studies for 3 found that it was retained in areas of the 
brain that are known to contain high levels of amyloid plaques and at present there 
are at least seventeen sites in North America and three in Europe that have 
successfully used 3 in patients with neurodegenerative diseases10. Further studies 
on 3 suggested brain uptake was controlled by the metabolic stability of the 
compound. It was found that the introduction of a 5-fluoro and either a 3’-methyl, 
or a 3’-chloro significantly increased the metabolic stability o f the compound and 
thus led to a higher brain uptake but also gave a faster clearance than predicted 
from their log P values1 *.
Although 3 showed promising clinical results one of its downfalls is its short 
radioactive half-life (20.4 min for nC). This necessitates the need for an onsite 
cyclotron and rapid synthesis of the tracer. Due to these constraints there is a vast 
amount of interest in developing alterative radionucleotides for PET imaging. 18F 
is one of the possible choices and is an ideal choice as the positron-emitting 
isotope due to a half-life o f 109.8 min. This strikes a balance between enough time 
to allow synthesis o f the radiotracer whilst limiting radioactive exposure for the 
patient.
[18F] 2-[4’-(2-fluoroethyl)aminophenyl]-6-hydroxybenzothiazole (FBTA), 
4, is the closest fluorine labelled structural analogue of 3 and binding affinity of 
FBTA for Ap plaques was shown to be higher than 3 12. Similarly 2-(4’- 
[l8F]fluorophenyl)-l,3-t>enzothiazole, 5, a structural analogue o f 3, showed 
comparable in vitro binding affinity which was assumed to be to the same site in 
the Ap plaques. Lipophilicity of the compound was within the optimal range (log 
P between 1 and 3) for passive diffusion through the blood-brain barrier (BBB)
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and showed a high initial brain uptake in normal mice followed by a brain washout 
more than two times faster than that observed for 3 13. Supplementary studies on 2- 
(4’-[18F]fluorophenyl)benzothiazole analogues showed that introduction of a 6- 
methyl group on the phenyl ring 6, gave a further increase in initial brain uptake 
and a brain washout four times that of 3, thus preliminary results showed that these 
are strong candidates for P-amyloid plaque imaging14. Although preclinical studies 
of 6 were promising, it showed poor results in a clinical study. This was thought to 
be due to its higher non-specific binding and its slower kinetics in comparison 
with PiB.
Three further fluorinated PiB analogues have shown higher binding affinity to p- 
amyloid in the AD human brain than PiB and have shown the potential to be 
developed as probes for detecting P-amyloid plaques in Alzheimer’s disease. In 
particular one of these compounds 2-(4’-(methylamino)phenyl)-6- 
fluorobenzothiazole (F-N-Me), 7, can bind to either P-amyloid plaques or 
neurofibrilliary tangles15.
18f
6 7
Figure 3: FBTA, 2-(4’-(l8F]fluorophenyl)benzothiazole, 6-methyl-(4’ 
[18F]fluorophenyl)benzothiazole and F-N-Me
Further series of 18F-labeled 2-phenylbenzothiazoles have been developed. These 
compounds contain a fluorine-18 label directly attached to the 2-phenyl ring and a
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(methyl substituted) amino group on the benzothiazole part. It is thought that the 
electron donating characteristic of the amino substituents contribute significantly 
to specific in vivo binding to amyloid and it is thought that this may increase the 
compounds binding affinity by introducing a positive electrostatic interaction 
around the sulphur atom of the phenylbenothiazole and thus have advantages over
1 fipreviously synthesised F-labeled 2-phenylbenzothiazoles. The most promising 
compound from the series was 6-amino-2-(4,-[18F]fluorophenyl)benzothiazole, 8, 
which in healthy mice showed four times more brain uptake than 3 16.
\  //
8
Figure 4: 6-Amino-2-(4'-[>8F]fluorophenyl)benzothiazole
A series of highly conjugated stilbenylbenzothiazole and stilbenylbenzoxazole, 9, 
derivatives were synthesised and evaluated in an in vitro competition binding 
assay. The compounds showed excellent binding affinities to Ap aggregates and in 
particular a 5-fluoroethyl substituted benzothiazole showed the highest binding 
affinity17.
R, = 5-0(CH2)2F 
6-0(CH2)2F
X = S or O R2 = NH2
NH(CH3)
N(CH3)2
Figure 5: Highly conjugated stilbenzothiazole and stilbenzoxazole
A series of dibenzothiazoles were also synthesised as possible amyloid imaging 
agents. These new possible imaging agents had optimum log P values for brain 
uptake. In vivo binding studies showed that these new compounds bound to the 
same site as PiB with high binding affinities in the range of 6.8-36 nM. A SAR
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analysis of the new series also demonstrated that compounds with electron 
donating groups lead to compounds with a higher binding affinity. The lead 
compound, 10, unlike PiB was labelled with l25i 18.
1251
10
Figure 6: Lead dibenzothiazole
From the foregoing it is apparent that the vast majority of research on imaging 
agents for Alzheimer’s disease has been dominated by PET and the related SPECT 
technique is lagging behind. This is especially the case for the " mTc-labeled 
radioactive probes which are hindered due to low brain uptake. " mTc is the most 
widely used radionucleotide for SPECT because of its favourable physical 
properties; it has a half-life of six hours, a low cost and widespread availability. A 
recent paper has reported the synthesis of 2-(4-aminophenyl)benzothiazole 
conjugated with a monoamine-monoamide (MAMA) and labelled with " mTc 
(99mTc-MAMA-BTA), 11, for use in SPECT as a potential tracer for visualisation 
of P-amyloid plaques. The complex was found to pass the BBB, as well as having 
a high initial uptake and a medium washout19.
M = 99mT c
11
Figure 7: 99mTc-MAMA-BTA complex
Another readily used radionucleotide for SPECT is 123I which has a half-life of 13 
h. Two neutral benzothiazoles, 2-[4’-(dimethylamino)phenyl]-6-iodobenzothiazole 
(TZDM), 12, and 2-[4’-(4” -methylpiperazin-l-yl)phenyl]-6-iodobenzothiazole 
(TZPI), 13, were developed as potential imaging agents. To test their binding to
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aggregates in human brain, a post-mortem Down’s syndrome brain was used. This 
was chosen since patients with Down’s syndrome invariably develop 
neuropathological changes characteristic of Alzheimer’s Disease and these
amyloid. The labelling of plaques with these compounds resulted in an excellent 
visualisation of the amyloid plaques aggregates. Biodistribution studies also 
showed that they had excellent brain uptake and retention20.
Figure 8: TZDM and TZPI
Radioiodinated variants of 3 have also been developed for potential SPECT 
imaging. Because iodine is a bulky element with low electronegativity, 
introduction of an aromatic iodo group normally increases the lipophilicity, thus 
altering in vitro and in vivo properties of the parent compound. The lead 
compound for the synthesised series is 2-(3’-iodo-4’-methylaminophenyl)-6- 
hydroxybenzothiazole (IMPY), 14. This compound is advantageous in that it can 
be n C labelled on the 4 ’-position for use as a PET tracer or 123I labelled on the 3’- 
position for use as a SPECT tracer. Other than the position and nature of the 
nucleotide the PET/SPECT tracer is chemically identical and thus directly 
comparable across modalities. The advantage of PET/SPECT tracer over a single 
tracer lies in the potential to combine the quantative ability of PET with the 
clinical utility o f SPECT. In vitro tests showed that the compounds displayed high 
binding affinity for P-amyloid fibrils and that 125I bound selectively to amyloid
changes begin with the deposition of senile plaques containing predominately p~
12
N
/ ~ ~ A
N  CH3
13
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deposits. In addition n C readily entered the brain. However there was relatively
slow clearance which suggests non-specific binding in the absence of amyloid 
deposits21.
Figure 9: IMPY
As can be seen from the above discussion there is now a wide range of 2- 
arylbenzothiazoles that are being tested for use as either PET or SPECT imaging 
agents. Because the main limiting factor for these imaging techniques is the short 
half-life of the radioisotopes, it is of utmost importance and has become a subject 
of worldwide interest to develop rapid methods for their synthesis. The simplicity 
of their structure, yet the lack of adequate methods for their preparation, is one of 
the issues that will be addressed in this thesis.
1.3 Benzothiazoles in Cancer
Cancer, the uncontrolled growth of cells, is a major cause of death throughout the 
world. In 2007 it accounted for almost 7,900,000 deaths22 and in the UK alone 
more than a quarter of a million people every year are diagnosed with cancer and 
more than one hundred and fifty thousand people die from a cancer related illness. 
O f these cases breast, lung, colorectal, and prostate cancer account for over half of 
all deaths23.
There are numerous examples of benzothiazole containing compounds in the 
literature that demonstrate anticancer activity. Of particular interest are 2- 
arylbenzothiazoles, which have shown a wide range of anticancer activity 
including but not limited to activity against ovarian, breast, lung, renal, and colon 
cancer.
nhch3
14
Chapter 1 Introduction
introduction of either, a hydroxy or methoxy substituent reduced activity, as did 
the replacement o f the amine group with a nitro group. Nonetheless an increase in 
activity was seen with the introduction of a 3’ methyl group, a compound called 
DF 203, 17, and sub-nanomolar GI50 values were obtained in MCF-7 and MDA 
468 cell lines.
Figure 11: CJM 126 and DF 203
Benzothiazole 17 was then tested against the NCI 60 cell line panel and showed a 
distinctive growth inhibitory profile. The mechanism of action of the drug was 
found to be unique, where in tumour cells that are drug sensitive, the active moiety 
binds to the aryl hydrocarbon receptor in the cytoplasm. This is then subsequently 
translated into the cell nucleus where induction of CYP1A1 results in an active 
electrophilic species. This then causes lethal damage at nucleophilic centres of 
DNA bases, and is the fundamental basis for its antitumour activity31,32,33,34. 
Unfortunately, CYP1A1 also catalyses detoxification o f 17 to 2-(4-amino-3- 
methylphenyl)-6-hydroxy benzothiazole 60H 203, 18. The production of this 
metabolite confers an inability of 17 to induce growth inhibition in tumour cells. A 
fluorination strategy was then devised to thwart this deactivation mechanism.
There are many literature examples of the isosteric replacement of a hydrogen 
atom with a fluorine atom to prevent the undesirable hydroxylation of bioactive 
substances35,36. A series of mono and di-fluorinated analogues of 17 were therefore 
synthesised to try to overcome the undesirable hydroxylation to 1837. It was 
subsequently found that 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole 5F 
203, 19, gave superior selectivity and potency against the NCI 60 cell line panel
• 38with negligible amounts of the inactive hydroxylated metabolites forming .
16 17
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18 19
Figure 12: 60H  203 and 5F 203
Regrettably, 19, has highly lipophilic and poor water solubility properties which 
cause a problem in the clinic setting. For these reason water-soluble prodrugs of 19 
was synthesised39. Lysyl amide acid prodrugs were chosen as the most suitable 
prodrug as they have good aqueous solubility and are chemically stable, i.e. there 
is no hydrolysis of the amide bond in the absence of cells40. The prodrug named 
Phortress 15, is now in clinical trials and shows potent in vitro and in vivo 
anticancer activity against ovarian and breast cancer41.
Following the success of 15 there was a surge of interest in the synthesis of 2- 
arylbenzothiazoles and their testing as potential anticancer agents. Below is a 
summary of those 2-arylbenzothiazoles that have shown the most promise.
A series of structurally related 2-(4-aminophenyl) benzothiazoles substituted in the 
3-position of the phenyl ring by cyano- or alkynyl substituents (20, 21), and 
fluorinated analogues thereof were synthesised and evaluated. In vitro screening 
showed that several of the analogues and most notably the 5-fluorinated 
compounds possess potent activity against MCF-7 and MDA 468 human cancer 
cell lines42.
- 12-
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Of the large number of antitumour agents in development, the most advanced 2- 
arylbenzothiazole antitumour agent is Phortress, 15, a 2-(4- 
aminophenyl)benzothiazole derivative that is currently progressing through Phase 
1 clinical study.
(CH2)4 NH2
15
Figure 10: Phortress
The discovery of this new antitumour class of drug is intriguing as it was found 
through a “Chemistry Driven” approach to drug design when the now accepted 
norm is “Target Driven” therapy24,25,26. Here the drug discovery process begins 
with a novel class o f compounds or scaffolds and lead selection is based on disease 
relevant changes in the cellular environment in vitro or in vivo which are induced 
by exposure to the lead compound27. Advantages of this approach are that they are 
based on novel chemical structures with dmg like properties28, and the drug 
discovery process is not biased towards a specific target, this reduces the risk of a 
competitor producing a similar dmg. Dmg molecules can then be screened against 
the NCI 60 cell-line panel or related screening system29. This screen can be used to 
show phenotypic responses to an array of chemical agents to produce a 
characteristic fingerprint of activity. This can then be compared to over 600,000 
compounds on the NCI database to reveal remarkable insights into potential target. 
The development o f the antitumour clinical candidate, 15 originated from the 
synthesis of a series of 2-arylbenzothiazoles. In vitro testing of the series showed 
that 2-(4-aminophenyl)benzothiazole, CJM 126, 16, exhibited selective activity 
against MCF-7 breast carcinoma cells, with an unusual biphasic dose response for 
the growth inhibition30. Resulting from the activity of 16 in vitro, a SAR analysis 
was carried out. This study showed that the benzothiazole core was essential for 
activity and that related heterocycles were significantly less active. The solitary
- 10-
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H
R
CN
<
R = H, 4F, 5F, 6F R = H, 4F, 5F, 6F
20 21
Figure 13: Substituted-(3’ cyano, 4’aminophenyl)benzothiazole and substituted-(3’ alkynyl, 
4’aminophenyl)benzothiazole
A further series of 2-arylbenzothiazoles have been synthesised and tested for their 
anticancer activity. 2-(Substituted-phenyl)-6-aminobenzothiazoles, 22, were 
synthesised as their hydrochloric salts and tested for their anticancer activity 
against a number of cell lines including cervical (HeLa), breast (MCF-7), and 
colon (CaCo-2) cancer, laryngeal carcinoma (Hep-2) and normal human fibroblast 
cell lines (WI-38). All benzothiazoles tested exhibited moderate antitumour 
activity with IC50 values ranging from 9x1 O'6 to 4x1 O'3 M with the most sensitive 
cells being HEP-2 and MCF-7. In agreement with previous groups results, here 
they also found that fluoro substituted benzothiazoles were more active43.
Figure 14: 2-(substituted-phenyl)-6-aminobenzothiazoles
A series of 2-arylbenzothiazoles bearing oxygenated substituents in the phenyl 
ring was also synthesised and tested in vitro. The lead compound was 5-fluoro-2- 
(3’,4’-dimethoxyphenyl)benzothiazole, (PMX 610), 23, and showed GI50 values 
<0.1 nM against two breast cell lines (MCF-7 and MDA 468). Minor structural 
changes to the methoxy groups had a deactivating effect and unlike 19 the non- 
fluorinated 2-(3’,4’-dimethoxyphenyl)benzothiazole was devoid of activity. 
Results from the NCI 60 Cancer Cell Line Panel confirmed these results and 23 
showed exquisite activity in the colon and NSCLC subpanels. GI50 values <10 nM
R = 2-NH2, 3-NH2, 4-NH2, 4-NMe2, 3-F, 4-F
22
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for 23 were reached in cell lines such as HCC 2998 colon and leukemia SR lines. 
Clear mechanistic differences are apparent between 23 and 19 and work is ongoing 
to establish a mechanism of action for this compound44.
Figure 15: PMX 610
A series o f phenolic 2-arylbenzothiazoles bearing substituents in the heterocycle 
moiety and one or more oxygen substituents in the 2-aryl fragment, 24, have also 
been synthesised and evaluated for their possible anticancer activity. Although it 
was reported above that demethylation of one or more of the methoxy groups of 23 
resulted in less active compounds, the activity of monohydroxylated 2- 
phenylbenozthiazoles bearing fluorine or related substituents on the benzothiazole 
ring was explored. The compounds were tested against MCF-7 and MDA 468 cell 
lines and were found to be more active against the ER -ve breast cancer cell line 
MDA 468, giving GI50 values at submicromolar level. However none of the new 
series showed activity equivalent to the potent antitumour properties of 2345.
Figure 16: Phenolic 2-arylbenzothiazoles
As can be seen from the preceding section, the simple 2-arylbenzothiazole scaffold 
has shown immense promise as a therapeutic agent. It is striking how such a 
simple scaffold can produce possible drug candidates from minor functional group 
changes to its core. It is therefore understandable as to why it has attracted 
tremendous attention in the field of medicinal chemistry. Although there is vast 
interest in these structures, their synthetic accessibility is limited by a number of
OMe
23
R = 5F, 5CF3, 6-F, 6-C1, 6-Br, 6-Et, 
6-OMe, 6-OEt, 6-S02Me 
R' = 3-OH, 4-OH
24
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factors and there still exists a need for improvement and simplification of the 
existing methods for their synthesis. In the subsequent chapters the shortcomings 
in synthesis of the 2-arylbenzothiazole scaffold will be discussed and methods will 
be proposed to overcome these issues.
1.4 Miscellaneous Benzothiazole Therapeutic Areas
As is apparent from the forgoing section, the major therapeutic focus of 
benzothiazoles has been as potential anticancer agents or in non-invasive imaging 
of Alzheimer’s disease. However there are a number of groups whom have looked 
at other therapeutic areas where the benzothiazole core has shown potential, one of 
which being for imaging cerebral ischemia.
Stroke is the third highest cause of death and one of the leading causes of 
disability among adults46. Markers for stroke ischemia are limited because of the 
difficulty in passing the BBB and their retention in cerebral ischemia. An analogue 
of PiB conjugated to a 2-nitroimidazole which is known to have selective 
accumulation in ischemic tissue has recently been developed. This compound 
named 2NUBTA, 25, has undergone in vitro tests which showed that it has the 
capability of crossing the BBB and evaluation using gerbil stroke models suggest 
it may be a possible cerebral ischemia marker for stroke47.
(CH2)10
25
Figure 17: 2NUBTA
The mentioned therapeutic areas for 2-arylbenzothiazoles above are not an 
exhaustive list o f their potential biological uses but compromises the areas that are 
most prominent in the literature.
- 15-
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Chapter 2 Unsubstituted Benzothiazoles
2 Solution Phase Synthesis of Unsubstituted 2- 
Aryl Benzothiazoles
As discussed in the preceding chapter, certain simple 2-arylbenzothiazoles have 
been shown to have exquisite anticancer activity and also great promise as 
potential imaging agents for Alzheimer’s disease. These activities do not represent 
all of their biological activity and currently there is intense biological interest in 
this family of compounds. It is as a result of their biological activity that new 
synthetic strategies are being devised and reported in the literature on a regular 
basis. Although there is great interest in their synthesis, the majority of synthetic 
procedures refer to the synthesis of those 2 -arylbenzothiazoles unsubstituted in the 
benzothiazole ring, 26, and since compounds with the most interesting biological 
activity are often substituted on the benzothiazole ring, 27, there is a need for 
further synthetic development in this area. Furthermore, there are a number of 
drawbacks from the reported methods of synthesis such as: the use of harsh 
reaction conditions or toxic reagents, catalysts, and solvents; long reaction times 
with high temperatures; tedious workup and low yields. Therefore, it was felt that 
there is an urgent need to overcome these limitations by developing an efficient 
and convenient methodology for their synthesis.
26 27
Figure 18: 2-arylbenzothiazole unsubstituted/substituted in the benzothiazole ring
In the subsequent chapters, a review of the various most popular synthetic routes 
to 26 and 27 using either thermal, microwave, solution or solid phase conditions 
will be described. The shortcomings of these synthetic methodologies will be 
discussed and new synthetic methodologies will be proposed.
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2.1 Literature Methods of Synthesis
2.1.1 Using Carboxylic Acids and their derivatives
2.1.1.1 Thermal Methods
One of the earliest examples of the synthesis of 26 and perhaps still the most 
valuable method for their synthesis today involves the condensation of an ortho- 
aminothiophenol with a benzoic acid or related derivative. Here 2- 
aminothiophenols such as 28, condense with a benzoic acid (29) or a related 
derivative by heating in a high boiling solvent to yield 2 -arylbenzothiazoles 
substituted on the phenyl ring, 267,11,38. 2 -aminothiophenols 28 are oxygen 
sensitive and can form derivatives such as acid salts, alkaline salts, or disulfides. 
This lability limits their general application in benzothiazole-forming reactions, 
especially in the case of substituted 2 -aminothiophenols.
28 29 26
Scheme 1: Synthesis of 2-arylbenzothiazoles from 2-aminothiophenol and benzoic acids
Alternatively, the benzoic or carboxylic acid can be converted to its corresponding 
acyl chloride (usually in situ) under acidic conditions (e.g. thionyl chloride48 or 
polyphosphoric acid30) before reacting with 28 in a basic solvent such as refluxing 
N,N-dimethylaniline/monochlorobenzene17 or N-methyl-pyrollidinone 
(NMP)49,50,51. In these cases, the intermediate will be o-acylaminothiophenols. In 
addition, ionic liquids have been found to promote room temperature formation of 
2652.
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2.1.1.2 Microwave Methods
More recently the microwave-promoted synthesis of a range of benzothiazoles
from 28 and benzoic acid (derivatives) under solvent-free conditions53 and 
promoted by Lawesson’s reagent54 has been described.
2.1.2 Using Aldehydes
2.1.2.1 Thermal Methods without Internal Oxidant
In either acidic or basic medium alkyl-, or aryl aldehydes will condense with 2-
aminothiophenol, 28, to give 2-substituted benzothiazoles. The reaction proceeds 
by the initial formation of the Schiff base 30 which cyclises to give a dihydro 
intermediate 31 which on dehydration yields the corresponding 2-substituted 
benzothiazole 32.
32 31
Scheme 2: Synthesis of 2-substituted benzothiazoles from 2-aminothiophenoI and aldehydes.
For example, the formation of 2-(4-hydroxy-3-methoxyphenyl)benzothiazole from 
28 and 4-hydroxy-3-methoxybenzaldehyde was found to proceed under neutral 
conditions in refluxing toluene55. Similarly, the synthesis of substituted 2- 
arylbenzothiazoles was reported via the condensation of 2 -aminothiophenol with
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substituted aryl aldehydes in hot dimethylsulfoxide (DMSO) 56,57,58 or ethanol44,59. 
Methods for the formation of 26 catalysed by acids such as: /?-toluenesulfonic 
acid58,60, chlorotrimethylsilane61, acetic acid62, trichloroisocyanuric acid (TCCA) 63 
have been reported. Formation of compound 26 can also be catalysed by silica gel 
supported sodium hydrogen sulfate64, cetyltrimethyl ammonium bromide 
(CTAB)65, copper catalysed cyclisation of 2-bromothiobenzamide using CuI/1,10- 
phenanthroline66, and the iridium complex [Cp*Irl2]2 (SCRAM catalyst)67. All 
these methods do not require any further oxidant in the system and it seems that air 
oxidation is sufficient.
2.1.2.2 Thermal Method with Internal Oxidant
In certain cases the final step of oxidation is not spontaneous and assistance by an
internal oxidant is required. A number of oxidants have been used to enable the 
complete conversion of 31 to 32. For example, this was achieved using activated 
carbon68 or scandium triflate under an oxygen atmosphere69,70, iodine71, bakers 
yeast in non-aqueous medium72, HTP/ZrP73, cerium (IV) ammonium nitrate 
(CAN)74, H2C>2/Fe(NC)3)375 and hydrogen peroxide/ceric ammonium nitrate under
7 f\solvent-free conditions .
2.1.2.3 Microwave Methods
With the advances of microwave technology and the production of dedicated
microwave reactors for synthesis, there has been a surge in the number of reported 
microwave-promoted approaches to the synthesis of 32. Microwave-based 
methods include direct condensation under solvent-free conditions either in the 
absence of catalyst77 or catalysed by iodine78. Solid-state based methods on 
silica79,80, p-toluenesulfonic acid/graphite81, Zr0 Cl2.8 H2 0 /CuS0 4  and anhydrous 
copper sulfate82, and montmorillonite K 10/nitrobenzene83 have been reported. The 
ionic liquid [pmlmJBr has also been reported to catalyse synthesis of 32 under 
microwave irradiation84.
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2.1.3 Using Esters
2.1.3.1 Thermal Methods
The synthesis of 26 has been reported by the treatment of phenolic ester, 33, with
2 -aminothiophenol, 28, in the presence of a catalytic amount of base.
x y
28 33 26
Scheme 3: Synthesis of 2-substituted benzothiazoles from phenolic esters
This method is of particular interest as the use of catalytic K2CO3 makes the 
reaction operative under mild conditions and therefore is suitable for acid and base 
sensitive substrates85. Synthesis of 2-alkylbenzothiazoles has also been reported 
from orthoesters in the presence of catalytic amounts of Zr0 Cl2.8 H2 0  under 
solvent free conditions86.
2.1.3.2 Microwave Methods
The synthesis of 32 under microwave promoted solvent-free reactions from
aromatic or aliphatic beta-keto esters has also been reported in excellent yield87.
2.1.4 via Thioamide Cyclization
Another important method for the synthesis of 26 is the Jacobson cyclisation
reaction of thiobenzanilides under basic conditions. An example of this is shown
30 88in the preparation of the 2-(4-aminophenyl)benzothiazole antitumour agents ’ . 
Here, thiobenzanilides, 34, (which are prepared from the corresponding amides by 
sulfurisation) are cyclised in basic medium by potassium ferricyanide to the 
corresponding 2 -arylbenzothiazoles, 26.
. A r
k 2c o 3
5mol%  ►
NMP, 100°C
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K3Fc(C N )6 
 >
N aO H (aq)
34
Scheme4: The thiobenzanilide synthesis of 2-arylbenzothiazoles
\ /R
26
Silica gel supported pyridinium chlorochromate (PCC) has also been used as an 
effective oxidant for the oxidative cyclisation of thiophenolic Schiff bases to the 
corresponding 2 -arylbenzothiazole89.
Although potassium ferricyanide is the most widely used agent in this cyclisation 
reaction, a range of other reaction conditions have been reported under 
basic/oxidising conditions. As these mainly refer to the synthesis of 27, they will 
be discussed later.
2.1.5 via Carbon-Carbon Bond Forming
A number of transition metal-catalysed carbon-carbon bond forming reactions 
between the C-2 of benzothiazole and leaving group-containing aryl rings (Ar-X) 
have been reported.
2.1.5.1 via Palladium-Catalysed Coupling of Grignard Reagents 
(Kumada-Tamao-Coriu Reaction)
A simple and versatile Kumada-Tamao-Coriu cross coupling reaction between 2- 
halobenzothiazole 35 and a range of arylmagnesium bromides catalysed by 
PEPPSI (pyridine, enhanced, precatalyst, preparation, stabilization and initiation) 
pre-catalysts to give 26 has been reported90.
PE PPSI-IPr
2mol%
X = C l, Br
35 26
Scheme 5: Kumada-Tamao-Coriu cross-coupling reaction catalysed by PEPPSI-IPr
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Alternatively, the synthesis of 26 can be performed by the milder coupling of 2- 
chlorobenzothiazole with phenylmagnesium chloride under manganese chloride 
catalysed conditions91.
2.1.5.2 via Palladium-Catalysed Suzuki-Miyaura Coupling
The synthesis of 26 can also be achieved by the reaction of arylboronate esters or
the corresponding arylboronic acids via palladium catalysed coupling with 2 - 
bromobenzothiazole92. The palladium-catalysed, base-free coupling of arylboronic 
acids has been extended to cross-coupling with benzothiazole-2 -thioether, 
mediated by copper (I) thiophene-2-carboxylate93.
2.1.5.3 via Stille-Type Coupling
The palladium-catalysed, copper-mediated cross-coupling of benzothiazole-2-
thioether with aryl stannanes to give 26 in good yields provides an interesting 
further dimension to the application of C-C bond forming reactions to 
benzothiazole systems94.
2.2 Thermal Synthesis of Unsubstituted Protected 
Benzothiazoles
In this study preliminary work was focused on optimising reaction conditions for 
the synthesis of 26. Due to their wide availability and numerous documented 
procedures, it was decided to use benzaldehydes as substrates in the reactions. 
Once a reliable route to 26 was found a comparison between thermal and 
microwave methods was sought and a library of 2 -arylbenzothiazoles synthesised. 
This new methodology will then be applied to benzothiazoles that are substituted 
in the benzothiazole ring, 27 as these show the most biological promise.
2.2.1 Finding a Suitable Protecting group
4-hydroxybenzaldehyde was used as the initial condensation partner to 28 during
method development. However, due to their nucleophilicity and therefore their 
potential involvement in numerous transformations a suitable phenol protecting 
group was sought. -
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A good protecting group should have the following characteristics; (i) simple to 
put on (ii) stable to the reaction conditions, and (iii) easily removed at the end of 
reaction in good yield. There are many known protecting groups of 
hydroxyl/phenol functionalities including cyclic acetals and ketals, cyclic ortho 
esters, silyl derivatives, and cyclic carbonates95,96.
Of the various hydroxy protecting groups, silyl and methoxy benzyl alcohols were 
studied. 4-Hydroxybenzaldehyde was successfully protected using both 
triisopropylsilane, 36, and para-methoxy benzyl bromide, 37, Scheme 6.
TIPS H
36
PM B
H
'OMe
37
Scheme 6: Protection of 4-hydroxybenzaldehyde with TIPS and PMB
In the case of TIPS, two synthetic routes were studied for the phenol protection. 
The first route (Method A) used trifluoromethanesulfonic acid. This was added to 
TIPS at 0 °C, allowed to stir at RT overnight after which time benzaldehyde, and 
2,6-lutidine in dry DCM were added. The reaction was complete after 2 h, and on 
purification gave the protected benzaldehyde in excellent yield97,98. Unfortunately, 
a disadvantage found with this procedure was that the acid 
(trifluoromethanesulfonic acid) is hygroscopic and once the acid comes in contact
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with air it has intense fuming leading to loss of reagent, hindering effective long­
term storage of the substance. For this reason, a second route (Method B) that 
involved less harsh conditions was tested. As an alternative to using a strong acid, 
the activated triisopropylsilyl chloride (TIPS-C1) was used. This enabled 
electrophilic substitution on the benzaldehyde ring with greater ease. In this 
instance, the TIPS-C1 was reacted with the benzaldehyde and imidazole in DMF at 
RT overnight". Purification for this method was minimal and involved an acidic 
wash to remove impurities. A benefit from using TIPS as a protecting group is that 
it can be readily cleaved with reagents such as tetrabutylammonium fluoride 
(TBAF) 100 at the final stage of synthesis. Results for both methods are shown 
below, Table 1. Although the reactions with TIPS worked well, another protecting 
group was studied in case of complications in further synthetic steps.
Para-methoxy benzyl bromine (PMB-Br) was chosen due to the robustness of its 
ether linkage to basic, nucleophilic, and mildly acidic conditions and its selectivity 
of protection of one alcohol over another on the same ring101,102. Deprotection of 
the PMB group can be accomplished under oxidative, reductive, or acidic 
conditions95.
The reaction between PMB-Br and 4-hydroxybenzaldehyde was found to work 
well, but it was established that a freshly prepared sample of PMB-Br (from p- 
methoxybenzyl alcohol and phosphorus tribromide103,104) gave purer products, 
Table 1. This was mainly due to the fact that the commercial sample is not 
sufficiently pure and contains 4-methoxy benzaldehyde which is found as a 
contaminant in the final product of the reaction.
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Table 1: Reaction times and yield for protection of 4-hydroxybenzaldehyde
Protecting Group 
(Method)
Product Time (h) Yield (%)
TIPS(A) 36 19 91
TIPS (B) 36 Overnight 60
PMB 37 4 77
Method A — TIPS, trifluoromethanesulfonic acid, 2,6-lutidine, and dry DCM  
Method B= TIPS-Cl, imidazole, DMF
After successful protection of 4-hydroxybenzaldehyde with PMB-Br, a number of 
different benzaldehydes were treated with PMB-Br to test the robustness of the 
reaction. Three further benzaldehydes were tested and results showed that after 
recrystalisation from ethanol pure product was obtained in relatively good yields. 
The results are illustrated below, Table 2.
Table 2: Various benzaldehydes protected with PMB
Starting Material Product Yield (%)
2 -hydroxy-5-methyl benzaldehyde 38 54
2-hydroxy-3-methylbenzaldehyde 39 54
3-hydroxy benzaldehyde 40 46
At this stage both the TIPS and PMB protected benzaldehydes were used as 
starting material for the synthesis of 26.
2.2.2 Ethanol Reaction
As stated above, there are numerous methods for synthesising 2-
arylbenzothiazoles unsubstituted in the benzothiazole ring, 26, from aldehydes. 
The simplest method is to reflux the corresponding benzaldehyde and 28 in 
ethanol, followed by recrystalisation from ethanol to give the desired product44.
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On attempt of this reaction with either a TIPS (*) or PMB (y) protected 4-hydroxy
benzaldehyde after prolonged reaction times, a mixture of the expected product 42
and intermediate 41 were found, Scheme 7, with the intermediate being in excess.
o
N , = v
x = TIPS, 43% yield 
y  = PMB, 49% yield
41
x = TIPS, 29% yield 
y  = PMB, 25% yield
42
Scheme 7: Mixture of products obtained from reaction using ethanol
A gradient column was necessary for purification and acquisition of low yields for 
42 were obtained, Table 3.
Table 3: Yield of protected benzothiazoles after reaction with ethanol
Protecting G roup Product Yield (%)
Triisopropylsilyl 42a 29
/?-methoxybenzyloxy 42b 25
Although the reaction did yield the desired product (in low yields), as the aim of 
this work is to synthesise a library of 2 -arylbenzothiazoles with minimal 
purification, it was decided to abandon this methodology and find a more suitable 
reaction that requires little purification.
Ethanol
Reflux
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i Me
H
38
MeO
50 mol% 1 ^  
DMF, 100°C, 3h
47% Yield
40% Yield
45
Scheme 10: Synthesis of 2-(2-methoxy-benzyloxy)-5-methyIbenzaldehyde with iodine
The yields of the various protected benzaldehydes that were reacted with iodine 
are given below, Table 4.
Protecting Reagent Products Yield (%)
4-triisopropylsilanyloxybenzaldehyde 42a 0
4-(4-methoxybenzyloxy)benzaldehyde 42b 57
2-(4-methoxybenzyloxy)-5-methylbenzaldehyde 44 47
The conclusion that was drawn from these results is that iodine does sufficiently 
oxidise the dihydro intermediate to the desired product, however a competing 
reaction is observed whereby the protecting group is cleaved. Furthermore, there 
appears to be a time dependence for the removal of the protecting group which is 
affected by the substituents on the ring. Although it is advantageous to have a 
reagent that both oxidises the reaction and cleaves the protecting group in one step
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at this point, it was decided to look at other potential oxidising agents where the 
reaction proceeds uniformly for all substrates.
2.2.4 Sodium Metabisulfite Reaction
On searching for a suitable internal oxidant that sufficiently oxidises the 
intermediate to 26 that does not involve a multi-step synthesis our attention turned 
to a number of reports on the synthesis of the related benzimidazole. There are 
numerous documented procedures for the synthesis of benzimidazole from 
aldehydes and o-phenylenedamine106. Taking inspiration from one such paper that 
used sodium metabisulfite as oxidant107,108 it was decided to test the feasibility of 
using this mild oxidant in the synthesis of 26.
The reaction was initially tested between 37 and 28 using an equimolar amount of 
sodium metabisulfite (Na2S2 0 s) with the polar aprotic DMF as solvent. Results 
were pleasing as the reaction was complete in a short time, with recrystalisation as 
purification method and a yield of 60% of the desired product, 42b, Scheme 11.
MeO
Na2 S2O5
28 37 42b
Scheme 11: Synthesis of 2-[4-(4-methoxy-benzyloxy)-phenyl]-benzothiazole using sodium 
metabisulfite
To ensure the robustness of the reaction it was undertaken with the other 
previously synthesised protected benzaldehydes. Under the same conditions, 
relatively good yields and short reaction times were obtained, Table 5.
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2.2.3 Iodine Reaction
As is the case with a number of synthetic methodologies for 26 (and as was found
in the ethanol reaction above), oxidation of the dihydro intermediate is not always 
spontaneous and where air oxidation is not sufficient an internal oxidant is 
required. Therefore, the logical progression for this work was to find a suitable 
oxidant that might enable the formation of 26 over the intermediate. Iodine is an 
inexpensive and readily available reagent which can be used as an effective 
oxidant and catalyst in organic synthesis. Previously, iodine has been reported to 
promote the condensation of 28 with various aldehydes71 and therefore it was 
hypothesised that iodine would effectively oxidise the intermediate 41 to 42.
The iodine reaction was initially tested with PMB protected benzaldehyde 4-(4- 
methoxybenzyloxy)benzaldehyde, 37, using 50 mol % iodine in DMF. The desired 
product, 42b, Scheme 8 , was obtained in good yield (57 %) after 1 h. Additional 
reaction time did not lead to higher yields of product.
MeO
50 mol%
DMF, 100°C, lh
57% Yield
37 42b
Scheme 8: Synthesis of 2-[4-methoxy-benzyIoxy-phenyl]-benzothiazole using iodine in DMF
However, although initial results with iodine looked promising when the reaction 
was carried out with the TIPS protection benzaldehyde, 36, results were not as 
expected. After 40 min the reaction clearly showed only one spot by TLC analysis, 
however on isolation of product and analysis of the NMR data it was found that 
this spot did not correspond to the expected product 42a, but to the unprotected 
benzothiazole 43, Scheme 9.
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o
.Si
>
42a
50mol% I2 DMF, 100°C, 40min
V
OH
75% Yield
43
Scheme 9: Unexpected product of TIPS and Iodine reaction
TIPS is reported to be stable to elemental U105 and although the bulkiness of the 
TIPS group makes it more stable than other silyl groups, in this instance h  appears 
to have the capacity to both oxidise the reaction and to remove the protecting 
group through oxidation. Which is advantageous as oxidising the dihydro 
intermediate and cleaving the protecting group occurs in one step.
When the reaction was first undertaken with PMB, the protecting group was stable 
to the reaction conditions and not removed by h. However when the reaction was 
tested with another PMB protected benzaldehyde the results showed that the PMB 
group was also susceptible to oxidation by U. In the case of 2-(4- 
methoxybenzyloxy)-5-methylbenzaldehyde, 38, after 3 h two spots were detected 
by TLC. On purification and analysis, the spots were found to corresponded to the 
expected product 44 and the cleaved protecting group 45, Scheme 10. Subsequent 
increase in reaction time did not lead to an excess of either 44 or 45 and column 
chromatography was necessary to isolate products after prolonged reaction times.
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operate at 2.45 GHz. In microwaves at this frequency the oscillation of the electric 
field is 4 .9 x l 0 9 times per second, which is about the same as the relaxation time 
for permanent dipoles present in the majority of molecules. This characteristic is 
responsible for the interaction between the electric field of the microwave and a 
chemical system. Irradiation of a sample at microwave frequencies results in the 
dipoles or ions aligning in the applied electric field. As the applied field oscillates, 
the dipole or ion attempts to realign itself with the alternating electric field. In this 
process energy is lost in the form of heat through either molecular friction or 
dielectric loss.
The ability o f a material to carry out this process is termed as the dissipation factor 
which is defined as tan 8  =e” /e’. Where, e”  is the dielectric loss factor, which is a 
measure o f the efficiency o f a molecule to transform the energy to heat, and e’ is 
the dielectric constant, a measure of the ability of a molecule to be polarized by an 
electric field. A reaction medium with a high tan 8  is therefore needed for efficient 
absorption and consequent rapid heating. Materials can be classed as either those 
that absorb microwaves or those that reflect them. Some materials are practically 
transparent to microwaves. Chemical reactors must be transparent to microwaves 
and are usually made o f Teflon or poly(ethylene). Listed below in Table 8  are the 
loss factors o f some common solvents117,118.
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if prior protection of the hydroxy was necessary. Surprisingly the reaction with 
either a 3- or 4-hydroxybenzaldehyde proceeded smoothly. The reaction showed 
that there was no need for prior protection of the hydroxy group to deliver pure 
product. Therefore, in future reactions there will be no protection of the hydroxy 
using either the TIPS or PMB group that was previously described, thus leading to 
a decrease in reaction sequence steps.
This reaction shows great promise as a new general method for the synthesis of 26 
as it appears to have no distinction of functional group.
2.4 Microwave Synthesis of Unsubstituted 
Benzothiazoles
High speed synthesis with microwaves has attracted a vast amount of interest in 
recent years and this is shown by the excess of three thousand articles published in 
the area since its first reports in 1986 by Gedye, and Giuere/ Majetich112,113. The 
number of publications in the field has increased dramatically owing to the 
introduction of dedicated microwave reactors which offer a safer reaction through 
on-line temperature and pressure control, more reproducible reactions, and an 
ability to demonstrate cleaner reactions with higher yields as well as significantly 
lower reaction times. Microwave synthesis is now being looked at in both 
academia and industry as a means of rapid synthesis of compounds for drug 
discovery114,115. As described earlier, there are a number of known microwave
78 79 83 84 116assisted synthesis o f benzothiazole containing compounds ’ ’ ’ ’ . I t  was 
postulated that the use of microwave irradiation in our reaction might lead to a 
reduction in reaction time, whilst also improving the yield of the reaction leading 
to a highly versatile route to 26.
2.4.1 Principles of Microwave Chemistry
Microwave radiation is electromagnetic radiation in the frequency range of 0.3 to
300 GHz while all domestic and dedicated microreactors for chemical synthesis
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Unfortunately, increasing the temperature to 120 °C resulted in a number of side 
products so reactions at this temperature were abandoned. These results therefore 
show that the use of microwave irradiation for this reaction does not lead to any 
improvement in either the reaction time or yield. As alluded to before, this was 
thought to be due to the reaction mixture being heterogeneous resulting from 
inadequate stirring in the microwave, low volumes of solvent and the inability of 
solvent to dissolve both organic and inorganic substances. This resulted in a build 
up of sodium metabisulfite at the bottom of the reaction vessel, therefore the 
intermediate was not fully oxidised leading to a mixture of products leading to low 
yields.
To investigate the possible effects of the solvent system on the reaction and to try 
to have a homogenous reaction system, it was decided to alter the solvent instead 
of abandoning the use of microwaves in this reaction. The first two solvents 
examined were toluene and ethanol, both these solvents are at extreme ends of the 
tan value system for microwave chemistry. They were chosen to see if the tan 
value o f the solvent also had an effect on the reaction rate. Results for both these 
solvents with various reaction temperatures are given below, Table 10.
Table 10: Reaction time and yield for reactions in toluene and ethanol
Solvent Tem perature (°C) Time (min) Yield (%)
Toluene (s) 70 60 50
Toluene (s) 90 30 53
Ethanol (s) 70 30 54
Ethanol (s) 90 40 61
Ethanol (s) 1 2 0 5 #
(s)sonicated
When toluene was used as solvent it gave similar solubility properties to DMF, 
while sonication was necessary and no improvement on the preceding reaction was 
found. In agreement, with the reactions using DMF as solvent, the reactions in
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toluene were found to progress at a slower rate at a lower temperature and a 
mixture of products was obtained at all temperatures. Separation by column 
chromatography or prolonged reaction time was therefore required to obtain the 
desired product in moderate yield.
Ethanol with a medium/high tan value should make it a good solvent for 
microwave use and possibly decrease the reaction time. The reaction was not 
completely homogenous after sonication but the solubility of all reagents was 
improved using ethanol and this transcribed to the reaction. A cleaner reaction was 
observed by TLC analysis. There was no presence of starting material after 5 min 
at 70 °C, and TLC analysis showed presence of both 49 and 26 1. After 30 min of 
irradiation there was still a mixture of the intermediate and final products. At 90 
°C, although there was still not full conversion to 26 1, the reaction appeared to be 
faster and a higher yield of the desired product was obtained. As with DMF, 
increasing the temperature to 120 °C resulted in formation of side products after a 
short irradiation time. These results allude to the fact that a solvent with a high tan 
value is necessary but that more importantly the reaction should be homogeneous 
for it to proceed efficiently. It was therefore decided to see if dimethylsulfoxide 
(DMSO) which has these two characteristics and was a suitable solvent for the 
reaction medium.
DMSO is widely known to be a solvent with excellent solubility proprieties and 
has been used previously in microwave chemistry due to its high boiling point, and 
good tan value. On preliminary attempts, all reagents dissolved homogeneously in 
DMSO with no sonication required. An initial temperature of 70 °C gave complete 
formation of the product, 26 1 in 2 h with 75 % yield. When the temperature was 
adjusted to 90 °C, the reaction went to completion in 25 min with a yield in excess 
of 80 %. And finally, although increasing the temperature beyond 90 °C led to no 
improvement on the reaction rate, there was no formation of side products, Table 
11 .
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Table 5: Yield and reaction times of protected benzaldehydes using sodium metabisulfite
Starting Material-Protected 
Benzaldehyde
Product Time (h) Yield
(%)
2-[4-(4-methoxy-benzyloxy)-
phenyl]benzothiazole
42b 3 60
2-[2-(4-methoxy-benzyloxy)-5-methyl-
phenyljbenzothiazole
44 3 67
2-[2-(4-methoxy-benzyloxy)-3-methyl-
phenyljbenzothiazole
46 4 67
As the reaction worked well with a variety of PMB protected benzaldehydes, it 
was therefore decided to abandon the use of TIPS protecting group in any future 
synthesis. The moderate yields for the reactions and the need for purification arose 
from residual 28 in the final product. Although this could be easily removed by a 
recrystalisation from ethanol, if the molar ratio of 28 was slightly less than the 
benzaldehyde then the reaction proceeds in higher yields with no purification.
2.2.5 Deprotection Reaction
Deprotection of both the TIPS, and PMB protecting group can be undertaken by a
number of methods95. For the deprotection of TIPS, a literature method employing 
tetra-«-butylammonium fluoride (TBAF) was employed to successfully yield 43, 
Scheme 12 in 96 % yield100.
TBAF
42a 43
Scheme 12: Deprotection of TIPS Benzothiazole
For the deprotection of PMB, the majority of literature reactions employ 2,3- 
dichloro-5,6-dicyanobenzoquinone (DDQ) as the cleavage agent109,110. This 
reaction (Method A) successfully deprotected all of the PMB protected
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Table 8: Loss factors (tan5) of common solvents
Solvent tan 6 Solvent tan 6
Ethylene glycol 1.350 DMF 0.161
Ethanol 0.941 1,2 -dichloroethane 0.127
DMSO 0.825 Water 0.123
Formic acid 0.722 Chloroform 0.091
2 -propanol 0.799 Chlorobenzene 0 .1 0 1
Methanol 0.659 Acetonitrile 0.062
Nitrobenzene 0.589 Ethyl acetate 0.059
1 -butanol 0.571 Acetone 0.054
2 -butanol 0.447 Tetrahydrofuran 0.047
1,2 -dichlorobenzene 0.280 Dichloromethane 0.042
NMP 0.275 Toluene 0.040
Acetic acid 0.174 Hexane 0 .0 2 0
The observed rate enhancement in microwave synthesis can be explained as a pure 
thermal/kinetic effect, which is a consequence of high reaction temperatures which 
are rapidly obtained by the irradiation of polar materials in a microwave field. In 
addition there is also the so called “non-specific microwave effects”. These are 
accelerations that cannot be achieved through conventional heating, for example 
the phenomenon of superheating119,120,121. It was anticipated that this rate 
enhancement could reduce reaction times for the synthesis of 26 using sodium 
metabisulfite.
2.4.2 Microwave synthesis of Unsubstituted Benzothiazoles
In order to evaluate if the reaction conditions used for the thermal synthesis
(sodium metabisulfite method) of a number of benzothiazoles unsubstituted in the 
benzothiazole ring could be transferred to microwave conditions, a single 
benzaldehyde derivate was used in the preliminary studies. For convenience, the 
benzaldehyde used for optimization of microwave reaction conditions was 4- 
bromobenzaldehyde (48), Scheme 14. This was chosen because it required the
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was not completely homogeneous and as the stirring mechanism of the microwave 
is not efficient, it is presumed that the outcome of the experiment is a result of an 
insufficient amount of the sodium metabisulfite reacting with the 2 - 
aminothiophenol and benzaldehyde in solution. It was thought that a possible 
solution to this would be to sonicate the reaction mixture prior to irradiation. It 
was anticipated that this would sufficiently homogenise the sample to allow 
adequate sodium metabisulfite to react with the reagents. A variety of temperatures 
were tested as well as sonicating the system prior to irradiation to observe the 
effect (if any) this had on the reaction rate/yield of the desired product. The results 
o f both sonication and temperature are presented in Table 9.
T em perature
(°C)
Sonication Time (min) Yield (%)
90 No 1 2 0 50
I
90 Yes 30 60
i
70 Yes 90 35 :
I
80 Yes 45 40 |
i
1 2 0 Yes 30 #
# Product not isolated
After sonication, the system was still not completely homogeneous, but TLC 
analysis after 30 min at 90 °C showed that the reaction was proceeding at a faster 
rate as only two spots were visible by TLC analysis, therefore illustrating that a 
homogeneous system has an impact on the reaction. On isolation of the mixture, 
the spots were found to correspond to 49 and 26 1.
Reducing the temperature to either 70 or 80 °C necessitated longer reaction times 
showing that the reaction is also temperature dependent. There was no starting 
material visible after 90 min at 70 °C but TLC analysis showed the presence of 
both the dihydro intermediate and product with a low isolated yield of 35 % for 26 
1. At 80 °C the reaction time was halved but the yield was still low. Prolonging the 
reaction time had little effect on improving the yield of 26 1.
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benzaldehyde, however column chromatography was necessary to obtain pure 
products. Therefore, a simplified method was sought and an interesting alternative 
using hydrochloric acid (HC1) to cleave the protecting group (Method B) was 
found111. Here the protected compounds were added to a 1 M HCl/EtOH solution 
and after 1 - 3 h pure products, 43 and 45, Scheme 13, were obtained with no 
further purification required. Yields for the deprotection reactions are given below, 
Table 6 .
Method A: DDQ, DCM, 16h
OPMB
Method B: 1M HCl/EtOH, 90min
OPMB HO
Method A: DDQ, DCM, 16h 
Method B: 1M HCl/EtOH, 90min
45
Scheme 13: Deprotection of PMB-protected Benzothiazoles
Starting M aterial Product Time
(h)
Yield
(%)
2-(4'-triisopropylsilyl)benzothiazole 43 5 84
2-(4'-methoxybenzyloxy- 
phenyl)benzothiazole (Method A)
43 16 40
2-(4'-methoxybenzyloxy- 
phenyl)benzothiazole (Method B)
43 1.5 87
2-(2’-methoxybenzyloxy-5-methylphenyl)
benzothiazole
45 2.5 67
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2.3 Thermal Synthesis of Unsubstituted Benzothiazoles
As shown above, the use of sodium metabisulfite as a mild oxidant in the reaction 
between 28 and protected benzaldehydes successfully yield the desired products 
with no need for laborious purification methods. In order to establish the 
generality of this method, its functional group tolerance was tested with a number 
of benzaldehydes bearing either electron withdrawing, donating or halogen- 
containing (neutral) groups, as shown in Table 7. As can be seen from the results, 
this novel method for synthesising 26, delivers products in high yields with 
relatively short reaction times, with little or no purification.
Table 7: Yield and reaction time of unprotected benzothiazoles
Benzaldehyde Product Time (h) Yield (%)
3-methoxy 26 a 8 80
4-methoxy 26 b 6 76
3,4-dimethoxy 26 c 4 79
3,4,5-trimethoxy 26 d 8 80
3-hydroxy 26 e 10 8 6
3-nitro 26 f 10 78
4-nitro 26 g 10 80
4-cyano 26 h 8 82
4-trifluoromethyl 26 i 8 79
3-fluoro 26 j 8 85
3-chloro 26 k 6 84
4-bromo 261 4 8 8
4-hydroxy 43 10 84
The reaction works well within a few hours irrespective of the nature of the 
benzaldehyde substituent. Minimum purification was required for all compounds 
and a sufficiently pure sample was obtained after recrystalisation from ethanol. It 
was decided to test the reaction with the unprotected hydroxy benzaldehydes to see
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shortest time thermally to deliver the corresponding benzothiazole, it is readily 
available, and inexpensive. Microwave experiments were performed in the 
Department o f Chemistry, Cardiff University in the laboratory of Dr. Mark 
Bagley.
N 3 2 S 2 0 5
DMF, MW
SH ^  'B r
28 47
Scheme 14: Synthesis o f 4-bromobenzothiazole
261
DMF was also used as solvent for microwave reactions and is expected to be an 
efficient solvent for microwave use as it has a high/medium tan value, and is a 
polar solvent. These two characteristics fit the general rule in microwave 
chemistry, i.e. that in order for a solvent to absorb microwave energy and 
transform this energy to heat it should be a polar solvent with a relatively high 
boiling point and a good tan value. Unfortunately, the reaction did not proceed as 
well as anticipated. The reaction showed initial formation of product after 1 h and 
after a further 2 h irradiation time there were three spots visible by TLC analysis. 
After isolation, it was found that these spots corresponded to starting material 48, 
the dihydro intermediate 49, and the desired product 261, Figure 19.
\  /
Br
48 49
Figure 19: Products isolated from microwave reaction in DMF at 90 °C
261
Isolation o f 26 1, after chromatography gave a yield of 50 % and a reaction time 
comparable to the thermal method, therefore it presented no improvement over this 
method. The reason for this was thought to be due to one of the limitations of 
microwave reactors, namely their inability to stir a solution to the same standard as 
a traditional hotplate stirrer. When the reagents were mixed in DMF the reaction
Chapter 2 Unsubstituted Benzothiazoles
For those benzaldehydes that had methoxy groups on the benzaldehyde, it was 
found that the product did not precipitate on addition of water and in these cases 
the product was isolated by an extraction between water and DCM.
Table 13: Reaction time and yield of microwave irradiated electron withdrawing
benzaldehydes
Benzaldehyde Product Time (min) Yield (%)
3-Nitro 26 f 90 80
4-Nitro 26 g 90 85
4-Cyano 26 h 30 98
4-T rifluoromethyl 26 i 60 90
Reaction times with nitro substituted benzaldehydes required slightly longer 
irradiation times, however they were still significantly shorter than times observed 
under thermal conditions.
Table 14: Reaction time and yields of microwave irradiation of halogen substituted
benzaldehydes
Benzaldehyde Product Time (min) Yield (%)
3-Fluoro 26 j 30 8 8
3-Chloro 26 k 60 90
4-Bromo 261 25 82
As is expected, the reaction also holds for benzaldehydes with halogen groups on 
the ring thus proving the versatility of the reaction.
Although a small library of compounds were successfully synthesised with short 
reaction times, it was found that this reaction time could be decreased further to 15 
min, if the irradiation was followed by column chromatography to isolate the 
product. Isolated yield of products were found to be on average 80 % of those 
reported in Table 12, Table 13, and Table 14. As the main focus of this work is 
for minimal purification of product and since the reaction times in general were 
less than 1 h with high yields it was decided that ease of purification was more 
advantageous over a slightly lower reaction time.
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Table 11: Results of reaction using DMSO as solvent
Solvent Tem perature
(°C)
Time (min) Yield (%)
DMSO 70 1 2 0 75
DMSO 90 25 84
DMSO 1 2 0 25 82
It can be concluded from this that the side product obtained previously were due to 
the system being heterogeneous and insufficient mixing of the sodium 
metabisulfite with the other reagents.
To ensure the general applicability of the reaction, an array of either electron 
withdrawing, donating, or halogen-substituted benzaldehydes were tested under 
the optimised microwave conditions at a scale of around 150mg, Scheme 15.
a DMSO, MW, 120°CSH ^  ' r
R = EWG/EDG/halogen
Scheme 15: General reaction scheme of optimised microwave conditions
The details of reaction times and yield are given below, Table 12, Table 13, and 
Table 14.
Benzaldehyde Product Time (min) Yield (%)
3-Methoxy 26 a 30 70
4-Methoxy 26 b 30 76
3,4-Dimethoxy 26 c 30 76
3,4,5-Trimethoxy 26 d 45 76
3-Hydroxy 26 e 30 84
4-Hydroxy 43 60 80
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There are also a number of solvent-free microwave synthetic routes reported, 
particularly in the early stages of microwave chemistry. Here reagents are 
dispersed on the surface of an inorganic or insoluble support such as silica gel, 
alumina, or used neat118. It was decided to test the reaction in the absence of 
solvent to see if the solvent of choice, namely DMSO, had an effect on the 
reaction apart from being able to dissolve all the reagents.
The solvent free reaction was undertaken using 28, 48 and sodium metabisulfite. 
To investigate the possible effects of the solvent on the reaction, after 25 min, 
which was the time required for reaction with solvent, the reaction was stopped 
and the product was collected and analysed. Surprisingly, it was found that the 
reaction worked reasonably well under solvent-free conditions with roughly half 
the amount of product formed compared to the DMSO reaction, but column 
chromatography was necessary to isolate 26 1 from 49. There are two possible 
reasons for this reduction in product formation. The first is non-uniform heating 
and the second that DMSO is aiding in the oxidation of the intermediate. It is 
assumed that non-uniform heating does play a part in the reaction, however, it is 
more likely that the reduction in product formation is due to the absence of 
DMSO.
To test this hypothesis, it was decided to test the reaction with no sodium 
metabisulfite but in the presence of DMSO as the solvent system. After 15 min 
irradiation TLC analysis showed formation of product spot, following a further 8 h 
reaction time, analysis showed the presence of both 26 1 and 49 and isolated yield 
of 26 1 was 45 %. From this result it can be concluded that DMSO alone does 
promote the formation of desired product but that it is not a powerful enough 
oxidant to drive the reaction to completion. However, when used in conjunction 
with sodium metabisulfite, it helps in the oxidation of the system. The optimum 
conditions therefore for the synthesis of 26 under microwave irradiation uses
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DMSO as the solvent system with sodium metabisulfite as a mild internal oxidant 
to give products in high yield in a short reaction time and more importantly with 
minimal purification.
2.5 Optimised Thermal Synthesis of Unsubstituted 
Benzothiazoles
As the choice o f solvent was found to have a large impact on reaction rate and 
product formation under microwave irradiation there is a strong possibility of this 
having the same effect thermally and thus improving on those results that were 
reported previously (Table 7). Therefore, it was decided to return to the thermal 
conditions to see if the optimised reaction conditions from the microwave could 
impact on these previous results.
To study the solvent effect 4-bromobenzaldehyde, 48, was once more chosen as 
the standard benzaldehyde to test this hypothesis. Similar to the results observed 
when using the microwave, the choice of solvent was also found to have an impact 
on the results of the reaction. Unsurprisingly, the best results were achieved using 
DMSO under thermal conditions. However, the optimum reaction temperature for 
thermal conditions in DMSO was 120 °C was Table 15.
Table 15: Reaction times and yield of 4-bromobenzaldehyde in various solvents
Solvent Tem perature (°C) Time (min) Yield (%)
DMF 90 240 8 8
Ethanol 90 360 80
Toluene Reflux 600 76
DMSO 90 60 78
DMSO 1 2 0 30 80
As can be seen from the results in Table 15 the time for the reaction of 28 and 48 
gave 26 1 in 80 % yield in a mere 30 min. This is Vg of the time required under the 
previous thermal conditions with DMF as solvent (Table 7) and is in fact on par 
with the results of the reaction in the microwave.
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Due to this dramatic reduction in reaction time, it was decided to resynthesise the 
library of compounds under the improved thermal conditions (i.e. DMSO as 
solvent at 120 °C) to see if the reduced reaction time was held for all the library of 
compounds. Results of the new reaction times and yields are given below Table 
16, Table 17 and Table 18.
Table 16: Reaction time and yield of electron donating benzaldehydes in DMSO
Benzaldehyde Product Time (min) Yield (%)
3-methoxy 26 a 25 80
4-methoxy 26 b 35 83
3,4-dimethoxy 26 c 30 88
3,4,5-trimethoxy 26 d 35 81
3-hydroxy 26 e 30 8 6
4-hydroxy 43 30 84
Table 17: Reaction time and yield of electron withdrawing benzaldehydes in DMSO
Benzaldehyde Product Time (min) Yield (%)
3-nitro 26 f 1 2 0 75
4-nitro 26 g 1 2 0 97
4-cyano 26 h 1 2 0 95
4-trifluoromethyl 26 i 1 2 0 91
Table 18: Reaction time and yields of halogen substituted benzaldehydes in DMSO
Benzaldehyde Product Time (min) Yield (%)
3-fluoro 26 j 1 2 0 90
3-chloro 26 k 1 2 0 96
4-bromo 261 30 80
In line with the results of 26 1, all synthesised benzothiazoles using DMSO as 
solvent showed a reduction in reaction time, with improved yields in the majority 
of cases. Surprisingly, the reaction times thermally were found to be comparable to
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those under microwave irradiation and in the case of benzaldehydes with electron 
donating groups the reaction time thermally was less than those reported in the 
microwave. Although under the new conditions benzaldehydes with electron 
withdrawing groups had a reaction time of 2 h, this is still a sufficiently short time 
as there is no need for laborious purification methods. Unlike the microwave 
conditions, here all products precipitated on addition of water and were shown to 
be adequately pure by NMR.
One of the problems associated with reaction is the formation of SO2. This is a 
particular problem under the microwave setup due to the closed setup which leads 
to a build up of pressure and a more concentrated exposure to the gas on 
completion of the reaction. Although this problem is not resolved under thermal 
conditions, the ventilated fumehood limits the exposure to SO2 and the unpleasant 
odours generated during the reaction.
With the short reaction time and high yields using the optimised thermal 
conditions, it was decided that the thermal method is the method of choice for the 
synthesis of 26, however this does not eliminate the use of the microwave reactor 
for experimental enhancement in the future.
2.6 Comparison with other methods
It can be concluded that this new method (using 2-aminothiophenol, substituted 
benzaldehydes and sodium metabisulfite in DMSO) for the synthesis of 
benzothiazoles unsubstituted in the benzothiazole ring is superior to previously 
reported methods in terms of ease of purification, yield and reaction time and a 
comparison of the efficiency of this method with selected previous methods is 
collected in Table 19 illustrating its advantages over previously reported methods.
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Table 19: Comparison of methods for the synthesis of 2-arylbenzothiazoles
ArCHO
Ar Conditions Time Yield (%)
4-BrC6H4 Na2S20 5, DMSO, 
120 °C
30 min 80
Bakers’ Yeast, 
DCM, RT72
24 h 82
CTAB (5 mol %), 
water65
2 h 96
TCCA (1 mol %), 
MeTHF, RT63
2 h 93
4-CH3OC6H4 Na2S20 5, DMSO, 
120 °C
35 min 83
Bakers’ Yeast, 
DCM, RT72
24 h 80
CTAB (5 mol %), 
water65
1.2 h 97
TCCA (1 mo 1%), 
MeTHF, RT63
2 h 98
4-N 02C6H4 Na2S20 5, DMSO, 
120 °C
2 h 97
Bakers’ Yeast, 
DCM, RT72
24 h 77
CTAB (5 mol %), 
water65
6 h 78
TCCA (1 mol %), 
MeTHF, RT63
5 h 87
2.7 Purity of Products
O f the library of compounds synthesised thus far all have been known compounds. 
Purity of final products was established by comparison with literature melting 
points/NMR data and mass spectrometry results, and according to these criteria 
samples were sufficiently pure following simple precipitation on addition of water 
followed by filtration and drying. A number of representative samples were 
analysed by % CHN and it was concluded from these results that dissolution in
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DCM followed by washing with excess water, and brine gave products which were 
sufficiently pure to pass % CHN.
2.8 Synthesis from Esters
As reported earlier, the initial synthesis of benzothiazoles unsubstituted in the 
benzothiazole ring (26) began with first protection of a phenol moiety of a 
benzaldehyde with either PMB or TIPS and then reacting this protected reagent 
with 2-aminothiophenol, 28. Before the sodium metabisulfite method was 
developed and due to the difficulties encountered with the previous reaction 
conditions with benzaldehydes, another suitable condensation partner was 
investigated. It was decided to use esters as the condensation partner as an 
alternative as they have been shown previously (2.1.3) to work well85,86,87.
Methyl-4-hydroxy benzoate (50) was the ester chosen as it is structurally related to 
the benzaldehyde used previously. It was protected with freshly prepared PMB-Br 
(51) using literature methodologies122 and on precipitation gave 4-(4- 
methoxybenzyloxy)benzoic acid methyl ester (52) in excellent yields. For this 
reaction it was found that the addition of 18-Crown-6 increased the yield of the 
reaction.
,Br
OMe
18-Crown-6
OMe
5250 51
Scheme 16: Synthesis of 4-(4-methoxy-benzyloxy)-benzoic acid methyl ester
Once the protected ester was synthesised a number of reaction conditions were 
tested to form the corresponding benzothiazole, 42 b, (Scheme 17).
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MeO
NH,
SH
28
+
OMe
52 42 b
Scheme 17: Synthesis of 2-[4-(4-methoxybenzyloxy)phenyI]benzothiazole from 4-(4- 
methoxybenzyloxy)benzoic acid methyl ester
As shown in Table 20, unfortunately none of the reactions tested gave satisfactory 
results.
Method Time (h) Yield (%)
A-Ethanol reflux 96 0
B-Methanol Reflux 96 0
C-Iodine 1 21
D-Sodium Metabisulfite 96 0
In the first two attempts of a simple reflux with either ethanol or methanol (A and 
B) after four days there were no visible sign of formation of the desired product by 
either TLC or NMR analysis of the reaction mixture. In the third attempt with 
iodine as an internal oxidant (C), the reaction was successful giving the desired 
benzothiazole, 42 b. However, after prolonged reaction times the yield of the 
reaction was low. This was as a result of the reaction not going to completion and 
column chromatography being necessary for isolation of product from unreacted 
starting materials.
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As none of these methods showed satisfactory results, it was decided at this point 
to return to the original method of using benzaldehydes as the condensation 
partner. The aim was now to find a suitable oxidising agent that would not cleave 
the protecting group and give satisfactory transformation of the intermediate to the 
final product, the results of which are illustrated previously in 2.2.4. As is shown 
in this section sodium metabisulfite was used as an efficient and mild internal 
oxidant in the reaction of a variety of benzaldehydes with 2-aminothiophenol. Due 
to its excellent activity in this reaction it was decided to see if it would have an 
effect on the coupling of the ester (52) with 28. Unfortunately as with the previous 
ester reactions, the sodium metabisulfite (D) reaction did not give good results and 
after a prolonged reaction time failed to show formation of product on analysis of 
either TLC or NMR and only starting material was visible. It is presumed that this 
is due to the fact that esters are less susceptible to nucleophilic attack then 
benzaldehydes. Therefore the synthesis of benzothiazoles unsubstituted on the 
benzothiazoles ring (26) from esters was abandoned and work concentrated on 
synthesis from benzaldehydes.
2.9 Summary
A method was developed for the rapid synthesis of benzothiazoles unsubstituted in 
the benzothiazole ring under either thermal or microwave reaction conditions. 
Here 2-aminothiophenol was reacted with a variety of substituted benzaldehydes 
in the presence of the mild oxidant sodium metabisulfite. DMSO was found to be 
the optimum solvent for the reaction with a reaction temperature of 120 °C. Under 
either thermal or microwave conditions the desired benzothiazole was obtained in 
short reaction times with no need for laborious purification protocol. As no 
exceptional time differences were obtained under microwave irradiation and limits 
reaction scale, it was decided that any future reactions would occur under thermal 
conditions.
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3 Solution Phase Synthesis of Substituted 
Benzothiazoles
As stated previously, the majority of reported synthetic methods for the synthesis 
of 2-arylbenzothiazoles relate to those that are unsubstituted in the benzothiazole 
ring, 26. The synthesis of 2-arylbenzothiazoles bearing benzothiazole ring 
substituents is more challenging due to the limited availability of appropriately 
substituted 2-aminothiophenol derivatives and their tendency towards spontaneous 
oxidation/dimerisaton in air. A further problem with the synthesis of 2- 
arylbenzothiazoles substituted in the benzothiazole ring is the possibility of 
regioisomer formation.
A common and useful synthetic route to 27 is from the reaction of the disulfide of 
a 2-aminothiophenol, with an aldehyde or its derivatives. Another commonly 
utilised route is via the Jacobson cyclisation reaction. These along with other less 
significant routes are outlined below. A discussion on the shortcomings of these 
methods will be followed and a description of research work undertaken 
culminating in a novel reliable method for their synthesis.
3.1 Literature Methods of Synthesising Benzothiazoles 
Substituted in the Benzothiazole Ring
3.1.1 From Carboxylic Acids and their derivatives
A number of examples of 2-arylbenzothiazoles containing substituent groups on 
the benzothiazole ring, 27, have been reported from carboxylic acids. For example 
the reaction of the zinc salt of 2-aminothiophenol disulfide 53 with p-nitrobenzoyl 
chloride, gave the 2-arylbenzothiazole-6-carboxylic acid product 54 that was 
further derivatised to yield a series of dibenzothiazoles 5518.
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p-NCyPhCOCI,
i) SOCI2
" ' XX nh2SH
no2
55
Scheme 18: Synthesis of dibenzothiazole from disulfides
3.1.2 From Aldehydes
The majority of reactions involving aldehydes to form benzothiazoles results in the
formation of 2-arylbenzothiazoles unsubstituted in the benzothiazole ring, 26. 
However, the formation of 2-arylbenzothiazoles substituted in the benzothiazole 
ring, 56, can be achieved by the reaction of a 2-aminothiophenol disulfide, 57, and 
substituted benzaldehydes in the presence of triphenylphosphine and catalysed by 
p-toluenesulfonic acid. Here the initial formation of the disulfide is achieved 
through the hydrolytic cleavage of the appropriate 2-aminobenzothiazole, 58,
i - . - . . 7 44 123 124under basic conditions ’ ’ ’
< x > NH,
58
nh2
Base
Reflux
57
ArCHO, PPh3 
/j-TsOH 
toluene, reflux
O r \ Ar
56
Scheme 19: Synthesis of 2-arylbenzothiazoles substituted on the benzothiazole ring from 
disulfide and benzothiazole
- 5 4 -
Chapter 3 Substituted Benzothiazoles
Although formation of 56 is usually achieved starting from a 2-aminothiophenol 
disulfide, there are limited examples of its synthesis from a substituted 2- 
aminothiophenol. For example, a number of 6-nitro-2-(substituted- 
phenyl)benzothiazoles were formed by the condensation of substituted 
benzaldehydes with 2-amino-5-nitrothiophenol, 59 in pyridine to give 6043.
Scheme 20: Synthesis of 6-nitrobenzothiazoles from 2-amino-5-nitrothiophenol
The reaction of benzaldehydes with either 2-amino-4-chlorobenzenethiol and 2- 
amino-4-(trifluoromethyl)benzenethiol (as its hydrochloride) to yield 27 in water 
in the absence of any acid/base catalyst is also reported125.
The major drawback of the above methods is the necessity of column 
chromatography to yield pure product. This is especially the case when 
triphenylphosphine is used in the reaction due to the production of 
triphenylphosphine oxide as an inert byproduct in the reaction which requires 
column chromatography for removal.
3.1.3 From Thiobenzanilides
As described in the preceding chapter benzothiazoles unsubstituted in the 
benzothiazole ring, 26 can be formed by the Jacobson cyclisation of 
thiobenzanilides. This method can also be applied to the synthesis of 27, and is one 
of the most important methods for their synthesis. A range of reaction conditions 
for thioanilide cyclisation have been described under basic/oxidising conditions 
including sodium hydride/iodine126, hypervalent iodine reagents (Dess-Martin 
periodinane)127, 2,3-dichloro-5,6-di-cyanobenzoquinone (DDQ)128,129, or caesium 
carbonate/CuI/l,10-phenanthroline130. Palladium catalyzed synthesis of 27 using a 
novel catalytic system consisting of Pd(II)/Cu(I)/Bu4NBr has also shown high
o
Pyridine
59 60
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There are a number of other examples in the literature using the above bromine 
displacement strategy to successfully synthesise the regiospecific product of 
interest. These include palladium catalysed intramolecular cyclisation135, and base- 
catalysed cyclisation conditions such as sodium /er/-butoxide136 or potassium
1 ^7amide . Various other halogens have been reported for the synthesis of 27. For 
example, by the displacement of fluoride138,139 or chloride/iodide under 
photochemical conditions140. The regioselective synthesis of 27 has more recently 
been reported using the hypervalent iodine reagent 
phenyliodine(III)bis(trifluoroacetate) (PIFA)141, and via an unusual ipso 
substitution of an aromatic methoxy group from ort/io-methoxythiobenzamides 
either under Jacobson conditions or azobisisobutyronitrile (A1BN) induced 
cyclisation, Scheme 22142.
OMe
r *
>Me
AIBN
R2
Ph
Scheme 22: AIBN induced Jacobson cyclisation
Although there are numerous reports of the successful synthesis of 27 using the 
Jacobson cyclisation route, this methods suffers from low functional group 
tolerance and the need for harsh acid/base catalyst to promote the formation of 
product. Chromatography purification is also necessary for this reaction even in 
the cases of regiospecific product formation.
3.2 Synthesis of Benzothiazoles Substituted in the 
Benzothiazole Ring from Disulfides
In continuation of our efforts to develop efficient methods for the synthesis of 
small benzothiazole containing molecules the next logical step in our research was 
the synthesis of those benzothiazoles substituted in the benzothiazole ring, 27. As 
the previously developed method involved the reaction of a benzaldehyde and 2- 
aminothiophenol, it was hoped that this reaction could also be applied to the 
synthesis of 27 starting from substituted thiophenols. Unfortunately, there are no
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substituted 2-aminothiophenols available commercially as they tend towards 
dimerisation but it was anticipated that the previous reaction protocol could be 
applied to disulfides.
Therefore, the aim here was to initially synthesise a number of disulfides and 
subsequently react these with an array of benzaldehydes to form a library of 
compounds with either known or potential biological activity. It was hoped that 
this reaction would be successful and therefore hold a number of key advantages 
over the previously reported synthetic methods. Most importantly this reaction was 
hoped to provide products in a minimum number of synthetic steps, and have short 
reaction times in good yield with little or no purification throughout the reaction 
sequence.
3.2.1 Formation of Disulfides
Unfortunately, as there are no substituted 2-aminothiophenols commercially
available the first step in the synthesis of 27 was to form a 2-aminothiophenol 
disulfide. There are a number of reported synthetic routes for achieving a 
substituted 2-aminothiophenol38’44’143,144,145,146. In general, these reported methods 
utilise a base (either potassium or sodium hydroxide) to treat a commercially 
available substituted 2-aminobenzothiazole, 58 yielding the disulfide 57 (Scheme 
23).
Reflux
58 57
Scheme 23: Base hydrolysis of substituted 2-aminothiophenol to yield substituted disulfides
A number of the reported methods were tested to find the optimum experimental 
conditions that could be applied to an array of commercially available 2- 
aminobenzothiazoles. 6-Fluoro-2-aminobenzothiazole 58 a was used as the test
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functional group tolerance and excellent yields131. The oxidising agent manganese 
(III) triacetate has been reported for the microwave assisted cyclisation of 
thiobenzanilides132. Although there are numerous documented conditions for the 
Jacobson cyclisation reaction, the most commonly used agent in the reaction is 
potassium ferricyanide38123,124)133> 134.
The major downfall with this particular method is that depending on the 
thiobenzanilide substitution pattern, the Jacobsen cyclisation can lead to mixtures 
of regioisomeric products. An example of this is provided by the cyclisation of 
3,4-difluoroaniline, 61, where cyclisation leads to a 2:1 mixture of 5,6-difluoro- 
(62) and 6,7-difluoro-2-arylbenzothiazole (63) isomeric products37. It has been 
found that when there is a halogen (bromine in this case) ortho to the nitrogen (64) 
the nucleophilic substitution reaction gives better yields and controls the 
regioselectivity of cyclisation to yield solely 6244.
61
K3Fe(CN)6, NaOH  ►
EtOH, H20 , 90°C
62 + 63
no2
Me
NaH.NMP, 1 4 0 °^  p
64
Scheme 21: Regiospecific synthesis via Jacobson Cyclization
no2
62
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It was also found that even after prolonged reaction time the reaction cannot be 
driven to completion and that the starting material is not fully converted to the 
disulfide 57 a. However, the product could be easily separated from the starting 
material through an ether wash. This was because the starting material was 
insoluble in ether whereas the product is soluble therefore the ether filtrate could 
be collected and subsequently evaporated to yield the pure product. Nevertheless 
because there will always be unreacted starting material in the reaction the yield of 
the reaction is relatively low.
A further observation with this reaction and presumably the reason for the long 
reaction time is the insolubility of the starting material in water. A correlation was 
found between reaction time and the time that it took for all reagents to dissolve in 
water, therefore it was thought that if the reagents formed a homogenous mixture 
the reaction would be faster. A reported method using the same reaction conditions 
as the KOH reaction above added ethylene glycol to the reaction system60. It was 
presumed that the reason for this was to improve the solubility of the reagents. The 
solubility of reagents was slightly improved on addition of ethylene glycol and 
after 15 h the reaction gave an adequate yield of 40 %, Table 21. Unfortunately, 
this did not give a significant advantage over the previous conditions and 
prolonging the reaction time did not impact significantly on yield. A further 
literature method utilising /-PrOH147 instead of water was tested but this did not 
lead to any improvement on the reaction conditions either. It was therefore decided 
that the KOH method (without ethylene glycol and with modified workup) would 
be used for the synthesis of a number of various disulfides.
The reaction was successfully applied to synthesise a number of disulfides from 
commercially available starting materials, Table 22.
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case for these reactions using either potassium or sodium hydroxide as base with a 
variety of reaction conditions as outlined below, Table 21.
Table 21; Reaction time and yield of various disulfide formation reactions
Method Time (h) Yield (%)
NaOH145 72 #
KOH143 16 53
KOH + ethylene glycol60 15 40
KOH + (PrOH147 48 35
# not isolated
The first method using aqueous NaOH as base was unsuccessful. According to the 
literature procedure, the reaction should be complete within 2 h after which the 
precipitate is treated with acetic acid to give the desired product. However, when 
tested there was minimal product formation after prolonged reaction times and an 
alternative method was sought.
By heating 58 a in a 50 % aqueous solution of KOH the desired product (57 a) 
was successfully formed. Although the reaction was reported to be complete in 6 h 
it was found that a reaction time of 16 h was necessary for product formation and 
on formation the solution was acidified to pH 6 using acetic acid. Water was then 
added and the precipitate collected to give the disulfide 57 a, Scheme 24.
Acetic Acid, pH 6
2
58 a 57 a
Scheme 24: Synthesis of bis(2-amino-5-fluorophenyl)disulflde
Whilst undertaking this experiment a number of problems were encountered. For 
instance, it was found that to avoid the formation of a tar like product which could 
make the product isolation complicated the temperature should be kept around 0 
°C on acidification of the reaction mixture.
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Table 22; Reaction time and yield of disulfides
2-Aminobenzothiazole Product Time (h) Yield (%)
2-amino-6-ethoxybenzothiazole 57 b 16 68
| 2-amino-6-chlorobenzothiazole 57 c 24 65
2-amino-6-methylbenzothiazole 57 d 12 72
2-amino-6-methoxybenzothiazole
i
57 e 16 71
2-amino-6-nitrobenzothiazole 57 f 48 68
As can be seen from the table above, the reaction is tolerable with a number of 
functional groups.
Unfortunately, 2-amino-5-fluorobenzothiazole is not commercially available. As 
stated in the introduction some 5-fluoro substituted benzothiazoles have exquisite 
biological activity and therefore it is important they are synthesised. A literature 
procedure was followed in order to obtain the 2-amino-5-fluorobenzothiazole44. 
Here the reaction of benzoyl chloride with ammonia thiocyanate gives benzoyl 
isothiocyanate, which then undergoes addition with 3-fluoroaniline 65 to afford 3- 
fluorophenylthiourea 66. This is subsequently reacted with bromine to promote the 
cyclisation of 2-amino-5-fluorobenzothiazole, 67, Scheme 25. It should be noted 
that this reaction appeared to be regiospecific as no presence of the regioisomer 
was found.
n h 4s c n Br2, DCM
Benzoyl isothiocyanate 
Acetone, reflux
65 66 67
Scheme 25: Synthesis of 2-amino-5-f1uorobenzothiazole
Once 67 is formed successful synthesis of its disulfide 68 was achieved under base 
hydrolysis using the previously described reaction conditions. A reaction time of 
16 h and an excellent yield of 83 % for 68 were obtained (Scheme 26).
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Acetic Acid, pH 6
67 68
Scheme 26: Synthesis of bis (2-amino-4-fluorophenyl)disulfide
In conclusion, a variety of substituted disulfides have been synthesised with good 
to excellent yields. Purity of the disulfides synthesised were compared to literature 
NMR data and used in subsequent reactions without further purification.
3.2.2 Formation of Substituted benzothiazoles from disulfides
After successful synthesis of the disulfide the logical progression was to synthesise
a small library of benzothiazole containing compounds substituted in the 
benzothiazole ring, 27. It was envisaged that the reaction conditions previously 
developed for the synthesis of 26, would also be applicable here. Thus starting 
with the disulfide and reacting with a variety of substituted benzaldehydes in the 
presence of sodium metabisulfite and DMSO it was hoped the desired product 
would be formed efficiently resulting in a reaction that eliminates the need for 
column chromatography and harsh reaction conditions to give pure product in 
short reaction times.
3.2.2.1 6-Fluoro Benzothiazole Compounds
The reaction was initially tested with 5-fluoro disulfide 57 a. This reaction would
produce 6-fluorobenzothiazoles (69) which are of particular importance since they 
have previously shown biological activity15,42,44,45 and fluoro containing 
compounds are known to have an impact on a variety of molecular properties 
including metabolic stability, binding affinity and the physical properties of the 
compound35,36,148. Using a slightly lower molar ratio of disulfide 57 a to 
benzaldehyde in DMSO compared to unsubstituted benzothiazole ring compounds, 
the corresponding 6-fluorobenzothiazole 69 (Scheme 27) was successfully
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synthesised using the mild oxidant sodium metabisulflte in excellent yield with 
fast reaction times (Table 23 and Table 24).
n h 2
F
H'
Ri
Na2S205
DMSO
57 a
Scheme 27: Synthesis of 6-fluorobenzothiazoles
F
R,, R2, R3 = F, Cl, Br, OH, OMe, CN or N 0 2
69
A wide variety of 6-flurobenzothiazoles were successfully synthesised under 
analogous conditions to unsubstituted benzothiazoles, 26. High functional group 
tolerance was observed for these compounds.
Benzaldehyde Product Time (min) Yield (%)
4-methoxy 69 a 90 96
3,4-dimethoxy 69 b 180 83
3,4,5-trimethoxy 69 c 90 97
4-hydroxy 69 d 50 91
4-nitro 69 e 60 96
Table 24: Reaction time and yield of unknown 6-fluorobenzothiazoles
Benzaldehyde Product Time (min) Yield (%)
3-methoxy 69 f 90 84
3-hydroxy 69 g 40 93
4-cyano 69 h 60 86
3-fluoro 69 i 60 91
3-chloro 69 j 60 91
4-bromo 69 k 60 89
As can be seen from above, high functional group tolerance was observed for this 
reaction. Reaction times for those benzaldehydes with methoxy groups on the ring
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required longer, presumably due to the increase in electron density at the carbonyl 
which makes electrophilic substitution more difficult. Microwave conditions were 
not tested for this group of products (or for any further benzothiazoles 
synthesised), as reaction times thermally were quick and, as determined previously 
(unsubstituted conditions), chromatography was necessary for purification when 
microwave conditions were used with short irradiation times.
For the majority of compounds, the only purification method used after product 
formation was quenching with excess water, dissolving the resulting precipitate 
with DCM and extracting with brine to remove traces of sodium metabisulfite and 
DMSO in the product. However, in the case of both 3- and 4-hydroxy products a 
further purification step was deemed necessary. In these cases after quenching 
with water and collection of the resulting precipitate by filtration, the solid was 
dissolved in minimal DCM and filtered through a short plug of silica to remove the 
minor impurities present in the product. This gave sufficiently pure products in 
both cases.
As can be seen from Table 23 and Table 24 above, a number of these 
benzothiazoles are novel compounds. In the case of those compounds that are 
known, purity of product was confirmed by comparison of literature melting points 
and/or NMR data and acquisition of MS. For novel compounds purity of product 
was confirmed by either elemental analysis and/or high resolution MS.
All synthesised compounds were subjected to in vitro analysis on four cell lines, 
namely A549, Lovo, MCF 7, and PC3 and results of these tests will be discussed 
later (Chapter 5). As these compounds contain a fluoro group, they also have the 
possibility of being used in 18F PET imaging.
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26 and purification of these samples was achieved as in previous cases by filtering 
the product through a short plug of silica.
Table 26: Synthesis of 6-ethoxybenzothiazoles requiring further purification
Benzaldehyde Product Time (min) Yield (%)
3-hydroxy 70 j 80 93
4-hydroxy 70 k 80 91
3-chloro 701 60 67
Purity of these products was determined by analysis of NMR, MP and MS data. 
Representative samples were sent for accurate mass and % CHN analysis. Details 
of biological results are discussed later.
3.2.2.3 6-Chloro Benzothiazole Compounds
Bis(2-amino-5-chlorophenyl)disulfide 57 c which was previously synthesised from
the commercially available 2-amino-6-chlorobenzothiazole was also reacted with a 
number of benzaldehydes to give a small library of 6-chlorobenzothiazoles, 71. A 
literature search demonstrated that although there are a number of reported 6- 
chlorobenzothiazoles, there has been no study on their biological activity. A small 
library was synthesised and tested for their biological activity. For their synthesis, 
57 c is reacted with a variety of substituted benzaldehydes to give 71 using the 
conditions developed previously, Scheme 29.
nh2
Cl
H
DMSO
Cl
R ,,R 2, R3 = B r,O H , OMe, C N o r N 0 2
57 c 71
Scheme 29: Synthesis of 6-chlorobenzothiazoles
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3.2.2.2 6-Ethoxy Benzothiazole Compounds
Starting from bis(2-amino-5-ethoxyphenyl)disulfide 57 b a variety of 6-ethoxy
benzothiazole derivatives were successfully synthesised 70 (Scheme 28). 
Interestingly there is a limited number of either reported synthesis or biological 
data for these compounds in the literature45. It was hoped that these compounds 
would reveal interesting activity in vitro against a number of cancer cell lines.
n h 2
DMSO
EtO EtO'
R ,, R2, R3 = F, Cl. Br, OH, OM e, CN or N 0 2
57 b 70
Scheme 28: Synthesis o f 6-ethoxybenzohtiazoles
___ Table 25: Reaction time and yields of 6-ethoxybenzothiazoles
Benzaldehyde Product Time (min) Yield (%)
3-methoxy 70 a 40 92
4-methoxy 70 b 30 88
3,4-dimethoxy 70 c 60 91
3,4,5-trimethoxy 70 d 60 82
3-nitro 70 e 70 80
4-nitro 70 f 60 86
4-cyano 70 g 50 82
3-fluoro 70 h 30 84
4-bromo 70 i 30 93
As can be seen above (Table 25), reaction conditions were similar to the 6- 
fluorobenzothiazoles when 6-ethoxy disulfide is used as the condensation partner. 
The reaction is applicable to a wide variety of substituents and in the majority of 
cases sufficient purification was achieved by a brine wash. However, there were a 
number of products that required further purification. These are presented in Table
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Table 27: Reaction time and yield of known 6-chlorobenzothiazoles
Benzaldehyde Product Time (min) Yield (%)
3-methoxy 71 a 30 89
4-methoxy 71 b 20 83
4-nitro 71 c 50 90
4-cyano 71 d 30 95
4-bromo 71 e 60 85
Table 28: Reaction time and yield of unknown 6-chlorobenzothiazoles
Benzaldehyde Product Time (min) Yield (%)
3,4-dimethoxy 71 f 60 88
3,4,5-trimethoxy 71 g 60 84
3-hydroxy 71 h 70 90
3-nitro 71 i 60 91
Again the reaction conditions deliver the expected benzothiazoles in high purity 
and as can be seen from the results above (Table 27 and Table 28) substituents on 
either the benzaldehyde or benzothiazole ring appear to have little effect on the 
rate of the reaction. In the case of 3,4- and 3,4,5-trimethoxy products (71 f and g ) 
the final product was passed through a short layer of silica to remove traces of 
starting material.
3.2.2.4 6-Methyl Benzothiazole Compounds
A small number of 6-methyl benzothiazoles, 72, derivatives were also successfully
synthesised from 57 d, Scheme 30. Reaction times were under 1 h, and excellent 
yields were obtained (Table 29 and Table 30). In these cases pure product were 
obtained by a brine wash.
- 6 7 -
Chapter 3 Substituted Benzothiazoles
increases this interchange150. It is therefore likely that what we are seeing in this 
reaction is the DMSO converting the disulfide to thiol thus allowing the reaction to 
occur. This might also explain part of the solvent effect observed for the reaction, 
since the paper suggests that solvents with higher dielectric constants have a faster 
interchange, agreeing with the observation that the reaction was faster in DMSO 
than DMF.
A further possible mechanism for this reaction involves the production of sulphur 
oxide (SO2). Although anhydrous DMSO was used during the reaction, there is 
inevitably a small amount of water present in the solvent. When water reacts with 
sodium metabisulfite it produces SO2 which is a well known reductant. Therefore 
it is plausible that SO2 is in fact produced in situ and this is reducing the disulfide 
to the thiol thus allowing the reaction to proceed.
In either case it is more than likely that a thiol is somehow reacting with the 
benzaldehyde and not the disulfide directly. Further studies are necessary to fully 
understand the mechanism of this reaction.
3.3 Summary
Unlike the previous benzothiazoles synthesised, were 2-aminothiophenol was 
commercially available, here substituted 2-aminothiophenols are not widely 
available and they tend towards dimerisaton. Therefore the initial starting point for 
the synthesis of benzothiazoles substituted on the benzothiazole ring focused on 
finding a suitable route to the formation of disulfides. This was successfully 
achieved by the base hydrolysis (KOH) of either a 5- or 6-substituted-2- 
aminobenzothiazole followed by acidification under controlled temperatures. The 
disulfide could then be reacted with a variety of substituted benzaldehydes under a 
slightly modified protocol to the method developed previously (2.5). A number of 
substituted benzothiazoles containing a variety of functional groups were obtained 
in short reaction times and in the majority of cases the only form of purification
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3.2.2.5 6-Nitro Benzothiazole Compounds
Two representative 6-nitro benzothiazoles, 60 were synthesised from bis(2-amino-
5-nitrophenyl)disulfide, 57 f to ensure that the method was applicable when strong 
electron withdrawing groups are on the benzothiazole ring (Scheme 31).
nh2
o2n
57 f
H
+
DMSO
R2
Scheme 31: Synthesis of 6-nitrobenzothiazoles
___________ Table 31: Reaction time and yield of 6-nitrobenzothiazoles
Benzaldehyde Product Time (min) Yield (%)
3,4-dimethoxy 60 a 20 91
3,4,5-trimethoxy 60 b 30 88
As can be seen in Table 31 results concur with the previous examples. Reaction 
times were rapid (less than 30 min) giving excellent yields of pure products with 
no laborious purification methods. Although there are no known biological 
properties of these compounds, the structurally related 6-amino benzothiazoles 
have shown moderate anticancer activity43 and can easily be obtained by a 
reduction of the 6-nitro group. They also show potential for the use as PET 
imaging agents16 where the nitro group can easily be converted to a radiolabelled 
18F by a nucleophilic substitution of the nitro group using 18F‘ and Kryptofix 
222149.
3.2.2.6 6-Methoxy Benzothiazole Compounds
For completeness, a 6-methoxybenzothiazole 73 was also synthesised from bis(2-
amino-5-methoxyphenyl)disulfide 57 e (Scheme 32).
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One possible explanation is that on attempted synthesis of the disulfide the thiol 
was partially synthesised, and an equilibrium exists between disulfide and thiol. 
On analysis of NMR data there was no evidence of a thiol peak in the NMR 
and chemical shifts corroborated with those of previously reported disulfides. To 
ensure that it is the disulfide reacting with the benzaldehyde the commercially 
available disulfide 2-aminophenyldisulfide (75) was tested under the same reaction 
conditions. Here 75 was successfully reacted with 3,4-dimethoxybenzaldehyde 
using the same reaction conditions as before (sodium metabisulfite, DMSO) to 
give 2-(3,4-dimethoxy-phenyl)benzothiazole 26 c in 72 % yield in 2 h (Scheme 
34).
nh2 OMe
H
+
DMSO
OMe
2
75
OMe
26 c
Scheme 34: Synthesis of 2-(3,4-dimethoxy-phenyl)benzothiazole from disulfide
As this commercial reagent is listed as 97 % pure, it can be confirmed that it is the 
disulfide in the reaction mixture and that the reaction does proceed starting from 
the disulfide. A further observation made regarding this reaction is that this 
disulfide is significantly less toxic than the corresponding thiol and it does not 
pose a significant risk to the environment. 2-Aminothiophenol is harmful to the 
environment and furthermore it is a viscous solution at RT. The disulfide is a solid 
powder which enables easier handling of the substance. For this reason it might 
serve as an attractive alternative to 2-aminothiophenol in future reactions.
Another possible explanation to account for the reaction starting from the disulfide 
is that the disulfide is in equilibrium with its thiol and that once formed the thiol is 
consumed in the reaction. A literature paper suggests that solvent choice has an 
effect on the interchange between thiol-disulfide and that DMSO as solvent
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n h 2
H'
Ri
N a 2  S 2 O 5
DMSO
57 d
Scheme 30: Synthesis of 6-methylbenzothiazoles
Rj, R2, R3 = C1, Br, OH, OMe
72
Benzaldehyde Product Time (min) Yield (%)
4-methoxy 72 a 60 94
4-hydroxy 72 b 25 90
4-bromo 72 c 60 83
Table 30: Reaction time and yield of unknown 6-methylbenzothiazoles
Benzaldehyde Product Time (min) Yield (%)
3,4-dimethoxy 72 d 20 81
3,4,5-trimethoxy 72 e 30 84
3-hydroxy 72 f 20 86
3-chloro 72 g 60 90
As can be seen from the results above reaction times for the synthesis of 6- 
methylbenzothiazoles were fast, and for hydroxy substituted benzothiazoles less 
time was required compared to previously synthesised benzothiazoles. In these 
cases no further purification of hydroxy substituted products was necessary. 
Similar to the previous benzothiazoles these compounds were evaluated for their 
biological activity. Another possible application of these compounds is there 
potential in PET imaging where similar structures have previously shown 
potential14.
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In the case of these products purification was necessary. In order to eliminate 
starting material and trace sodium metabisulfite, the product was filtered through a 
short plug of silica. Comparison of product and literature NMR data along with 
MS confirms pure product formation. The synthesis of these benzothiazoles holds 
significant improvements over the previously reported methods as mild reaction 
conditions were utilised and no extensive chromatography was required at any 
stage of their synthesis. In the above reaction the 4-nitro group also holds the 
possibility of being reduced to the corresponding amine which has shown 
biological activity previously.
3.2.3 Possible Mechanism
It is apparent from the number of benzothiazoles (substituted in the benzothiazole
ring) successfully synthesised that this method using sodium metabisulfite as a 
mild oxidant is a truly versatile reaction allowing the synthesis of a range of 
substituted benzothiazoles in high yield with short reaction times. This novel 
method holds a number of advantages over previous methods in that it requires 
minimal synthetic steps, uses mild reaction conditions, and most importantly 
requires minimal purification. However, the mechanism of action of this reaction 
needs to be addressed.
In the previously reported methods for the synthesis of 27, there is usually a 
reducing agent (such as triphenylphosphine) present in the experimental protocol. 
The reason for this is the need to reduce the disulfide to the corresponding thiol. 
The thiol is necessary to enable ring cyclisation from the Schiff base to the dihydro 
intermediate, which is followed by oxidation to the desired benzothiazole.
In the reactions detailed above there is no reducing agent present in the system and 
in fact the reaction proceeds in an oxidising environment, therefore raising the 
question as to how the reaction proceeds and what is the mechanism of action of 
this procedure.
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D M SO
57 e 73
Scheme 32: Synthesis of 6-methoxybenzothiazole
The reaction was found to go to completion in 1 h with an excellent yield of 93 %, 
with a brine wash the only method of purification to give pure product.
3.2.2.7 5-Fluoro Benzothiazole Compounds
The final set of benzothiazoles synthesised were 5-fluorobenzothiazoles, which are
of particular importance. The sodium metabisulfite reaction was tested with bis(2- 
amino-4-fluorophenyl)disulfide 68 to ascertain whether this reaction gives the 
expected 5-fluorobenzothiazole 74. Some of these compounds have exquisite 
biological activity in particular as described earlier, their anticancer activity is 
demonstrated by Phortress 15 and PMX 610 23. More recently also their potential 
as PET imaging agents has been reported.
n h 2
68
Na2S20.
+  H'
DM SO
R2
R 1; R 2 = O M e, N 0 2
Scheme 33: Synthesis of 5-flurobenzothiazoIes
From Table 32 below, it is clear that the reaction proceeds in short reaction time 
with excellent yield.
Table 32: Reaction time and yields of 5-fluorobenzothiazoles
Benzaldehyde Product Time (min) Yield (%)
3,4-dimethoxy 23 60 87
4-nitro 74 a 60 90
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was an aqueous wash. However, in a small number of instances a wash through a 
short plug of silica was required. Although some products required this extra 
purification this method shows clear advantages over literature methods in: the use 
of mild reaction conditions, short reaction times with limited number of synthetic 
steps, and ease of purification.
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4 Solid Phase Synthesis of Benzothiazoles
Solid phase synthesis and in particular polymer-supported synthesis is an efficient 
methodology for the construction of compound libraries as it facilitates handling, 
purification, and separation of products. The particular advantage of using this 
approach in synthesis is that the solid support or solid supported reagent can easily 
be filtered off at the end of the reaction, recovered and reused. A number of 
interesting literature papers have demonstrated solid phase synthesis and its ability 
to synthesise a small library of 2-phenylbenzothiazoles either substituted or 
unsubstituted on the benzothiazole ring (26 and 27) and a limited number of 
examples are shown below.
4.1 Literature Solid Phase Methods
Compared to traditional solvent based methods, the solid phase synthesis of 27 has 
been shown in the literature as an alternative and attractive method with a number 
of advantages. For example, the solid-phase combinatorial synthesis of 2- 
phenylbenzothiazoles has been described using trityl resins151,152 (Scheme 35) and 
Wang resins153,154. Here the resin is bound either directly to the thiol of the 2- 
aminothiophenol moiety prior to reaction with either carboxylic acid (derivatives) 
or aldehydes under similar reaction conditions to solution phase synthesis. The 
successful synthesis of diverse compounds having various functional groups in 
small scale (30 mg scale) has been achieved.
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COCI DIPEA
DM F
TES TFA
Scheme 35: Synthesis of benzothiazoles by resin bound 2-aminothiophenol
The preparation of an array of benzothiazoles from polymer-bound esters has also 
been disclosed155 and the solid-phase synthesis of 2-phenylbenzothaizoles has also 
been accomplished using a traceless 4-alkoxyaniline linker, where the desired 
products were released from the polymer supported azomethine intermediate 
though an imine-exchange reaction coupled with air oxidation (Scheme 36)156,157.
1) 4-formylbenzoic acid 
DMF, RT
N.
2) nBuOH, DIC 
DMAP, DCM
N
H
2-aminothiophenol 
Air, DMF, 100°C
Scheme 36: Polymer-supported synthesis of 2-phenylbenzothiazoles using a traceless aniline 
linker
Microwave-assisted condensation of Wang resin-bound esters with various 2- 
aminthiophenols in methanesulfonic acid has also been disclosed158.
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In the majority of solid-phase approaches to the synthesis of 26 and 27 either the 
aminthiophenol or the aldehyde/acid derivative has been attached to the resin/solid 
support. This restricts the diversity of the library and a new strategy involves the 
use of solid supported reagents. The successful solid phase synthesis of 2- 
phenylbenzothiazoles both substituted and unsubstituted in the benzothiazole ring 
has been accomplished using the solid supported hypervalent iodine reagent 
poly[4-diacetoxyiodo]styrene (PDAIS)159, Scheme 37.
Scheme 37: Synthesis of benzothiazoles using PDAIS
The presence of PDAIS accelerates the synthesis of benzothiazoles by fast 
oxidation of the intermediate. Another important benefit is that after reaction 
PDAIS can be recovered by filtration and reused following re-oxidation of the 
iodosytrene by-product.
It was anticipated that this polymer-supported reagent methodology could also be 
applied to the synthesis of benzothiazoles based on the methodology reported in 
the previous chapters. In the majority of literature methods for the synthesis of 
benzothiazoles substituted in the benzothiazole ring, 27, (using the disulfide 
methods (3.2.1) the most commonly used agent to reduce the disulfide to the thiol 
is triphenylphosphine. As stated previously this causes complications in product 
isolation due to the formation of triphenylphosphine oxide. Taking inspiration 
from the above paper where solid supported reagents are shown to facilitate 
handling and purification of polymer-bound intermediates and separation of 
products it was envisaged that a polymer supported triphenylphosphine in the 
reaction would enable easier product purification.
R P
^  l(OAc)2
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4.2 Polymer-supported Synthesis of Benzothiazoles
Although a viable method (as illustrated in chapter 3) was developed for the 
synthesis of benzothiazoles substituted in the benzothiazole ring, a further solid- 
phase approach was probed. As shown above a number of solid-phase polymer 
supported methods have been developed for the synthesis of libraries of 
benzothiazole molecules and advantages that these approaches hold is in their ease 
of purification. Triphenylphosphine, a reagent used in the synthesis of 
benzothiazoles is available commercially (3.2 mmol/g triphenylphosphine loading) 
attached to a polymer resin. The key advantage here is that the phosphine oxide 
by-product remains bound to the polymer and is thus easily separated from the 
soluble benzothiazole product by filtration. To test this hypothesis, a small number 
of 6-fluoro benzothiazoles (69) were synthesised (Scheme 38).
Scheme 38: Polymer supported synthesis of 6 -fluorobenzothiazoles
Initial reaction conditions utilised dry acetonitrile as solvent with polymer- 
supported triphenylphosphine. After prolonged reaction times, a mixture of 
products was obtained and therefore an alternative method was sought. The 
corresponding benzaldehyde and disulfide were reacted with polymer-supported 
triphenylphosphine with /?-toluenesulfonic acid in toluene as an alternative 
reaction160. Here the reaction was found to proceed smoothly in a short reaction 
time however final product was found to be contaminated with benzaldehyde in all 
cases. Removal o f the excess aldehyde was unsuccessful using Girard’s Reagent 
T161 and variation of molar quantity had no significant effect on reducing residual 
benzaldehyde present in the product. Therefore, column chromatography was 
necessary to separate the product from starting material. However, based on the 
study carried out by Hughes et al using DMF as a co-solvent160 the desired 6-
o
O  C6H4-P(C6H5)2
57 a 69
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fluorobenzothiazoles were synthesised without the need for chromatographic 
separation (Table 33).
Table 33: Reaction time and yield of polymer-supported synthesis of 6 -fluorobenzothiazoles
Benzaldehyde Product Time (min) Yield (%)
4-methoxy 69 a 70 88
4-hydroxy 69 d 90 87
4-nitro 69 e 60 93
4-cyano 69 h 120 89
4-bromo 69 k 60 92
The reaction is successful with a number of benzaldehydes, as can be seen above. 
In comparison to literature solution-phase methods this procedure was 
advantageous as purification of product was a simple filtration through Celite® to 
remove the polymer support and any traces of by-products followed by a washing 
with brine to remove residual solvent.
The polymer-supported reaction is also applicable starting from bis(2-amino-5- 
ethoxyphenyl)disulfide (Scheme 39) and results (Table 34) from this reaction 
showed a decrease in reaction time in comparison to the earlier reported method 
(3.2.2.2)
Q  C6H4-P(C6H5)2
PTSA
EtO
T oluene/D M F
EtO
57 b 70
Scheme 39: Polymer supported synthesis of 6 -ethoxybenzothiazoles
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Table 34: Reaction time and yield of polymer-supported synthesis of 6 -ethoxybenzothiazoles
Benzaldehyde Product Time (min) Yield (%)
4-methoxy 70 b 60 87
4-nitro 70 f 70 87
4-bromo 70 i 60 80
4-hydroxy 70 k 60 94
Finally the reaction was used to form benzothiazoles unsubstituted in the 
benzothiazole ring (Scheme 40) and as can be seen from the results below (Table 
35) a number of benzothiazoles were successfully synthesised.
^ ------ C6H4-P(C6H5)2
PTSA
Toluene/D M F
\/R
28 26
Scheme 40: Polymer-supported synthesis of benzothiazoles unsubstituted in the benzothiazole 
ring
Table 35: Polymer-supported synthesis of benzothiazoles unsubstituted in the benzothiazole
Benzaldehyde Product Time (min) Yield (%)
4-methoxy-26a 26 b 90 97
3,4,5-trimethoxy-26d 26 d 120 92
3-nitro-26g 26 f 120 94
4-nitro-26h 26 g 120 83
4-bromo-26m 261 60 86
4-hydroxy-26f 43 90 97
In the case of 4-nitro and 4-bromo benzothiazoles further purification was 
necessary. Here the samples were recrystalised from methanol to give pure 
product. Reaction times were comparable to the previous reactions (2.5) and only 
benzaldehydes with electron donating groups showed a decrease in reaction time.
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4.3 Summary
In conclusion the use of polymer-supported triphenylphosphine improved on the 
analogous solution-phase method, as it eliminated the need for column 
chromatography. However, in comparison to the sodium metabisulfite method few 
enhancements in reaction conditions were found. Due to the expense of the 
polymer-supported reagent it is suggested that the sodium metabisulfite method is 
the most favourable when synthesising benzothiazoles from disulfides in future.
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As can be seen from the previous chapters, a number of both known and unknown 
small molecule benzothiazoles were synthesised. Antitumour evaluation for these 
compounds was tested on four human cancer cell lines, namely, A549 (non-small 
cell lung), LoVo (colorectal), MCF7 (breast), and PC3 (prostate) using an MTT 
assay. Analysis was undertaken in the TENOVUS laboratories at the Welsh 
School of Pharmacy, Cardiff University by Mr. Huw Mottram. It was of particular 
interest to see if the novel compounds had activity on MCF-7 cells as previous 2- 
phenylbenzothiazoles had shown interesting activity on this cell line38,44.
5.1 Principles of the MTT assay
The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay 
was first described by Mossmann in 1983 . It is based on the ability of a
mitochondrial dehydrogenase enzyme from viable cells to cleave the tetrazolium 
rings of the MTT and form purple crystals which are largely impermeable to cell 
membranes. This results in their accumulation within healthy cells. The number of 
active cells is directly proportional to the level of purple formazan product created 
and the colour can be quantified using a multiwall scanning spectrophotometer.
Mitochondrial
Reductase
Scheme 41: Reduction of MTT to formazan
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5.2 Assay Protocol
Anti-tumour evaluation in A549, LoVo, MCF7, and PC3 cell lines was performed 
using the MTT assay. Compounds were prepared as 0.1-100 mM stock solutions 
dissolved in DMSO and stored at -20 °C. Cells were seeded into 96-well microtitre 
plates at a density o f 5* 103 (MCF7 and LoVo) and 3x 103 cells per well (PC3 and 
A549), and allowed 24 hours to adhere. Decimal dilutions of compounds were 
prepared in cell growth medium immediately prior to each assay (PC3 and Lovo in 
DMEM +10% FCS, A549 and MCF7 in RPMI + 10% heat inactivated FCS), final 
concentrations o f 0.1 - 100 pM. Following 96 hours of compounds exposure at 37 
°C, 5% CO2, and MTT reagent (Sigma Aldrich) were added to each well (final 
concentration 0.5 mg/mL). Incubation at 37 °C for 4 hours allowed reduction of 
MTT by viable cells to an insoluble formazan product. MTT was removed and 
formazan solubilised by addition of 10% Triton X-100 in PBS. Absorbance was 
read on a Tecan Sunrise plate reader at 540 nm as a measure of cell viability; thus 
inhibition relative to control was determined (IC50).
5.3 Determination of IC50
MTT assay was carried out for each compound; serial dilutions were used from 0.1 
to up to 100 pM. The results obtained were plotted as a Dose-Response curve 
using OriginPro® Software and IC50 values calculated.
5.4 Results
5.4.1 Results for Benzothiazoles Unsubstituted in the 
Benzothiazole Ring
Data obtained from the evaluation of a series of benzothiazoles unsubstituted in
the benzothiazole ring on human cancer cell lines A549, L0 V0 , MCF-7, and PC3 
are summarised in Table 36.
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5.4.2 Results for Benzothiazoles Substituted in the 
Benzothiazole Ring
Data obtained from the evaluation of a series of benzothiazoles substituted in the 
benzothiazole ring on human cancer cell lines A549, LoVo, MCF-7, and PC3 are 
summarised in Table 37 and Table 38.
Table 37: ICso Values (jiM) for 6 -nitro, 6 -fluoro and 6 -ethoxybenzothiazoles
Com pound No. A549
(pM)
LoVo
(H M )
MCF-7
(pM)
PC3
(pM)
60 b (R=N02, R,=OMe, R2=OMe, R3=H) >100 50 50 40
69 a (R=F, R,=H, R2=OMe, R3=H) >100 >100 >100 >100
69 b (R=F, R,=OMe, R2=OMe, R3=H) >100 >100 90 >100
69 C (R=F, R,=OMe, R2=OMe, R3=OMe) 100 90 50 >100
69 e  (R=F, R]=H, R2= n o 2, R3=H) 50 >100 50 >100
69 f  (R=F, R,=OMe, R2=H, R3=H) >100 >100 >100 >100
69 h (R=F, R,=H, R2=CN, R3=H) 60 >100 40 >100
69 i (R=F, Rj=F, R2=H, R3=H) >100 >100 >100 >100
69 j (R=F, R,=C1, R2=H, R3=H) 60 100 50 >100
69 k (R=F, R,=H, R2=Br, R3=H) >100 >100 8 >100
70 a (R=OEt, R,=OMe, R2=H, R3=H) >100 >100 >100 >100
70 b (R=OEt, R,=H, R2=OMe, R3=H) >100 >100 >100 >100
70 C (R=OEt, R,=OMe, R2=OMe, R3=H) >100 >100 >100 >100
70 e  (R=OEt, r , = n o 2, r 2= h , R3=H) >100 >100 >100 >100
70 f (R=OEt, Rj=H, R2-N 0 2, R3=H) >100 >100 >100 >100
70 h (ROEt, R,=F, R2=H, R3=H) >100 >100 >100 >100
70 i (R=OEt, R]=H, R2=Br, R3=H) >100 >100 >100 >100
70 I (R=OEt, Ri=Cl, R2=H, R3=H) >100 50 50 >100
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Table 36: IC50 values (jiM) for benzothiazoles unsubstituted in the benzothiazole ring
r2
R3
i Compound No. A549 L0 V0 MCF-7 PC3
(pM) (pM) (pM) (pM)
26 a (R,=OMe, R2=H, R3=H) >100 >100 50 >100
26 b (R,=H, R2=OMe, R3=H) >100 50 50 >100
26 C (R,=OMe, R2=OMe, R3=H) >100 >100 >100 50
26 d (R]=OMe, R2=OMe, R3=OMe) >100 >100 >100 >100
26 e  (R,=OH, R2=H, R3=H) >100 50 50 >100
26 f  (r ,=no2, r2=h , R3=H) >100 >100 >100 >100
26 g  (R|=H, R2=N02, R3=H) 5 >100 50 >100
26 h (R,=H, R2=CN, R3=H) >100 80 80 >100
26 i (Rt=H, R2=CF3, R3=H) >100 90 >100 >100
26 j (R,=F, R2=H, R3=H) >100 >100 >100 >100
26 k (R,=C1, R2=H, R3=H) >100 100 50 >100
26 1 (R,= R2=Br, R3=H) >100 >100 >100 >100 !
43 (Ri=H, R2=OH, R3=H) 50 50 50 50
Based on the above data, the colon and breast cell lines were the most 
chemosensitive cell lines. The most potent compound of the series was 26 g (2-(4- 
nitrophenyl)benzothiazole) with an IC50 value of 5 pM against A549 cell line.
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4-Hydroxybenzaldehyde (1.83 g, 15 mmol) was dissolved in dry DMF (45 mL) 
and cooled to -5 °C. Sodium hydride (0.94 g, 39 mmol) was added under stirring. 
After 1 h /?-methoxybenzyl bromide (2.16 mL, 15 mmol) in dry DMF (30 mL) was 
added dropwise to the reaction mixture over 1 h and allowed to stand for a further 
hour at -5 °C. The reaction was quenched with ice water, concentrated to an oil, 
extracted with dichloromethane, dried, concentrated, and recrystalised from 
ethanol to give 37 as a yellow solid in 77% yield (2.8 g).
'H-NMR (500MHz, CDC13) 6 (ppm) 9.92 (s, 1H, CHO), 7.86 (d, 2H, J=8.5Hz, H- 
2, H-6), 7.38 (d, 2H, J=9Hz, H -2\ H-6’), 7.09 (d, 2H, J=9Hz, H-3, H-5), 6.96 (d, 
2H, J=9Hz, H-3’, H-5’), 5.10 (s, 2H, CH2) 3.85 (s, 3H, OCH3)
13C-NMR (125MHz, CDC13) 5 (ppm) 190.83, 163.83, 159.73, 132.01, 130.04, 
129.34, 127.91, 115.14, 114.15, 70.12, 55.34
Synthesis of 2-(4-methoxybenyloxy)-5-methylbenzaldehyde [38J
C i6H ]60 3 
Mol. Wt.: 256.30
H
2-hydroxy-5-methylbenzaldehyde (0.68 g, 5 mmol) was dissolved in dry DMF (15 
mL) and cooled to -5 °C. Sodium hydride (0.31 g, 13 mmol) was added under 
stirring. After 1 h /?-methoxybenzyl bromide (0.72 mL, 5 mmol) in dry DMF (5 
mL) was added drop’Wise to the reaction mixture over lh and allowed to stand for 
a further 1 h at -5 °C. The reaction was quenched with ice water, concentrated to
OMe
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initial condensation partner was a 2-aminophenyldisulfide that was obtained by the 
basic hydrolysis of the corresponding substituted 2-aminobenzothiazole. This 
resulted in a small library of highly pure products without the need for 
chromatographic purification.
The synthesis of a number of 2-phenylbenzothiazoles either substituted or 
unsubstituted in the benzothiazole ring was also achieved by the polymer- 
supported synthesis utilising polymer-supported triphenylphosphine and p- 
toluenesulfonic acid as catalysts for the reaction.
Biological evaluation of the library of 2-phenylbenzothiazoles synthesised was 
undertaken on four cancer cell lines, namely A549, LoVo, MCF-7, and PC3. The 
compounds were most active against either MCF-7 or A549 cell lines with IC50 
values in the range of 40-60 pM for a number of compounds. Unfortunately, the 
majority of compounds showed poor anticancer activity with an average IC50 
values > 100 pM, but a small number of compounds showed excellent activity. For 
example 69 k, 71 h had an IC50 of 8 and 9 pM, respectively, against MCF-7 cell 
line. Results from the biological evaluation concluded that benzothiazoles 
containing either a fluorine or chlorine atom led to compounds with better in vitro 
activity.
6.2 Recommendation for future work
Although the results obtained in vitro against four cancer cell lines were not 
encouraging, since the majority of the compounds synthesised have the possibility 
to be labelled by either n C or 18F and structurally related molecules are already 
under evaluation as imaging agents, it is recommended that the future work on 
these known and novel compounds will focus on their potential use in PET 
imaging.
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heated under reflux and monitored by TLC until complete. On completion the 
solution was cooled to RT and then acidified to pH 6 with acetic acid in an ice 
bath. Water was added and the precipitate collected. The solid precipitate was then 
washed with excess diethyl ether and the filtrate evaporated in vacuo.
7.2.4 Standard Procedure D; Synthesis of 2- 
Phenylbenzothiazoles Substituted on the Benzothiazole 
Ring
The appropriate 4- or 5-substituted disulfide (1.00 mol/eq), substituted 
benzaldehyde (1.01 mol/eq) and sodium metabisulfite (1.01 mol/eq) was dissolved 
in DMSO. The resulting reaction mixture was stirred at 120 °C and the formation 
of the desired compound was monitored by TLC analysis. On completion of 
reaction the mixture was cooled to RT, water was added and the resulting 
precipitate was filtered. The precipitate was then washed with excess water, 
dissolved in dichloromethane and the remaining traces of sodium metabisulfite 
were removed by washing with brine. The organic layer was dried over anhydrous 
magnesium sulphate and the solvent was removed in vacuo. In some cases further 
purification was required. In these cases the sample was dissolved in 
dichloromethane and washed through a plug of silica and reduced to dryness.
7.2.5 Standard Procedure E; Solid Phase Synthesis of 
Benzothiazoles
The appropriate substituted benzaldehyde (1.00 mol/eq), p-toluenesulfonic acid 
(0.19 mol/eq) and polymer-bound triphenylphosphine (0.98 mol/eq) was added to 
either 2-aminothiophenol or the appropriate disulfide (0.98 mol/eq) in toluene and 
DMF and refluxed. Formation of the desired compound was monitored by TLC 
analysis. The mixture was then cooled, filtered through Celite® and the polymer 
was washed well with methanol. The filtrate was then washed with water (2 x 20 
mL) and brine (20 mL), then dried with anhydrous magnesium sulphate and 
evaporated in vacuo.
- 9 7 -
Chapter 7 Experimental
an oil, extracted with dichloromethane, dried, concentrated, and recrystalised from 
ethanol to give 38 as a white powder in 54% yield (700 mg).
'H-NMR (500MHz, CDC13) 5 (ppm) 10.40 (s, 1H, CHO), 7.55 (s, 1H, H-6), 7.27- 
7.23 (m, 3H, H-4, H-2’, H-6’), 6.87 (d, J=8.5Hz, 1H, H-3), 6.83 (d, J=9Hz, 2H, H- 
3’, H-5’), 5.00 (s, 2H, CH2), 3.73 (s, 3H, OCH3), 2.22 (s, 3H, CH3) 
l3C-NMR (126MHz, CDC13) 8 (ppm) 189.97, 159.64, 159.30, 136.52, 130.39, 
129.07, 128.37, 128.30, 124.97, 114.43, 113.29, 70.53, 55.31, 20.28
Synthesis o f  2-(4-m ethoxybenyloxy)-3-m ethylbenzaldehyde [39]
OMe
C 16H 16O3
| Mol. Wt.: 256.30
H
2-hydroxy-3-methylbenzaldehyde (0.68 g, 5 mmol) was dissolved in dry DMF (15 
mL) and cooled to -5 °C. Sodium hydride (0.31 g, 13 mmol) was added under 
stirring. After 1 h p-methoxybenzyl bromide (0.72 mL, 5 mmol) in dry DMF (5 
mL) was added dropwise to the reaction mixture over lh and allowed to stand for 
a further 1 h at -5 °C. The reaction was quenched with ice water, concentrated to 
an oil, extracted with dichloromethane, dried, concentrated, and recrystalised from 
ethanol to give 3 9  as a white powder in 54% yield (700 mg).
'H-NMR (500MHz, CDC13) 6 (ppm) 10.14 (s, 1H, CHO), 7.59 (d, J=7.5Hz, 1H, 
H-6), 7.36 (d, J=7.5Hz, 1H, H-4), 7.22 (d, J=8.5Hz, 2H, H-2’, H-6’), 7.05 (t, 
J=7.5Hz, 1H, H-5), 6.82 (d, J=8.5Hz, 2H, H-3’, H-5’), 4.82 (s, 2H, CH2), 3.72 (s, 
3H, OCH3), 2.26 (s, 3H, CH3)
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6.1 Conclusion and Discussion
2-Phenylbenzothiazoles have emerged in recent years as an important 
pharmacophore in a number of therapeutic and diagnostic settings. Although there 
are a number of documented procedures for their synthesis the majority of these 
cases refer to those benzothiazoles unsubstituted in the benzothiazole ring. 
Conversely, the majority of 2-phenylbenzothiazoles with biological activity are 
substituted in the benzothiazole ring. Moreover, the majority of those limited 
number of synthetic routes, involve either the use of harsh reaction conditions, 
multi-step synthesis or chromatographic purification which are time-consuming, 
laborious, expensive and subsequently not desirable.
The aim of the work presented in this thesis was to establish a novel method for 
the synthesis of biologically relevant 2-phenylbenzothiazoles that would allow 
access to a range of 2-phenylbenzothiazoles and more importantly the developed 
method would require minimal purification and in particular would require no 
chromatographic purification.
A simple one-step procedure for the synthesis of 2-phenylbenzothiazoles 
unsubstituted in the benzothiazole ring was developed under both thermal and 
microwave-promoted conditions. It was found that the condensation of 2- 
aminothiophenol with substituted benzaldehydes in the presence of sodium 
metabisulfite and DMSO produced high yielding products with short reaction 
times and simple product isolation without the need for column chromatography.
The methodology Was extended to the synthesis of biologically relevant 2- 
phenylbenzothiazoles substituted in the benzothiazole ring. In these cases, the
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Table 38: IC50 Values (pM) for 6 -chloro, 6 -methyl and 6 -methoxybenzothiazoles
Compound No. A549 LoVo MCF-7 PC3
1
(pM) (HM) (fiM) (pM)
71 a (R=C1, R,=OMe, R2=H, R3=H) 50 >100 50 >100
71 b (R=C1, R,=H, R2=OMe, R3=H) 40 >100 >100 >100 :
71 C (R=C1, R,=H, R2=N02, R3=H) >100 >100 >100 >100 !
71 d (R=C1, R|=H, R2=CN, R3=H) >100 >100 >100 >100 :
71 e (R=C1, R,=H, R2=Br, R3=H) >100 >100 >100 >100
71 g (R=C1, R,=OMe, R2=OMe, R3=OMe)
1
>100 >100 95 >100 ;
1 71 h (R=C1, R,=OH, R2=H, R3=H) 100 40 9 ' 100 ;
71 i (R=C1, R,=N02, R2=H, R3=H) 25 >100 50 >100
72 a (R=Me, R,=H, R2=OMe, R3=H) >100 >100 >100 >100
72 b (R=Me, R,=H, R2=OH, R3=H)
..
>100 100 100 100
72 C (R=Me, R,=H, R2=Br, R3=H) >100 >100 >100 >100
72 d (R=Me, Ri=OMe, R2=OMe, R3=H) 100 100 100 100 |
72 e  (R=Me, R,=OMe, R2=OMe, R3=OMe) >100 50 50 5°
72 f  (R=Me, R]=OH, R2=H, R3=H) 50 50 50 50
73 (R=OMe, Ri=OMe, R2=OMe, R3=H) >100 >100 >100 >100
As can be seen from the results above, the majority o f compounds tested showed 
no significant activity against the four cancer cell lines.
The most active series were the 6-fluoro and 6-chlorobenzothiazoles. Here the 
most sensitive cell lines in both cases were A549 (lung) and MCF-7 (breast). In 
particular compound 69 k was shown to be potent (8 pM) against MCF-7 cell line, 
and 71 h showed low micromolar activity against MCF-7 (9 pM) and L0 V0  (40
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7.1.5 Mass Spectroscopy (MS)
High and low resolution mass spectroscopy using electroionisation (El) were run 
on a Waters GCT Premier, and using electrospray (ES) on a Waters LCT Premier 
XE. Mass spectroscopy was performed as a service by Cardiff University, School 
of Chemistry.
7.1.6 Elemental Analysis (CHN)
CHN microanalysis was performed as a service by MED AC Ltd, Surrey.
7.1.7 Microwave Chemistry
Microwave chemistry was carried out using a CEM Discover Labmate system.
7.1.8 Melting Points
Melting points are given uncorrected and were measured on a Griffen melting
point apparatus.
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7.2 Standard Procedures 
7.2.1 Standard Procedure A; Thermal Synthesis of 2- 
Phenylbenzothiazoles Unsubstituted on the 
Benzothiazole ring by the Sodium Metabisulfite Method
2-aminothiophenol (1.00 mol/eq), the appropriate substituted benzaldehyde (1.01
mol/eq) and sodium metabisulfite (1.01 mol/eq) were dissolved in DMSO. The 
resulting reaction mixture was stirred at 120 °C and the formation of the desired 
compound was monitored by TLC analysis. On completion of reaction the mixture 
was cooled to RT, water was added and the resulting precipitate was filtered. The 
precipitate was then washed with excess water, dissolved in dichloromethane and 
the remaining traces of sodium metabisulfite were removed by washing with brine. 
The organic layer was dried over anhydrous magnesium sulphate and the solvent 
was removed in vacuo. It should be noted that sulfur oxide is liberated in this 
reaction and therefore the reaction should be carried out in a ventilated area at all 
times.
7.2.2 Standard Procedure B; Microwave Synthesis of 2- 
Phenylbenzothiazoles Unsubstituted on the 
Benzothiazole ring by the Sodium Metabisulfite Method
A mixture of 2-aminothiophenol (1.00 mol/eq), the appropriate substituted
benzaldehyde (1.01 mol/eq) and sodium metabisulfite (1.01 mol/eq) in DMSO was 
either stirred or sonicated to form a homogeneous mixture. The sealed vessel was 
then placed in the microwave and irradiated at 120 °C with a power of 100W and a 
maximum pressure of 100 psi for a time ranging between 25 min to an hour. The 
reaction mixture was allowed to cool to RT, excess water was added and the solid 
precipitate was collected by filtration. The precipitate was washed with excess 
water, and reduced to dryness.
7.2.3 Standard Procedure C; Synthesis of 2-Aminodisulfide
The appropriate 5- or 6-substituted 2-aminobenzothiazole (1 mol/eq) was added to
a solution of potassium hydroxide (15 mol/eq) in water. The resulting mixture was
- 9 6 -
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7.1 General Experimental Conditions
7.1.1 Solvents and Reagents
The following anhydrous solvents were bought from Aldrich with subaseal
stopper; Chloroform (CHCI3), dichloromethane (DCM), diethyl ether (Et20), N,N- 
dimethylformamide (DMF). All other reagents commercially available were used 
without further purification.
7.1.2 Thin Layer Chromatography (TLC)
Precoated, aluminium backed plates (60 F254, 0.2mm thickness, Merck) were
visualized under both short and long wave ultraviolet light (254nm and 366nm).
7.1.3 Column Chromatography (CC)
Column chromatography processes were carried out using silica gel supplied by 
Fischer (60A, 35-70pm). Glass columns were slurry packed using the appropriate 
eluent and samples were applied either as a concentrated solution in the same 
eluent or pre-absorbed on silica gel.
7.1.4 Nuclear Magnetic Resonance (NMR)
'H-NMR (500 MHz), 13C-NMR (126 MHz), 31P-NMR (202 MHz) and 19F-NMR
(471 MHz) were recorded on a Bruker Avance 500MHz spectrometer at 25°C. 
Spectra were calibrated to the residual signal of the deuterated solvent used. 
Chemical shifts are given in parts per million (ppm) and coupling constants (J) in 
Hertz.
The following abbreviations are used in the assignment of NMR signals; s 
(singlet), d (doublet), t (triplet), q (quartet), m (multiplet), bs (broad singlet), dd 
(doublet of doublet),_dt (doublet of triplet).
- 9 4 -
Chapter 7 Experimental
7.3 Protection Reactions
Synthesis o f  4-triisopropylsilanyloxybenzaldehyde9 8 [361
o
H ( Ci6H2602Si Mol. Wt.: 278.46
Si
O'
>
CF3SO3H (0.52 mL, 4 mmol) was added to triisopropylsilane (1.09 mL, 8 mmol) 
at 0 °C. The mixture was stirred at RT for 15 h. A solution of 4- 
hydroxybenzaldehyde (0.49 g, 4 mmol) and 2, 6-lutidine (0.95 mL, 9 mmol) in dry 
dichloromethane (10 mL) was added. After 4 h the reaction was quenched with 
water, extracted with dichloromethane, and purified by column chromatography 
with 4:1 ethyl acetate/hexane to give 36 as an orange solid in 91% yield (1.02 g)
4-Hydroxybenzaldehyde (2.00 g, 16.4 mmol), triisopropylsilane chloride (3.6 mL, 
16.9 mmol) and imidazole (2.54 g, 37.3 mmol) in DMF (57 mL) was stirred at RT 
overnight. The reaction was quenched with water and extracted with chloroform 
followed by 10%HC1. The solution was concentrated to give 36 as a yellow oil in 
60% yield (2.72 g)
1 H-NMR (500MHz, CDC13) 5 (ppm) 9.90 (s, 1H, CHO) 7.80 (d, 2H, J=8.5Hz, H- 
2, H-6), 7.00 (d, J=8.5Hz, 2H, H-4, H-7), 1.32 (septet, J=7.5Hz, 3H,_CH-(CH3)3),
1.14 (s, 18H, J=8.5Hz, CH-(C H ^ )
Synthesis o f  4-(4-m ethoxybenzyloxy)-benzaldehyde101 [37]
0
C15H14O3 
Mol. Wt.: 242.27
Chapter 7 Experimental
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pM). 71 i also showed low micromolar activity against A549 (25 pM) and MCF-7 
(50 pM). Compounds 69 c, 69 e, 69 j, 69 h, 71 a, and 71 b all showed moderate 
activity against either cell line in the micromolar range 40-60 pM.
The majority of either the 6 -ethoxy or 6 -methyl benzothiazoles synthesised 
showed poor activity against all of the cancer cell lines. 70 1, 72 e, and 72 f  showed 
moderate activity (50 pM) against either LoVo or MCF-7 cell lines.
Unfortunately, 6 -methoxy benzothiazole did not show any anticancer activity on 
the cell lines. However, the 6 -nitrobenzothiazole, 60 b, showed moderate activity 
against LoVo, MCF-7, and PC3 (50, 50, and 40 pM respectively).
5.5 Summary
In conclusion, a number of known and novel benzothiazole containing compounds 
were synthesised and tested on four cancer cell lines. Unfortunately, the majority 
of these compounds showed no significant anticancer activity. Of the four cell 
lines on which the compounds were evaluated, the most active were on either the 
A549 or MCF-7 cell line. In particular, it was found that where compounds 
contained a halogen group, a significant increase in activity was found compared 
to non-halogenated compounds. In agreement with previously reported 
benzothiazoles, it was also found here that a 6 -fluoro group on the benzothiazole 
led to compounds with better in vitro activities38,44.
Although the library of compounds did not show significant anticancer activity,
they still hold the potential as PET imaging tracers in either n C labelling or more
1 8importantly labelled with the longer lived F radionuclide.
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dichloromethane, extracted with water, dried, and concentrated to give 52 as a 
white solid in 70% yield (1.53 g)
A mixture of methyl-4-hydroxy benzoate (0.79 g, 5.25 mmol), /?-methoxybenzyl 
bromide (1.1 mL, 5 mmol), K2CO3 (2.06 g, 15 mmol), 18-crown-6 (0.02 g, 0.09 
mmol) and acetone (37 mL) was stirred at RT under N2 for 48 h. The solvent was 
removed the solid was diluted with dichloromethane, washed with sat. NaHC03 
and brine, dried and recrystalised from dichloromethane to give the product 52 as a 
white solid in 89% yield (1.21 g).
*H (500MHz, CDCI3) 5 (ppm) 7.91 (d, J=9.0Hz, 2H, H-2, H-6 ) 7.28 (d, J=8.5Hz, 
2H, H-2’, H-6 ’), 6.90 (d, J=9.0Hz, 2H, H-3, H-5), 6.85 (d, J= 8.5Hz, 2H, H-3’, H- 
5’), 4.96 (s, 2H, C H 2), 3.80 (s, 3H, C O O C H 3 ), 3.74 (s, 3H, O C H 3)
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‘H-NMR (500MHz, CDCIj) 5 (ppm) 8.06 (d, J=8Hz, 1H, H-4), 7.90 (d, J=8Hz, 
1H, H-7), 7.74 (d, 2Hz, 1H, H-2’), 7.63 (dd, J=2, 8Hz 1H, H-5’), 7.49 (dt, J=2, 
8Hz 1H, H-6), 7.38 (dt, J= l, 8Hz,lH, H-5 ), 6.97 (d, J=8.5Hz, 1H, J-6’ ), 4.05 (s, 
3H, OMe), 3.98 (s, 3H, OMe)
13C-NMR (126MHz, CDC13) 6 (ppm) 167.93, 154.18, 151.61, 149.39, 134.93, 
126.72, 126.23, 124.89, 122.86, 121.50, 121.16, 111.07, 109.86, 56.15.
MS (El positive ion) m/z 271.07 (M+)
Synthesis o f  2-(3, 4, 5-trim ethoxyphenyl)benzothiazole [26 d]
OMe
Ci6H15N 03S 
OMe Mol. Wt.: 301.36
OMe
Prepared according to Standard Procedure A, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 3, 4, 5-trimethoxybenzaldehyde (0.31 g, 1.58 mmol), sodium 
metabisulfite (0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was 
stirred at 120 °C for 35 min. Water was added, the precipitate was collected and 
washed to give 26 d as a yellow solid in 81% yield (382 mg).
Prepared according to Standard Procedure B, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 3,4,5-trimethoxybenzaldehyde (0.31 g, 1.58 mmol), sodium 
metabisulfite (0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was 
irradiated at 120 °C for 45 min. Water was added and the product was isolated by 
extraction with DCM to give 26 d as a yellow solid in 76% yield (357 mg).
Prepared according to Standard Procedure E, from 3,4,5-trimethoxybenzaldehyde 
(0.14 g, 0.73 mmol), p-tolunesulfonic acid (0.02 g, 0.14 mmol), polymer-bound 
triphenylphosphine (0.24 g, 0.74 mmol), and 2-aminothiophenol (0.08 mL, 0.74 
mmol), in toluene (7.5 mL) and DMF (1.5 mL). The reaction mixture was refluxed
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for 120 min, cooled, filtered through Celite® washed with methanol followed by 
subsequent extraction with water and brine. The resulting product was evaporated 
to dryness to give 26 d as a white solid in 92% Yield (39 mg).
Mp=142-145 °C Lit =141-144 °C152
*H-NMR (500MHz, d6-DMSO) 8 (ppm) 8.14 (d, J=8Hz, 1H, H-4), 8.07 (d, J=8Hz, 
1H, H-7), 7.51 (dt, J= 1.5, 8Hz, 1H, H-5), 7.46 (dt, J=1.5, 8Hz 1H, H-6), 7.34 (s, 
2H, H-2’, H-6’), 3.92 (s, 6H, OMe ), 3.76 (s, 3H, OMe)
13C-NMR (126MHz, d6-DMSO) 8 (ppm) 167.09, 153.44, 153.36, 140.25, 134.52, 
128.27, 126.61, 125.38, 125.70, 122.19, 104.47, 60.20, 56.11.
MS (El positive ion) m/z 301.07 (M+)
Synthesis o f 3-Benzothiazol-2-yl-phenol [26 ej
OH
C13H9NOS 
Mol. Wt.: 227.28
Prepared according to Standard Procedure A, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 3-hydroxybenzaldehyde (0.19 g, 1.58 mmol), sodium metabisulfite 
(0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was stirred at 120 
°C for 30 min. Water was added, the precipitate was collected and washed to give
26 e as a white solid in 86% yield (305 mg).
Prepared according to Standard Procedure B, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 3-hydroxybenzaldehyde (0.19 g, 1.58 mmol), sodium metabisulfite 
(0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was irradiated at 
120 °C for 30 min. Water was added, the precipitate was collected and washed to
give 26 e as a white solid in 84% yield (300 mg).
Mp= 159-160 °C, lit 161-163 °C77
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‘H-NMR (500MHz, d6-DMSO) 8 (ppm) 9.92 (s, 1H, OH), 8.13 (d, J=8 Hz, 1H, H-
l3C-NMR (126MHz, CDC13) 8 (ppm) 167.32, 157.96, 153.49, 134.34, 134.01,
Prepared according to Standard Procedure A, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 3-nitrobenzaldehyde (0.23 g, 1.58 mmol), sodium metabisulfite (0.30 
g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was stirred at 120 °C for 
120 min. Water was added, the precipitate was collected and washed to give 26 f 
as a brown solid in 75% yield (300 mg).
Prepared according to Standard Procedure B, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 3-nitrobenzaldehyde (0.23 g, 1.58 mmol), sodium metabisulfite (0.30 
g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was irradiated at 120 °C 
for 90 min. Water was added, the precipitate was collected and washed to give 26 f 
as a brown solid in 80% yield (310 mg).
Prepared according to Standard Procedure E, from 3-nitrobenzaldehyde (0.11 g, 
0.73 mmol), p-tolunesulfonic acid (0.02 g, 0.14 mmol), polymer-bound 
triphenylphosphine (0.24 g, 0.74 mmol), and 2-aminothiophenol (0.08 mL, 0.74 
mmol), in toluene (7-5 mL) and DMF (1.5 mL). The reaction mixture was refluxed 
for 120 min, cooled, filtered through Celite® washed with methanol followed by
4), 8.06 (d, J=8Hz, 1H, H-7), 7.56-7.50 (m, 3H, H-2’, H-5’, H-6’), 7.46 (dt, J=l, 
8Hz, 1H, H-5), 7.37 (t, J=8Hz, 1H, H-6), 6.92-7.96 (m, 1H, H-4’)
130.51, 126.58, 125.47, 122.83, 122.27, 118.52, 118.07, 113.42 
MS (El positive ion) m/z 227.04 (M+)
Synthesis o f  2-(3-Nitrophenyl)benzothiazole [26 f]
no2
// C13H8N2O2S
Mol. Wt.: 256.28
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13C-NMR (126MHz, CDC13) 8  (ppm) 190.33, 160.19, 159.99, 137.53, 132.57, 
130.48, 130.15, 128.19, 126.40, 123.91, 114.12, 77.56,55.31, 16.36
Synthesis o f Para m ethoxybenzyl brom ide104 [51]
» y OMe CsHgBrO
J  \ — J  Mol. Wt.: 201.06
Para-methoxy benzyl alcohol (2.76 g, 20 mmol) was dissolved in dry 
dichloromethane (33 mL) and cooled to 0 °C. PBr3 (20 mL, 20 mmol) was added 
dropwise and the reaction was warmed to RT and stirred overnight. On completion 
the reaction was quenched with sat. NaHC0 3 , extracted with dichloromethane, 
dried and concentrated to give 51 as a yellow oil in 87% yield (3.53 g).
‘H-NMR (500MHz, CDCI3) 5 (ppm) 7.25 (d, 2H, J=8.5Hz, H-2, H-6 ) 6.79 (d, 2H, 
J=8.5Hz, H-3, H-5), 4.42(s, 2H, CH2), 3.73(s, 3H, OCH3)
l3C-NMR (126MHz, CDCI3) 8  (ppm) 162.62, 130.43, 129.97, 114.22, 55.32, 33.94 
Synthesis o f  4-(4-m ethoxybenzyloxy)benzoic acid m ethyl ester [52]
C 1 6 H 1 6 O 4
Mol. Wt.: 272.30
A mixture of methyl-4-hydroxy benzoate (1.21 g, 8 mmol), /?-methoxybenzyl 
bromide (1.8 mL, 8 mmol), K2CO3 (2.21 g, 16 mmol), and DMF (60 mL) was 
stirred at 40 °C overnight. The reaction was cooled to RT and water (100 mL) was 
added. After stirring for 10 min the solid precipitate was filtered, dissolved in
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7.4 Synthesis of Unsubstituted Benzothiazoles
Synthesis o f  2-(3-m ethoxyphenyl)benzothiazole [26 a]
OMe
C14H i,NOS 
Mol. Wt.: 241.31
Prepared according to Standard Procedure A, from 2-aminothiophenol (0.15 mL,
1.56 mmol), m-anisaldehyde (0.19 mL, 1.58 mmol), sodium metabisulfite (0.30 g,
1.58 mmol), and DMSO (5 mL). The reaction mixture was stirred at 120 °C for 25 
min. Water was added, the precipitate was collected and washed to give 26 a as an 
orange solid in 80% yield (301 mg).
Prepared according to Standard Procedure B, from 2-aminothiophenol (0.15 mL,
1.56 mmol), m-annisaldehyde (0.19 mL, 1.58 mmol), sodium metabisulfite (0.30 
g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was irradiated at 120 °C 
for 30 min. Water was added and the product was isolated by extraction with 
DCM to give 26 a as an orange solid in 70% yield (265 mg).
Mp= 80-81 °C, Lit = 81 -82 °C'63
'H-NMR (500MHz, CDC13) 8 (ppm) 7.98 (d, J=8Hz, 1H, H-4), 7.79 (d, J=8Hz, 
1H, H-7), 7.58 (s, 1H, H-2’), 7.54 (d, J=7.5Hz, 1H, H-6’), 7.39 (t, J=7.5Hz, 1H, H-
5), 7.30-7.27 (m, 2H, H-6, H-5’), 6.95-6.93 (m, 1H, H-4’), 3.81(s, 3H, OMe) 
,3C-NMR (126MHz, CDC13) 5 (ppm) 167.96, 160.09, 154.05, 135.09, 134.91, 
130.04, 126.33, 125.24, 123.26, 121.61, 120.26, 117.38, 112.09, 55.53 
MS (El positive ion) m/z 241.06 (M+)
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Synthesis o f 2-(4-m ethoxyphenyl)benzothiazole [26 bj
OMe
CuHuNOS 
Mol. Wt.: 241.31
Prepared according to Standard Procedure A, from 2-aminothiophenol (0.15 mL,
1.56 m m ol),/7-anisaldehyde (0.19 mL, 1.58 mmol), sodium metabisulfite (0.30 g,
1.58 mmol), and DMSO (5 mL). The reaction mixture was stirred at 120 °C for 35 
min. Water was added, the precipitate was collected and washed to give 26 b as a 
white solid in 83% yield (315 mg).
Prepared according to Standard Procedure B, from 2-aminothiophenol (0.15 mL,
1.56 mmol),/?-anisaldehyde (0.19 mL, 1.58 mmol), sodium metabisulfite (0.30 g,
1.58 mmol), and DMSO (5 mL). The reaction mixture was irradiated at 120 °C for 
30 min. Water was added and the product was isolated by extraction with DCM to 
give 26 b as a white solid in 76% yield (289 mg).
Prepared according to Standard Procedure E, from /?-annisaldehyde (0.09 mL, 0.73 
mmol), p-tolunesulfonic acid (0.02 g, 0.14 mmol), polymer-bound 
triphenylphosphine (0.24 g, 0.74 mmol), and 2-aminothiophenol (0.08 mL, 0.74 
mmol), in toluene (7.5 mL) and DMF (1.5 mL). The reaction mixture was refluxed 
for 90 min, cooled, filtered through Celite® washed with methanol followed by 
subsequent extraction with water and brine. The resulting product was evaporated 
to dryness to give 26 b as a white solid in 97% yield (33 mg).
Mp= 122-124 °C Lit = 123-125 °C85
1 H-NMR (500MHz, CDC13) 5 (ppm) 7.97-7.94 (m, 3H, H-2’, H-6 ’, H-4), 7.79 (d, 
J=7.5Hz, 1H, H-7), 7.39 (t, J=7.5Hz, 1H, H-5), 7.27 (t, J=7.5Hz, 1H, H-6 ), 6.93- 
6.92 (m, 2H, H-3’, H-5’), 3.81 (s, 3H, OMe)
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513C (125MHz, CDC13) 5 (ppm) 167.73, 154.06, 153.57, 140.70, 135.03, 129.02, 
126.65, 125.50, 123.25, 122.40, 105.02,30.85 
MS (El positive ion) m/z 241.05 (M+)
Anal, calcd for C mH uNOS; C, 69.68; H, 4.59; N, 5.80; found C, 69.53; H, 4.53; 
N, 5.82.
Synthesis o f 2-(3, 4-diniethoxyphenyl)benzothiazole [26 c]
OMe
Ci5H13N 02S 
OMe Mol. Wt.: 271.33
Prepared according to Standard Procedure A, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 3,4-dimethoxybenzaldehyde (0.26 g, 1.58 mmol), sodium 
metabisulfite (0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was 
stirred at 120 °C for 30 min. Water was added, the precipitate was collected and 
washed to give 26 c as a yellow solid in 8 8 % yield (372 mg).
Prepared according to Standard Procedure B, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 3,4-dimethoxybenzaldehyde (0.26 g, 1.58 mmol), sodium 
metabisulfite (0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was 
irradiated at 120 °C for 30 min. Water was added and the product was isolated by 
extraction with DCM to give 26 c as a yellow solid in 76% yield (324 mg).
3,4-Dimethoxybenzaldehyde (0.14 g, 0.87 mmol), 2-aminophenyl disulfide (0.21 
g, 0.86 mmol), and sodium metabisulfite (0.17 g, 0.87 mmol) in DMSO (3 mL) 
was heated at 120 °C for 2 h. Water was added the precipitate was collected, 
washed with water, and dried to give 26 c as a yellow solid in 72% yield (170 mg).
Mp=129-131 °C Lit =132-133 °C71
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subsequent extraction with water and brine. The resulting product was evaporated 
to dryness to give 26 f  as a brown solid in 94% yield (34 mg).
Mp= 186-188 °C, lit 183-185 °C71
1 H-NMR (500MHz, d6-DMSO) 5 (ppm) 8.84 (t, J=1.5Hz, 1H, H-2’), 8.52-8.51 (m, 
1H, H-4’), 8.43-8.41 (m, 1H, H-7’), 8.22 (d, J=7.5Hz, 1H, H-7), 8.16 (d, J=7.5Hz, 
1H, H-4), 7.88 (t, J=8 Hz, 1H, H-5’), 7.61 (dt, J=1.5, 7.5Hz, 1H, H-6 ), 7.55 (dt, 
J=l, 7.5Hz, 1H, H-5)
13C-NMR (126MHz, d6-DMSO) 6  (ppm) 164.83, 153.27, 148.40, 134.72, 134.16,
133.42, 131.21, 127.02, 126.17, 125.57, 123.29, 122.61, 121.14.
MS (El positive ion) m/z 256.02 (M+)
Synthesis o f  2-(4-Nitrophenyl)benzothiazole [26 g]
N° 2 c I3h 8n 2o 2s
Mol. Wt.: 256.28
Prepared according to Standard Procedure A, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 4-nitrobenzaldehyde (0.23 g, 1.58 mmol), sodium metabisulfite (0.30 
g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was stirred at 120 °C for 
120 min. Water was added, the precipitate was collected and washed to give 26 g 
as a brown solid in 97% yield (390 mg).
Prepared according to Standard Procedure B, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 4-nitrobenzaldehyde (0.23 g, 1.58 mmol), sodium metabisulfite (0.30 
g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was irradiated at 120 °C 
for 90 min. Water was added, the precipitate was collected and washed to give 26 
g as a brown solid in-85% yield (340 mg).
- 109-
Chapter 7 Experimental
Prepared according to Standard Procedure E, from 4-nitrobenzaldehyde (0.11 g, 
0.73 mmol), p-tolunesulfonic acid (0.02 g, 0.14 mmol), polymer-bound 
triphenylphosphine (0.24 g, 0.74 mmol), and 2-aminothiophenol (0.08 mL, 0.74 
mmol), in toluene (7.5 mL) and DMF (1.5 mL). The reaction mixture was refluxed 
for 120 min, cooled, filtered through Celite® and washed with methanol followed 
by subsequent extraction with water and brine. The product was purified by 
recrystalisation from methanol to give 26 g a brown solid in 83% yield (30 mg).
Mp= 230-232 °C, Lit = 228-230 °C85
'H-NMR (500MHz, CDC13) 8  (ppm) 8.38 (d, J= 8.5Hz, 2H, H-3’, H-5’), 8.30 (d, 
J=8.5Hz, 2H, H-2’, H-6 ’), 8.15 (d, J= 8Hz, 1H, H-4), 7.98 (d, J= 8 Hz, 1H, H-7),
7.58 (dt, J= 1.5, 8 Hz, 1H, H-5), 7.49 (dt, J= 1.5, 8 Hz, 1H, H- 6  )
13C-NMR (126M Hz, CDC13) 8 (ppm) 164.83, 154.11, 149.10, 139.19, 135.53, 
128.24, 126.97, 126.23, 124.31, 123.92, 121.84 
MS (El positive ion) m/z 256.02 (M+)
Synthesis o f  2-(4-cyanophenyl)benzothiazole [26 h]
CN Ci4H8N2S
Mol. Wt.: 236.29
Prepared according to Standard Procedure A, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 4-cyanobenzaldehyde (0.20 g, 1.58 mmol), sodium metabisulfite 
(0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was stirred at 120 
°C for 120 min. Water was added, the precipitate was collected and washed to give 
26 h as a green solid in 95% yield (350 mg).
Prepared according to Standard Procedure B, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 4-cyanobenzaldehyde (0.20 g, 1.58 mmol), sodium metabisulfite 
(0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was irradiated at
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120 °C for 30 min. Water was added, the precipitate was collected and washed to 
give 26 h as a pink solid in 98% yield (363 mg).
Mp= 169-172 °C, lit 169-170 °C164
'H-NMR (500MHz, d6-DMSO) 8  (ppm) 8.28 (d, J=8.5Hz, 2H, H-3’, H-5’), 8.21
13C-NMR (126M Hz, d6-DMSO) 5 (ppm) 165.33, 153.41, 136.68, 134.90, 133.16,
Prepared according to Standard Procedure A, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 4-(trifluoromethyl)benzaldehyde (0.21 mL, 1.58 mmol), sodium 
metabisulfite (0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was 
stirred at 120 °C for 120 min. Water was added, the precipitate was collected and 
washed to give 26 i as a pink solid in 91% yield (400 mg).
Prepared according to Standard Procedure B, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 4-(trifluoromethyl)benzaldehyde (0.21 mL, 1.58 mmol), sodium 
metabisulfite (0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was 
irradiated at 120 °C for 60 min. Water was added, the precipitate was collected and 
washed to give 26 i as a pink solid in 90% yield (395 mg).
(d, J=8.0Hz, 1H, H-4), 8.13 (d, J=8.5Hz, 1H, H-7), 8.04 (d, J=8.5, 2H, H-2’, H-6 ’), 
7.6 (td, J=1.5, 7.5Hz, 1H, H-5), 7.53 (td, J= l.l, 7.5Hz, 1H, H-6 )
127.84, 127.01, 126.22, 123.36, 122.59, 118.28, 113.35 
MS (El positive ion) m/z 236.04 (M+)
Synthesis o f  2-(4-Trifluorom ethylphenyl)benzothiazole [26 i]
Ci4H8F3NS
Mol. Wt.: 279.28
Mp= 156-159 °C, lit 1:61 -162 °C164
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A lternative m ethods for the synthesis o f  2-(2’-m ethoxybenzyloxy-5-m ethylphenyl)
benzothiazole [44]
MeO
C 22H 19N 0 2S 
M ol. Wt.: 361.46
o
Method A:
2-aminothiophenol (0.09 mL, 0.85 mmol) and 2-(4-methoxybenyloxy)-5- 
methylbenzaldehyde (0.22 g, 0.85 mmol) were dissolved in DMF (2.55 mL). To 
this was added a solution of iodine (0.10 g, 0.42 mmol) in DMF (2.5 mL) and the 
resulting solution was heated at 100 °C for 3 h. The reaction was then cooled to 
RT and 10% sodium thiosulfate was added until the iodine disappeared. The 
precipitate was filtered and washed with water and purified by column 
chromatography 1:9 ethyl acetate/hexane to give 44 in 47% yield (55 mg)
Method B:
A mixture of 2-aminothiophenol (0.33 mL, 3.13 mmol), 2-(4-methoxybenyloxy)- 
5-methylbenzaldehyde (0.80 g, 3.16 mmol) and sodium metabisulfite (0.60 g, 3.16 
mmol) in DMF (4 mL) was heated at 100 °C for 3 h. Cooled to room temperature, 
water was added and the precipitate was filtered and washed with water to give 44 
as a yellow solid in 67% yield (770 mg).
'H-NMR (500MHz, CDC13) 6  (ppm) 8.28 (s, 1H, H-6 ’), 8.00 (d, J=8 Hz, 1H, H-4), 
7.80 (d, J=8 Hz, 1H, H-7), 7.40-7.38 (m, 3H, H-5, H-8 ’, H-12’), 7.26 (t, J=8.5Hz, 
1H, H-6 ), 7.13 (d, J=8 Hz, 1H, H-4’), 6.93 (d, J=8Hz, 1H, H-3’), 6.85 (d, J=9Hz, 
2H, H-9’, H-l 1 ’), 5.15 (s, 2H, CH2), 3.75 (s, 3H, OCH3), 2.30 (s, 3H, CH3)
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‘H-NMR (500MHz, CDC13) 8 (ppm) 7.97-7.95 (m, 3H, H-5, H-2’, H-6 ’), 7.81 (d, 
J=7.5Hz, 1H, H-4), 7.41 (t, J=7.5Hz, 1H, H-6 ), 7.32-7.26 (m, 3H, H-7, H-8 \  H- 
12’), 7.00 (d, J=9Hz, 2H, H-3’, H-5’), 6 . 8 6  (d, J-9Hz, 2H, H-9’, H - l l ’), 5.00 (s, 
2H, CH2), 3.75 (s, 3H, OCH3)
13C-NMR (126MHz, CDC13) 5 (ppm) 161.26, 159.55, 155.78, 154.24, 149.02,
129.43, 128.41, 126.53, 126.22, 124.90, 124.71, 122.85, 121.56, 115.32, 114.12, 
70.41,55.07
Synthesis o f 2-(4'-m ethoxybenzyloxy-phenyl)benzothiazole (from  ester) [42 b]
MeO
C2 lH ,7N 0 2S 
Mol. Wt.: 347.43
2-aminothiophenol (0.84 mL, 8 mmol) and 4-(4-methoxybenzyloxy)benzoic acid 
methyl ester (2.16 g, 8 mmol) were dissolved in DMF (20 mL). To this was added 
a solution of iodine (1.00 g, 4 mmol) in DMF (10 mL) and the resulting solution 
was heated at 100 °C for 1 h. The reaction was then cooled to RT and 10% sodium 
thiosulfate was added until the iodine disappeared. The precipitate was filtered and 
washed with water. The product was purified by column chromatography 1:9 ethyl 
acetate/hexane to give 42 b as a purple solid in 21% yield (300 mg)
'H-NMR (500MHz, CDC13) 8  (ppm) 7.91 (d, J=9Hz, 2H, H -2\ H-6 ’), 7.39 (d, 
J=8.5Hz, 2H, H-8 \  H-12’), 7.11-7.06 (m, 3H, H-5, H-3’, H-5’), 7.02 (d, J=8.5Hz, 
1H, H-4), 6.95 (d, J=7.5Hz, 2H, H-9’, H - l l ’), 6.73 (d, J=8 Hz, 1H, H-7), 6.43 (t, 
J=8 Hz, 1H, H-6 ), 5.09 (s, 2H, CH2), 3.81 (s, 3H, OCH3)
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'H-NMR (500MHz, d6-DMSO) 5 (ppm) 10.30 (s, 1H, OH), 8.07 (d, J=7Hz, 1H, 
H-4), 7.98 (d, J=8 Hz, 1H, H-7), 7.93 (d, J=8.5Hz, 2H, H-2’, H-6 ’), 7.50 (t, 
J=7.5Hz, 1H, H-5), 7.40 (t, J=7.5Hz, 1H, H-6 ), 6.94 (d, J=8.5Hz, 2H, H-3’, H-5’) 
,3C-NMR (126MHz, CDC13) 5 (ppm) 167.43, 160.49, 153.70, 134.08, 129.01,
126.38, 124.86, 124.03, 122.26, 122.06, 116.06 
MS (El positive ion) m/z 227.03 (M+)
Anal, calcd for C 13H9NOS; C, 68.70; H, 3.99; N, 6.16; found C, 68.43; H, 4.05; N, 
6.25.
Synthesis o f  2 -(4’-triisopropyloxyphenyl)benzothiazoIe [42 a]
C22H29NOSSi 
Mol. Wt.: 383.62
A mixture of 2-aminothiophenol (0.54 mL, 5 mmol), 4-triisopropylsilanyloxy- 
benzaldehyde (1.31 g, 5 mmol) and ethanol (7.5 mL) was heated at reflux for 2 h. 
Cooled to room temperature, concentrated, extracted with ethyl acetate, dried, and 
concentrated. The product was then purified by column chromatography (2:8 
dichloromethane/pet. ether) to give 42 a as a white solid in 29% yield (548 mg)
*H-NMR (500MHz, CDC13) 5 (ppm) 8.05 (d, J=7.5Hz, 1H, H-4 ), 7.99 (d, 
J=8.5Hz, 2H, H-2’, H-6 ’), 7.90 (d, J=7.5Hz, 1H, H-7) 7.49 (t, J=8 Hz, 1H, H-5 ), 
7.37 (t, J=8 Hz, 1H, H-6 ), 7.00 (d, J=8.5, 2H, H-3’, H-5’) 1.55 (m, 3H, CH- 
(CH3)2), 1.16 (d, J=7.3Hz 18H, .CH-(CH.b)
13C-NMR (126MHz, CDC13) 6  (ppm) 171.40, 158.91, 155.30, 133.90, 129.09, 
127.93, 126.17, 124.76, 122.85, 121.50, 120.41, 17.90, 12.71
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Synthesis o f 2-(4-Brom ophenyl)benzothiazole [26 1]
Ci3H8BrNS 
Mol. Wt.: 290.18
Prepared according to Standard Procedure A, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 4-bromobenzaldehyde (0.29 g, 1.58 mmol), sodium metabisulfite 
(0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was stirred at 120 
°C for 30 min. Water was added, the precipitate was collected and washed to give
26 1 as a pink solid in 80% yield (360 mg).
Prepared according to Standard Procedure B, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 4-bromobenzaldehyde (0.29 g, 1.58 mmol), sodium metabisulfite 
(0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was irradiated at 
120 °C for 25 min. Water was added, the precipitate was collected and washed to
give 26 1 as a pink solid in 82% yield (370 mg).
Prepared according to Standard Procedure E, from 4-bromobenzaldehyde (0.135 g, 
0.73 mmol), /?-tolunesulfonic acid (0.03 g, 0.14 mmol), polymer-bound 
triphenylphosphine (0.25 g, 0.74 mmol), and 2-aminothiophenol (0.08 mL, 0.74 
mmol), in toluene (7.5 mL) and DMF (1.5 mL). The reaction mixture was refluxed 
for 60 min, cooled, filtered through Celite®, and washed with methanol, followed 
by subsequent extraction with water and brine. The product was purified by 
recrystalisation from methanol to give 26 1 a pink solid in 8 6 % yield (35 mg).
Mp= 127-129 °C, lit 132 °C44
]H-NMR (500MHz, CDC13) 5 (ppm) 8.10 (d, J=8 Hz, 1H, H-4), 7.99 (d, J=7.5Hz, 
2H, H-3’, H-5’), 7.93(d, J=8 Hz, 1H, H-7), 7.65 (d, J=7.5Hz, 2H, H-2’, H-6 ’), 7.53 
(t, J=8 Hz 1H, H-6 ), 7.43 (t, J=8Hz, 1H, H-5)
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A lternative m ethods for synthesis o f 2-(4,-m ethoxybenzyloxy-phenyl)benzothiazole
Method A:
A mixture of 2-aminothiophenol (0.54 mL, 5 mmol), 4-(4- 
methoxybenzyloxy)benzaldehyde (1.14 g, 5 mmol) and ethanol (7.5 mL) was 
heated at reflux for 2 h. Cooled to room temperature, concentrated, extracted with 
ethyl acetate, dried, concentrated, and purified by column chromatography 1:9 
ethyl acetate/hexane to give 42 b as a white solid in 25% yield (430 mg)
2-aminothiophenol (0.7 mL, 6.5 mmol) and 4-(4-methoxybenzyloxy)benzaldehyde 
(1.5 g, 6.5 mmol) were dissolved in DMF (15 mL). To this was added a solution of 
iodine (0.83 g, 3.2 mmol) in DMF (15 mL) and the resulting solution was heated at 
100 °C for 1 h. The reaction was then cooled to RT and 10% sodium thiosulfate 
was added until the iodine disappeared. The precipitate was filtered and washed 
with water to give 42 b in 57% yield (630 mg)
A mixture of 2-aminothiophenol (0.33 mL, 3.13 mmol), 4-(4-methoxybenzyloxy)- 
benzaldehyde (0.72 g, 3.16 mmol) and sodium metabisulflte (0.6 g, 3.16 mmol) in 
DMF (4 mL) was heated at 100 °C for 3 h. Cooled to room temperature, water was 
added and the precipitate was filtered washed with water, and recrystalised from 
methanol to give 42 b as a yellow solid in 60% yield (630 mg).
(42 bj
MeO
C2iH17N 02S 
Mol. Wt.: 347.43
Method B
Method C
- 117-
Chapter 7 Experimental
13C (126MHz, C DC I3 ) 6  (ppm) 166.44, 164.05, 162.09, 153.97, 135.10, 130.65, 
126.53, 125.56, 123.47, 123.34, 121.68, 117.91, 114.24.
MS (El positive ion) m/z 229.01 (M+)
Synthesis o f  2-(3-chlorophenyl)benzothiazole [26 k]
CnHgClNS 
Mol. Wt.: 245.73
Prepared according to Standard Procedure A, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 3-chlorobenzaldehyde (0.17 mL, 1.58 mmol), sodium metabisulfite 
(0.30 g, 1.58 mmol), and DMSO (5 ml). The reaction mixture was stirred at 120 
°C for 120 min. Water was added, the precipitate was collected and washed to give 
26 k as a brown solid in 96% yield (370 mg).
Prepared according to Standard Procedure B, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 3-chlorobenzaldehyde (0.17 mL, 1.58 mmol), sodium metabisulfite 
(0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was irradiated at 
120 °C for 60 min. Water was added, the precipitate was collected and washed to 
give 26 k as a brown solid in 90% yield (348 mg).
MP= 97-99 °C, lit 96.5 °C81
'H-NMR (500MHz, d6-DMSO) 8  (ppm) 8.13 (d, J=7.5Hz, 1H, H-4), 8.08-8.06 (m, 
2H, H-5, H-2’), 8.01 (d, J=7.5Hz, 1H, H-7), 7.63-7.55 (m, 3H, H-4’, H-5’, H-6 ’), 
7.48 (t, J=7.5Hz, 1H, H-6 )
13C-NMR (126MHz, d6-DMSO) 8  (ppm) 165.55, 153.32, 134.72, 134.60, 134.08, 
131.32, 131.04, 126.81, 126.34, 125.99, 125.86, 123.08, 122.43 
MS (El positive ion) m/z 245.01 (M+)
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13C-NMR (126MHz, CDC13) 5 (ppm) 166.69, 154.11, 135.07, 132.59, 132.25, 
128.92, 126.51, 125.46, 125.42, 123.35, 121.67 
MS (El positive ion) m/z 290.94 (M+)
Anal, calcd for CnHgBrNS; C, 53.81; H, 2.78; N, 4.82; found C, 53.91; H, 2.78; 
N, 4.70.
Synthesis o f  4-Benzothiazol-2-ylphenol [43]
o h  C n H g N O S
Mol. Wt.: 227.28
Prepared according to Standard Procedure A, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 4-hydroxybenzaldehyde (0.19 g, 1.58 mmol), sodium metabisulfite 
(0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was stirred at 120 
°C for 30 min. Water was added, the precipitate was collected and washed to give
43 as a white solid in 84% yield (301 mg).
Prepared according to Standard Procedure B, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 4-hydroxybenzaldehyde (0.19 g, 1.58 mmol), sodium metabisulfite 
(0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was irradiated at 
120 °C for 60 min. Water was added, the precipitate was collected and washed to
give 43 as a white solid in 80% yield (360 mg).
Prepared according to Standard Procedure E, from 4-hydroxybenzaldehyde (0.08 
g, 0.73 mmol), / 7-tolunesulfonic acid (0.02 g, 0.14 mmol), polymer-bound 
triphenylphosphine (0.24 g, 0.74 mmol), and 2-aminothiophenol (0.08 mL, 0.74 
mmol), in toluene (7.5 mL) and DMF (1.5 mL). The reaction mixture was refluxed 
for 90 min, cooled, filtered through Celite® washed with methanol followed by 
subsequent extraction with water and brine. The resulting product was evaporated 
to dryness to give 43 as a white solid in 97% yield (31 mg).
Mp= 228-230 °C, lit 227 °C79
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'H-NMR (500MHz, d6-DMSO) 5 (ppm) 8.32 (d, J=8 Hz, 2H, H-3’, H-5’), 8.22 (d, 
J=8 Hz, 1H, H-4 ), 8.13 (d, J=8 Hz, 1H, H-7 ), 7.95 (d, J=8 Hz, 2H, H-2’, H-6 ’ ), 
7.60 (dt, J=1.5, 8 Hz, 1H, H-5), 7.53 (dt, J=8 Hz, 1H, H-6 ) 
l9F-NMR (471MHz, d6-DMSO) 8  (ppm) 61.85
13C-NMR (126MHz, d6-DMSO) 8  (ppm) 165.53, 153.41, 136.41, 134.76, 131.05, 
130.80, 127.93, 126.93, 126.31, 126.08, 123.26, 122.54 
MS (El positive ion) m/z 279.00 (M+)
Synthesis o f  2-(3-fluorophenyl)benzothiazolelis [26 j |
F
CnHgFNS 
Mol. Wt.: 229.27
Prepared according to Standard Procedure A, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 3-fluorobenzaldehyde (0.16 mL, 1.58 mmol), sodium metabisulfite 
(0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was stirred at 120 
°C for 120 min. Water was added, the precipitate was collected and washed to give 
26 j as a green solid in 90% yield (322 mg).
Prepared according to Standard Procedure B, from 2-aminothiophenol (0.15 mL,
1.56 mmol), 3-fluorobenzaldehyde (0.16 mL, 1.58 mmol), sodium metabisulfite 
(0.30 g, 1.58 mmol), and DMSO (5 mL). The reaction mixture was irradiated at 
120 °C for 30 min. Water was added, the precipitate was collected and washed to 
give 26 j as a green solid in 8 8 % yield (318 mg).
MP= 71-73 °C
'H-NMR (500MHz, CDC13) 6  (ppm) 8.11 (d, J=8.2Hz, 1H, H-4), 7.93 (d, J=7.9Hz, 
1H, H-7), 7.86 (d, J=5.6Hz, 2H, H-5, H-6 ), 7.53 (t, J=7.7Hz, 1H, H5’), 7.51-7.41 
(m, 2H, H-2’, H-6 ’), 7.21 (td, J=8.2Hz, 1H, H-4’)
I9F-NMR (471M Hz, CDC13) 6  (ppm) 112.02
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7.5 Deprotection of Unsubstituted Benzothiazoles
Synthesis o f  4-Benzothiazol-2-yl-phenol (from pm b-protected interm ediate ) 79  [43]
2-(4'-methoxybenzyloxyphenyl)benzothiazole (0.1 g, 0.28 mmol), was dissolved 
in dichloromethane ( 6  mL) and water (0.5 mL). 2,3-dichloro-5,6- 
dicyanobenzoquinone (0 .2  g, 0 . 8 6  mmol) was added and the reaction mixture was 
stirred at RT overnight. Sat. NaHCCb (aq) was added and the product was 
extracted with dichloromethane, dried and concentrated to give 43 as a brown 
solid in 40% yield (26 mg).
To 2-(4'-methoxybenzyloxy-phenyl)benzothiazole (0.13 g, 0.39 mmol) was added 
ethanol (40 mL) and 1M HCL (20 mL) and the solution was refluxed for 90 min 
upon which time solvents were removed to give the product 43 as a brown solid in 
87% yield (77 mg)
*H-NMR (500MHz, d6-DMSO) 8 (ppm) 10.19 (s, 1H, OH), 8.08 (d, J=8.5Hz, 1H, 
H-4), 7.98 (d, J=8.5Hz, 1H, H-7), 7.93 (d, J= 8.5Hz, 2H, H-2’, H-6 ’), 7.60 (t, 8 Hz, 
1H, H-5), 7.40 (t, J=8 Hz, 1H, H-6 ), 6.95 (d, J=8.5Hz, 2H, H-3’, H-5’)
13C-NMR (126MHz, d6-DMSO) 8 (ppm) 167.45, 160.56, 153.66, 134.06, 128.99,
126.39, 124.86, 123.96, 122.24, 116.07
Synthesis o f  4-Benzothiazol-2-yl-phenol (from TIPS-protected interm ediate) 7 9 [43]
0H C13H9NOS 
Mol. Wt.: 227.28
0H C13H9NOS
Mol. Wt.: 227.28
- 121 -
Chapter 7 Experimental
13C-NMR (126MHz, d6-DMSO) 5 (ppm) 148.68, 134.18, 130.99, 118.45, 116.98, 
116.16.
Synthesis o f  Bis(2-am ino-5-m ethylphenyl)disulfide166 [57 d]
Prepared according to Standard Procedure C, from 2-amino-6- 
methylbenzothiazole (2.4 g, 15 mmol), in a solution of potassium hydroxide (12.5
g, 222 mmol), and water (25 mL). The reaction mixture was stirred at reflux for 12
h. Cooled to RT acidified to pH 6  with acetic acid. Water was added, the solution 
was stirred overnight and the precipitate was collected and washed with diethyl 
ether. The filtrate was the evaporated to dryness to give 56 d as a yellow solid in 
72% yield (3.0 g).
'H-NMR (500M Hz, d6-DMSO) 6  (ppm) 6.94-6.92 (m, 2H, H-4), 6.83 (s, 2H, H-6 ), 
6 . 6 6  (d, J=8.2Hz, 2H, H-3), 5.21 (bs, 4H, NH2), 2.07 (s, 6 H, CH3).
13C-NMR (126MHz, d6-DMSO) 5 (ppm) 153.75, 152.03, 145.86, 119.96, 117.89, 
115.50, 24.71.
Synthesis o f  Bis (2-am ino-5-m ethoxyphenyl)disulfide4 4  [57 e]
C14H16N2S2 
Mol. Wt.: 276.42
s
2
Ci4H16N20 2S2 
Mol. Wt.: 308.42
2
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Prepared according to Standard Procedure C, from 2-amino-6-ethoxybenzothiazole 
(2.91 g, 15 mmol), in a solution of potassium hydroxide (12.5 g, 222 mmol), and 
water (25 mL). The reaction mixture was stirred at reflux for 16 h. Cooled to RT 
acidified to pH 6  with acetic acid. Water was added, the solution was stirred 
overnight the precipitate was collected and washed with diethyl ether. The filtrate 
was the evaporated to dryness to give 57 b as a grey solid in 6 8 % yield (3.5 g).
*H-NMR (500MHz, d6-DMSO) 5 (ppm) 6.77 (dd, J=2.8, 8 .8 Hz, 2H, H-4), 6.70 (d, 
J=8 .8 Hz, 2H, H-3), 6.60 (d, J=2.8Hz, 2H, H-6 ), 3.77 (q, J=6.9Hz, 4H, CH2), 1.22 
(t, J=7.0Hz, 6 H, CH3)
13C-NMR (126MHz, d6-DMSO) 6  (ppm) 149.29, 143.72, 119.51, 119.03 117.05, 
116.07, 63.38, 14.68.
Synthesis o f  Bis (2-am ino-5-chlorophenyI)disulfide167 [57 cl
C 1 2 H 1 0 C I 2 N 2 S 2  
Mol. Wt.: 317.26
Prepared according to Standard Procedure C, from 2-amino-6-chlorobenzothiazole 
(2.75 g, 15 mmol), in a solution of potassium hydroxide (12.5 g, 222 mmol), and 
water (25 mL). The reaction mixture was stirred at reflux for 24 h. Cooled to RT 
acidified to pH 6  with acetic acid. Water was added, the solution was stirred 
overnight and the precipitate was collected and washed with diethyl ether. The 
filtrate was the evaporated to dryness to give 57 c as a yellow solid in 65% yield
(3.1 g).
'H-NMR (500MHz; d6-DMSO) 5 (ppm) 7.14 (dd, J=2.5, 9Hz, 2H, H-4), 6.92 (d, 
J=2.5Hz, 2H, H-6 ), 6.76 (d, J=8 Hz, 2H, H-3), 5.69 (bs, 4H, NH2).
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2-(4'-Triisopropylsilyloxyphenyl)benzothiazole (0.51 g, 1.3 mmol) was dissolved 
in THF (13 mL) and cooled to 0 °C. A mixture of tetra-n-butylammonium fluoride 
(2mL, 3.11 mmol), and acetic acid (0.2 mL, 3.11 mmol) was added. The 
temperature was increased to 30 °C and stirred for 5 h. The solution was then 
extracted with ethyl acetate and was with sat. NaHCC>3, dried and concentrated to 
give 43 as a brown solid in 84% yield (250 mg)
‘H-NMR (500MHz, d6-DMSO) 8  (ppm) 10.20 (s, 1H, OH), 8.08 (d, J=8 Hz, 1H, 
H-4), 7.98 (d, J=8 Hz, 1H, H-7), 7.94 (d, J=8.5Hz, 2H, H-2’, H-6 ’), 7.50 (dt, J=1.5, 
7.5Hz, 1H, H-5), 7.40 (dt, J=1.5, 7.5Hz, 1H, H-6 ), 6.94 (d, J=8.5Hz, 2H, H-3’, H- 
5’)
,3C-NMR (126MHz, d6-DMSO) 8  (ppm) 167.43, 160.56, 153.70, 134.09, 129.00, 
127.99, 126.37, 124.84, 123.99, 122.04, 116.06
Synthesis o f  2-(2'-hydroxy-5-m ethyl-phenyl)benzothiazoIe [45]
To 2-(2'-methoxybenzyloxy-5-methylphenyl)benzothiazole (0.13 g, 0.35 mmol) 
was added ethanol (40 mL) and 1M HC1 (20 mL) and the solution was refluxed for 
150 min upon which time solvents were removed to give the product 45 as a 
yellow solid in 67% yield (57 mg)
‘H-NMR (500MHz, d6-DMSO) 8 (ppm) 8.14 (d, J=7.5Hz, 1H, H-4), 8.06 (d, 
J=8 Hz, 1H, H-7), 7.98 (d, J=1.5Hz, H-6 ’), 7.54 (dt, J= l, 8 Hz, 1H, H-5), 7.45 (dt, 
J= l, 8 Hz, 1H, H-6 ), 7,22 (dd, J=2, 7.5Hz, 1H, H-4’), 7.00 (d, J=8.5Hz, 1H, H-3’), 
2.33 (s, 3H, CH3)
HO
/ = \  CuHnNOS 
\  /  Mol. Wt.: 241.31
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7.6 Synthesis of Disulfides for Substituted 
Benzothiazoles
Synthesis o f Bis(2-amino-5-fluorophenyI)disulfIde [57 a]
C 1 2 H 1 0 F 2 N 2 S 2
Prepared according to Standard Procedure C, from 2-amino-6-fluorobenzothiazole 
(2 g, 11.8 mmol), in a solution of potassium hydroxide (10 g, 178 mmol), and 
water (40 mL). The reaction mixture was stirred at reflux for 16 h. Cooled to RT 
acidified to pH 6  with acetic acid. Water was added, the solution was stirred 
overnight and the precipitate was collected and washed with diethyl ether. The 
filtrate was the evaporated to dryness to give 56 a as a yellow solid in 53% yield 
(1-8 g)-
Mp=74-76 °C, lit=75-76 °C123
'H-NMR (500MHz, d6-DMSO) 5 (ppm) 6.98 (td, J= 2.9, 8.7Hz, 2H, H-4), 6.84 
(dd, J=2.9, 8 .6 Hz, 2H, H-6 ), 6.75 (dd, J=5.1, 8.9Hz, 2H, H-3), 5.3 (bs, 4H, NH2) 
19F-NMR (471MHz, CDC13) 5 (ppm) 128.73
13C-NMR (126MHz, d6-DMSO) 5 (ppm) 154.01, 152.20, 146.08, 119.71, 118.16, 
115.82
Synthesis o f  Bis (2-amino-5-ethoxyphenyl)disulfide4 4  [57 b]
E ta
Ci6H2oN20 2S2 
Mol. Wt.: 336.47
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13C-NMR (126MHz, CDC13) 5 (ppm) 161.92, 158.08, 152.92, 150.60, 134.72, 
130.76, 129.21, 128.26, 128.06, 126.82, 124.30, 122.93, 121.50, 120.87 119.77, 
112.48, 111.65, 69.45, 53.78, 18.96
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7.8 Synthesis of 6-Fluoro Substituted Benzothiazoles
Synthesis o f  6-Fluoro-2-(4-m ethoxyphenyl)benzothiazole169 [69 a]
Jj) OMe C 14H 10F N O S
/  Mol. Wt.: 259.30
Prepared according to Standard Procedure D, from bis(2-amino-5- 
fluorophenyl)disulfide (0.24 g, 0.86 mmol), /?-anisaldehyde (0.1 mL, 0.88 mmol), 
sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The reaction 
mixture was stirred at 120 °C for 90 min, water was then added and the resulting 
precipitate collected. This precipitate was washed with excess water, followed by a 
brine wash and finally dried to give 69 a as a grey solid in 96% yield (216 mg).
Prepared according to Standard Procedure E, from /7-anisaldehyde (0.09 mL, 0.73 
mmol), / 7-tolunesulfonic acid (0.03 g, 0.14 mmol), polymer-bound 
triphenylphosphine (0.25 g, 0.74 mmol), and bis(2-amino-5-fluorophenyl)disulfide 
(0.21 g, 0.74 mmol), in toluene (1.5 mL) and DMF (7.5 mL). The reaction mixture 
was refluxed for 70 min, cooled, filtered through Celite® washed with methanol 
followed by subsequent washing with water and brine. The resulting product was 
evaporated to dryness to give 69 a as a yellow solid in 8 8 % yield (32 mg).
Mp=l 10-112 °C
'H-NMR (500MHz, CDC13) 6  (ppm) 7.97 (d, J= 8.5Hz, 2H, H-3’, H-5’), 7.93 (dd, 
J=4.5, 8.5Hz, 2H, H-4), 7.53 (dd J= 2.5, 7.5Hz, 1H, H-7), 7.18 (dt, J= 3.0, 9Hz, 
1H, H-5), 6.98 (d, J= 8.5Hz, 2H, H-2’, H-6 ’ ), 3.86 (s, 3H, OMe ) 
i9F-NMR (471MHz, CDC13) 6  (ppm) 116.62
l3C-NMR (126MHz, CDC13) 8  (ppm) 161.97, 161.24, 159.29, 150.87, 135.87, 
129.11, 126.19, 123.67, 114.80, 114.43, 107.86, 55.57
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MS (El positive ion) m/z 259.05 (M+)
Synthesis of 6-Fluoro-2-(3,4-Dimethoxyphenyl)benzothiazole [69 b]
OMe
OMe C15H12FNO2S 
Mol. Wt.: 289.32
Prepared according to Standard Procedure D, from bis(2-amino-5- 
fluorophenyl)disulfide (0.24 g, 0.86 mmol), 3,4-dimethoxybenzaldehyde (0.14 g, 
0.88 mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 180 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 69 b as a yellow solid in 83% 
yield ( 2 1 0  mg).
Mp= 151-153 °C, Lit= 153-155 “C44
‘H-NMR (500MHz, CDC13) 5 (ppm) 7.90 (dd, J=4.5, 9Hz, 1H, H-4), 7.70 (d,
l9F-NMR (471MHz, CDC13) 5 (ppm) 116.40
i3C-NMR (126MHz, CDC13) 5 (ppm) 161.32, 159.37, 151.70, 150.69, 149.44,
MS (El positive ion) m/z 289.04 (M+)
Synthesis of 6-FIuoro-2-(3, 4, 5-Trimethoxyphenyl)benzothiazole [69 c]
J=2.Hz, 1H, H-2’), 7.59-7.58 (m, J=2.1, 2H, H-5, H-7), 7.23 (dt, J=2.5, 8.5Hz, 1H, 
H-6 ’), 6.97 (d, J=8 Hz, 1H, H-5’), 4.04 (s, 3H, OMe), 3.98 (s, 3H, OMe)
135.87, 126.36, 123.61, 121.10, 114.80, 111.09, 109.73, 107.89, 56.15.
OMe
OMe C 16H 14F N O 3S
Mol. Wt.: 319.35
OMe
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13C-NMR (126MHz, d6-DMSO) 6 (ppm) 166.58, 136.55, 125.13, 123.37, 122.27, 
115.49
Synthesis o f  3-(fluorophenyl)thiourea168 [66]
i . , nh2
C7H7FN2S 
Mol. Wt.: 170.21
Benzoyl chloride (1.72 mL, 14.84 mmol) was added dropwise to a solution of 
ammonium thiocyanate (1.13 g, 14.84 mmol) in acetone (2 mL). The suspension 
was heated at reflux for 5 min. 3-Fluoroaniline (1.3 mL, 13.5 mmol) in acetone 
(1.5 mL) was added and refluxed for a further 1 h. To this mixture a solution of 
sodium hydroxide (1.69 g, 42.25 mmol) in water (10 mL) was added and refluxed 
for a further 2 h. The reaction was cooled, concentrated and adjusted to pH 5 with 
Dil. HC1, and then pH 11 with ammonium hydroxide, the precipitate was collected 
and washed with ether to give the product 66 as a white solid in 45% yield (105 
mg).
lH NMR (500MHz, d6-DMSO) 5 (ppm) 9.82 (bs, 1H, NH), 7.56-7.35 (m, 3H, H-2, 
NH2), 7.34 (dt, J= 8.0, 15.0Hz, 1H, H-5), 7.16 (d, J=8.0Hz, 1H, H-6), 6.93 (dt, 
J=2.5, 8.5Hz, 1H, H-4)
13C-NMR (126MHz, d6-DMSO) 5 (ppm) 162.80, 160.87, 141.13, 130.29, 118.14, 
110.56, 109.26
Synthesis o f  2-am ino-5-fluorobenzothiazole123[671
C7H5FN2S
NH2 Mol. Wt.: 168.19
A solution of bromine (0.74 mL, 1.46 mmol) in dichloromethane (0.6 mL) was 
added dropwise to a solution of 3-fluorophenylthiourea (0.25 g, 1.46 mmol) in
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Prepared according to Standard Procedure C, from 2-amino-6- 
methoxybenzothiazole (2.68 g, 15 mmol), in a solution of potassium hydroxide 
(12.5 g, 222 mmol), and water (25 mL). The reaction mixture was stirred at reflux 
for 16 h. Cooled to RT acidified to pH 6  with acetic acid. Water was added, the 
solution was stirred overnight and the precipitate was collected and washed with 
diethyl ether. The filtrate was the evaporated to dryness to give 57 e as a yellow 
solid in 71% yield (3.3 g).
’H-NMR (500M Hz, d6-DMSO) 5 (ppm) 6.81 (s, 2H, H-6 ), 6.70 (d, J=8.5Hz, 2H, 
H-3), 6.51 (d, J=8.5Hz, 2H, H-5), 5.44 (bs, 2H, NH2), 3.60 (s, 6 H, OCH3). 
13C-NMR (126M Hz, d6-DMSO) 6 (ppm) 164.71, 154.27, 146.79, 118.04, 112.85, 
105.51,55.51.
Synthesis o f  Bis (2-am ino-5-nitrophenyl)disulfide167 [57 f]
Prepared according to Standard Procedure C, from 2-amino-6-nitrobenzothiazole 
(2.92 g, 15 mmol), in a solution of potassium hydroxide (12.5 g, 222 mmol), and 
water (25 mL). The reaction mixture was stirred at reflux for 48 h. Cooled to RT 
acidified to pH 6  with acetic acid. Water was added, the solution was stirred 
overnight and the precipitate was collected and washed with diethyl ether. The 
filtrate was the evaporated to dryness to give 57 f  as a grey solid in 6 8 % yield (3.5
’H-NMR (500MHz, d6-DMSO) 5 (ppm) 6.93 (dd, J=2, 8 Hz, 2H, H-4), 6.82 (d,
C 1 2 H 1 0 N 4 O 4 S 2  
Mol. Wt.: 338.36
2
g)-
J=1.5Hz, 2H, H-6 ), 6 . 6 6  (d, J-8.5Hz, 2H, H-5), 5.26 (bs, 4H, NH2)
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7.7 Synthesis of 6-Nitro Substituted Benzothiazoles
Synthesis o f  2-(3,4-D im ethoxyphenyl)-6-nitrobenzothiazole[60 a]
Prepared according to Standard Procedure D, from bis(2-amino-5- 
nitrophenyl)disulfide (0.29 g, 0.86 mmol), 3,4-dimethoxybenzaldehyde (0.14 g, 
0.88 mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 20 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 60 a as a brown solid in 91% 
yield (250 mg).
'H-NMR (500MHz, CDCI3) 5 (ppm) 7.95 (d, J=8.5Hz, 1H, H-4), 7.75 (d, J=1.5Hz,
l3C-NMR (126MHz, CDC13) 5 (ppm) 167.16, 151.71, 149.45, 148.05, 145.45,
OMe C 15H 12N 20 4 S 
Mol. Wt.: 316.33
OMe
1H, H-7), 7.67 (s, 1H, H-2’), 7.59 (dd, J=2, 8.5Hz, 1H, H-5), 7.31-7.28 (m, 1H, H- 
6 ’), 6.95 (d, J=8.5Hz, 1H, H-5’), 4.04 (s, 3H, OCH3), 3.96 (s, 3H, OCH3)
140.95, 135.20, 128.00, 126.40, 122.14, 121.34, 111.04, 109.94, 56.12
Synthesis o f  2-(3, 4, 5-Trim ethoxyphenyl)-6-nitrobenzothiazole[60 b]
OMe
OMe
Ci6Hi4N20 5S 
Mol. Wt.: 346.36
OMe
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dichloromethane (4 mL). The resulting mixture was heated at reflux for 3 h, and 
cooled to RT. The precipitate was collected, suspended in water and basified with 
ammonium hydroxide to pH 11. The product was then extracted with ethyl acetate, 
washed with brine, dried, and conc. in vacuo. The solid was then washed with 
ether and the filtrate reduced to dryness to give 67 as a white solid in 53% yield 
(130 mg).
NMR (500MHz, d6-DMSO) 5 (ppm) 7.65-7.62 (m, 3H, H-7, NH2,), 7.13 (dd, 
J=2.5, 9Hz, 1H, H-4), 6.84 (dt, J=2, 9Hz, 1H, H-6 )
I9F-NMR (47 1MHz, d6-DMSO) 5 (ppm) 117.80
13C-NMR (126MHz, d6-DMSO) 5 (ppm) 168.73, 162.17, 160.28, 154.13, 121.62, 
108.00, 104.35.
Synthesis o f  Bis(2-am ino-4-fluorophenyl)disulfide44 [68]
C 1 2 H 1 0 F 2 N 2 S 2  
Mol. Wt.: 284.35
Prepared according to Standard Procedure C, from 2-amino-5-fluorobenzothiazole 
(2 g, 11.8 mmol), in a solution of potassium hydroxide (10 g, 178 mmol), and 
water (40 mL). The reaction mixture was stirred at reflux for 16 h. Cooled to RT 
acidified to pH 6  with acetic acid. Water was added, the solution was stirred 
overnight the precipitate was collected and washed with diethyl ether. The filtrate 
was the evaporated to dryness to give 6 8  as a yellow solid in 83% yield (2.8 g).
MP=75-76°C
‘H-NMR (500MHz, CDCI3) S (ppm) 7.52 (dd, J=5, 8.5Hz, 2H, H-6 ), 7.27 (dd, 
J=2.5, 8.5Hz, 2H, H-3), 6.90 (dt, J=5, 8.5Hz, 2H, H-5), 5.26 (bs, 4H, NH2)
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Prepared according to Standard Procedure D, from bis(2-amino-5- 
fluorophenyl)disulfide (0.24 g, 0.86 mmol), 3,4,5-trimethoxybenzaldehyde (0.18 
g, 0.88 mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 90 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 69 c as a purple solid in 97% 
yield (270 mg).
MP=153-155 °C Lit= 151-152 °C123
'H-NMR (500MHz, CDCI3) 8  (ppm) 8.20 (dd, J=4.5, 9Hz, 1H, H-4), 7.99 (s, 2H, 
H-2’, H-6 ’), 7.72 (dd, J=2.5, 8 Hz, 1H, H-7), 7.36 (dt, J=2.5, 9Hz, 1H, H-5), 4.01 
(s, 3H, OMe), 4.0 (s, 6 H, OMe)
,9F-NMR (471MHz, CDCI3) 8  (ppm) 111.39
13C-NMR (126MHz, CDCI3) 8  (ppm) 183.15, 163.01, 161.02, 152.96, 150.52, 
143.79, 129.52, 126.98, 116.25, 109.05, 108.96,61.04, 56.35
Synthesis of 4-(6-Fluoro-benzothiazol-2-yl)-phenol1M (69 d]
Prepared according to Standard Procedure D, from bis(2-amino-5- 
fluorophenyl)disulfide (0.24 g, 0.86 mmol), 4-hydroxybenzaldehyde (0.10 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 50 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash. The sample was then dissolved in dichloromethane and 
washed through a plug of silica and reduced to dryness to give 69 d as a white 
solid in 91% yield (195 mg).
o h  Ci3H8FNOS 
Mol. Wt.: 245.27
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Prepared according to Standard Procedure D, from bis(2-amino-5- 
nitrophenyl)disulfide (0.29 g, 0.86 mmol), 3,4,5-trimethoxybenzaldehyde (0.18 g, 
0.88 mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 30 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 60 b as a brown solid in 8 8 % 
yield (265 mg).
Mp=105-108 °C
1 H-NMR (500MHz, CDC13) 6  (ppm) 7.95 (d, J=8.5Hz, 1H, H-4), 7.70 (s, 1H, H- 
7), 7.36 (s, 2H, H-2’, H-6 ’), 7.33 (d, J= 8.5Hz, 1H, H-5), 4.01 (s, 6 H, OCH3, 
OCH3), 3.94 (s, 3H, OCH3)
13C-NMR (126MHz, CDC13) 5 (ppm) 166.73, 153.60, 152.24, 140.55, 135.31, 
135.23, 129.25, 127.94, 122.59, 121.31, 104.72, 56.71.
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13C-NMR (126MHz, CDC13) 6  (ppm) 166.41, 164.44, 150.45, 138.80, 105.56, 
101.61.
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Prepared according to Standard Procedure E, from 4-hydroxybenzaldehyde (0.09 
g, 0.73 mmol), p-tolunesulfonic acid (0.03 g, 0.14 mmol), polymer-bound 
triphenylphosphine (0.25 g, 0.74 mmol), and bis(2-amino-5-fluorophenyl)disulfIde 
(0.21 g, 0.74 mmol), in toluene (1.5 mL) and DMF (7.5 mL). The reaction mixture 
was refluxed for 90 min, cooled, filtered through Celite® washed with methanol 
followed by subsequent extraction with water and brine. The resulting product was 
evaporated to dryness to give 69 d as a yellow solid in 87% yield (30 mg).
H-NMR (500MHz, d6-DMSO) 5 (ppm) 10.23 (bs, 1H, OH), 8.02-7.98 (m, 2H, H- 
4, H-7), 7.92 (d, J=9Hz, 2H, H-2’, H-6 ’), 7.37 (td, J=2.5, 9Hz, 1H, H-5), 6.94 (d, 
J=9Hz, 2H, H-3’, H-5’)
l9F-NMR (471MHz, CDC13) 5 (ppm) 116.60
13C-NMR (126MHz, d6-DMSO) 8  (ppm) 167.33, 160.59, 158.30, 150.69, 135.11, 
128.86, 123.63, 123.35, 116.03, 114.61, 108.71
Synthesis o f  6-Fluoro-2-(4-nitrophenyl)benzothiazole [69 e]
N02 C 1 3 H 7 F N 2 O 2 S  
Mol. Wt.: 274.27
Prepared according to Standard Procedure D, from bis(2-amino-5- 
fluorophenyl)disulfide (0.24 g, 0.86 mmol), 4-nitrobenzaldehyde (0.13 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 69 e as a grey solid in 96% yield 
(230 mg).
Prepared according to Standard Procedure E, from 4-nitrobenzaldehyde (0.11 g, 
0.73 mmol), / 7-tolunesulfonic acid (0.03 g, 0.14 mmol), polymer-bound
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Prepared according to Standard Procedure D, from bis(2-amino-5- 
ethoxyphenyl)disulfide (0.29 g, 0.86 mmol), /?-anisaldehyde (0.1 mL, 0.88 mmol), 
sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The reaction 
mixture was stirred at 120 °C for 30 min, water was then added and the resulting 
precipitate collected. This precipitate was washed with excess water, followed by a 
brine wash and finally dried to give 70 b as a yellow solid in 8 8 % yield (220 mg).
Prepared according to Standard Procedure E, from p-anisaldehyde (0.09 mL, 0.73 
mmol), p-tolunesulfonic acid (0.03 g, 0.14 mmol), polymer-bound 
triphenylphosphine (0.25 g, 0.74 mmol), and bis(2-amino-5- 
ethoxyphenyl)disulfide (0.25 g, 0.74 mmol), in toluene (1.5 mL) and DMF (7.5 
mL). The reaction mixture was refluxed for 60 min, cooled, filtered through 
Celite® washed with methanol followed by subsequent extraction with water and 
brine. The resulting product was evaporated to dryness to give 70 b as a white 
solid in 87% Yield (36 mg).
Mp=172-174 °C Lit= 173-174 °C146
'H-NMR (500MHz, CDC13) 5 (ppm) 8.00 (d, J=9Hz, 2H, H-2’, H-6 ’), 7.91 (d, 
J=9Hz, 1H, H-4), 7.34 (d, J=2.5Hz, 1H, H-7), 7.08 (dd, J=2.5, 9Hz, 1H, H-5), 7.00 
(d, J=9Hz, 2H, H-3’, H-5’), 4.13 (q, J=7Hz, 2H, OCH2), 3.89 (s, 3H, OCH3), 1.48 
(t, J=7Hz, 3H, CH3)
bC-NMR (126MHz, CDC13) 5 (ppm) 165.38, 161.58, 156.85, 148.68, 136.15, 
128.75, 126.65, 123.26, 115.79, 114.34, 105.03, 64.13, 53.45, 14.95.
MS (El positive ion) m/z 285.08 (M+)
Anal, calcd for Ci6H 15N0 2 S; C, 67.35; H, 5.30; N, 4.91; found C, 66.78; H, 4.89; 
N, 4.86
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Synthesis o f  4-(6-Fluorobenzothiazol-2-yl)benzonitrile [69 h]
CN C14H7FN2S
Mol. Wt.: 254.28
Prepared according to Standard Procedure D, from bis(2-amino-5- 
fluorophenyl)disulfide (0.24 g, 0.86 mmol), 4-cyanobenzaldehyde (0.11 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 69 h as a yellow solid in 8 6 % 
yield (190 mg).
Prepared according to Standard Procedure E, from 4-cyanobenzaldehyde (0.11 g, 
0.73 mmol), p-tolunesulfonic acid (0.03 g, 0.14 mmol), polymer-bound 
triphenylphosphine (0.25 g, 0.74 mmol), and bis(2-amino-5-fluorophenyl)disulfide 
(0.21 g, 0.74 mmol), in toluene (1.5 mL) and DMF (7.5 mL). The reaction mixture 
was refluxed for 120 min, cooled, filtered through Celite® washed with methanol 
followed by subsequent extraction with water and brine. The resulting product was 
evaporated to dryness to give 69 h as a yellow solid in 89% yield (32 mg).
M p=218-220 °C
'H-NMR (500MHz, CDC13) 5 (ppm) 8.38 (d, J=9Hz, 2H, H -2\ H-6 ’), 8.26 (d, 
J=9Hz, 2H, H-3’, H-5’), 8.10 (dd, J=5, 8.5Hz, 1H, H-4), 7.66 (dd, J=2.5, 8.5Hz, 
1H, H-7) 7.32 (td, J=2.5, 8.5Hz, 1H, H-5)
19F-NMR (471MHz, CDC13) 5 (ppm) 113.79
,3C-NMR (125MHz, CDC13) 8  (ppm) 185.30, 161.95, 159.98, 150.40, 137.22,
132.85, 127.84, 124.91, 118.19, 115.69, 114.27, 108.05
HRMS (El positive ion) m/z = 254.0312, calcd for C14H7FN2S m/z = 254.0314
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Prepared according to Standard Procedure D, from bis(2-amino-5- 
fluorophenyl)disulfide (0.24 g, 0.86 mmol), 4-bromobenzaldehyde (0.16 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 69 k as a green solid in 89% 
yield (240 mg).
Prepared according to Standard Procedure E, from 4-bromobenzaldehyde (0.135 g, 
0.73 mmol), p-tolunesulfonic acid (0.03 g, 0.14 mmol), polymer-bound 
triphenylphosphine (0.25 g, 0.74 mmol), and bis(2-amino-5-fluorophenyl)disulfide 
(0.21 g, 0.74 mmol), in toluene (1.5 mL) and DMF (7.5 mL). The reaction mixture 
was refluxed for 60 min, cooled, filtered through Celite® washed with methanol 
followed by subsequent extraction with water and brine. The resulting product was 
evaporated to dryness to give 69 k as a white solid in 92% yield (40 mg).
Mp=144-146 °C
‘H-NMR (500MHz, CDC13) 6  (ppm) 8.04 (dd, J=4.5, 9Hz, 1H, H-4), 7.96 (d, 
J=8.5Hz, 2H, H -3 \ H-5’), 7.66 (d, J=8.5Hz, 2H, H-2’, H-6 ’), 7.61 (dd, J=2.5, 
7.5Hz, 1H, H-7), 7.27 (dt, J= 2.5, 7.5Hz, 1H, H-5)
19F-NMR (471MHz, CDC13) 6  (ppm) 115.31
13C-NMR (126MHz, CDC13) 8  (ppm) 166.37, 161.58, 159.63, 150.71, 136.08, 
132.27, 128.75, 125.50, 124.22, 116.55, 107.88.
HRMS (El positive ion) m/z = 306.9461, calcd for CnHyBrFNS m/z = 306.9467
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'H-NMR (500MHz, CDC13) 5 (ppm) 8.04 (dd, J=5, 9Hz, 1H, H-4), 7.66-7.58 (m, 
3H, H-7, H-2’, H-6 ’), 7.42 (t, J=8 Hz, 1H, H-5’), 7.25 (dt, J=2.5, 9Hz, 1H, H-5), 
7.08-7.06 (m, 1H, H-4’), 3.94 (s, 3H, OCH3)
19F-NMR (471MHz, CDCIj) 6  (ppm) 115.76
i3C-NMR (126MHz, CDC13) S (ppm) 161.49, 160.07, 159.54, 150.66, 136.10, 
134.60, 130.12, 124.18, 120.11, 117.38, 115.08, 111.95, 107.97, 55.53 
MS (El positive ion) m/z 259.05 (M+)
Anal, calcd for Q 4H 10FNOS; C, 64.85; H, 3.89; N, 5.40; found C, 64.81; H, 3.99; 
N, 5.58
Synthesis o f  3-(6-F luorobenzoth iazol-2-y l)phenol [69 g]
OH
^  ^  Ci3H8FNOS
Mol. Wt.: 245.27
Prepared according to Standard Procedure D, from bis(2-amino-5- 
fluorophenyl)disulfide (0.24 g, 0.86 mmol), 3-hydroxybenzaldehyde (0.10 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 40 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash. The sample was then dissolved in dichloromethane and 
washed through a plug of silica and reduced to dryness to give 69 g as a white 
solid in 93% yield (201 mg).
'H-NMR (500MHz, d6-DMSO) 5 (ppm) 9.89 (bs, 1H, OH), 8.09-8.04 (m, 2H, Ar- 
H), 7.50-7.48 (m, 2H, Ar-H), 7.42-7.39 (m, 2H, Ar-H), 6.99-6.97 (m, 1H, Ar-H) 
I3C-NMR (126MHz, d6-DMSO) 5 (ppm) 160.62, 158.71, 157.98, 150.35, 135.60,
133.81, 130.55, 123.99, 1 18.56, 118.01, 115.01, 113.32, 108.63
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Synthesis o f 2-(3-C hlorophenyl)-6-fluorobenzothiazole [69 j]
ci
C13H7CIFNS 
Mol. Wt.: 263.72
Prepared according to Standard Procedure D, from bis(2-amino-5- 
fluorophenyl)disulfide (0.24 g, 0.86 mmol), 3-chlorobenzaldehyde (0.1 mL 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 69 j as a green solid in 91% 
yield (210 mg).
Mp=101-103 °C
’H-NMR (500MHz, CDC13) 6 (ppm) 8.11 (t, J=1.5Hz, 1H, H-2’), 8.05 (dd, J=5.0, 
9.0Hz, 1H, H-7), 7.93 (dt, J=1.5, 7.5Hz, 1H, H-4), 7.62 (dd, J=2.5, 8Hz, 1H, H-6’), 
7.50-7.40 (m, 2H, H-4’, H-5’), 7.28-7.35 (m, 1H, H-5)
19F-NMR (471MHz, CDC13) 6 (ppm) 115.10
813C (125MHz, CDCI3) 5 (ppm) 166.26, 161.72, 159.78, 150.38, 136.05, 134.79, 
130.83, 130.54, 127.29, 125.32, 124.38, 115.25, 107.80 
MS (El positive ion) m/z 263.00 (M+)
Anal, calcd for C13H7CIFNS; C, 59.21; H, 2.68; N, 5.31; found C, 59.21; H, 2.80; 
N, 5.78.
Synthesis o f  2-(4-Brom ophenyl)-6-fluorobenzothiazoIe [69 k]
y  Br Ci3H7BrFNS
^  Mol. Wt.: 308.17
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triphenylphosphine (0.25 g, 0.74 mmol), and bis(2-amino-5-fluorophenyl)disulfide 
(0.21 g, 0.74 mmol), in toluene (1.5 mL) and DMF (7.5 mL). The reaction mixture 
was refluxed for 60min, cooled, filtered through Celite® washed with methanol 
followed by subsequent extraction with water and brine. The resulting product was 
evaporated to dryness to give 69 e as a grey solid in 93% yield (36 mg).
Mp=193-195 °C, lit= 194-195 °C38
'H-NMR (500MHz, d6-DMSO) 8 (ppm) 8.40 (d, J=8.5Hz, 2H, H-3’, H-5’), 8.34 
(d, J=8.5Hz, 2H, H-2’, H-6’), 8.19-8.18 (m, 2H, H-4, H-7), 7.99 (dt, J=2.5, 9Hz, 
1H, H-5)
l9F-NMR (471M H z, d6-DMSO) 5 (ppm) 114.23
l3C-NMR (126MHz, d6-DMSO) 8 (ppm) 161.19, 159.24, 150.33, 148.71, 138.02,
134.42, 128.27, 124.88, 124.53, 115.74, 108.83.
MS (El positive ion) m/z 274.02 (M+)
Synthesis o f  6-Fluoro-2-(3-m ethoxy-phenyl)-benzothiazole [69 f]
Prepared according to Standard Procedure D, from bis(2-amino-5- 
fluorophenyl)disulfide (0.24 g, 0.86 mmol), m-anisaldehyde (0.1 mL 0.88 mmol), 
sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The reaction 
mixture was stirred at 120 °C for 90 min, water was then added and the resulting 
precipitate collected. This precipitate was washed with excess water, followed by a 
brine wash and finally dried to give 69 f as a green solid in 84% yield (190 mg).
Mp=84-86 °C
OMe
ChH ioFNOS 
Mol. Wt.: 259.30
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Anal, calcd for C i4H7FN2S; C, 66.13; H, 2.77; N, 11.01; found C, 65.58; H, 2.86; 
N, 10.93
Synthesis o f  6-Fluoro-2-(3-fluorophenyl)benzothiazole [69 i]
C13H7F2NS 
Mol. Wt.: 247.26
Prepared according to Standard Procedure D, from bis(2-amino-5- 
fluorophenyl)disulfide (0.24 g, 0.86 mmol), 3-fluorobenzaldehyde (0.1 mL, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 69 i as a yellow solid in 91% 
yield (196 mg).
Mp=102-104 °C
'H-NMR (500MHz, CDCI3) 6 (ppm) 8.05 (dd, J=4.5, 7.5Hz, 1H, Ar-H), 7.84-7.81 
(m, 2H, Ar-H), 7.62 (dd, J=2.5, 8Hz, 1H, Ar-H), 7.51-7.47 (m, 1H, Ar-H), 7.27- 
7.20 (m, 2H, Ar-H)
l9F-NMR (471 MHz, CDCI3) 6 (ppm) 115.37, 111.92
i3C-NMR (126MHz, d6-DMSO) 8 (ppm) 163.42, 161.47, 159.01, 150.18, 135.90,
134.82, 131.66, 124.42, 123.47, 118.29, 115.46, 113.54, 108.9 
MS (El positive ion) m/z 247.02 (M+)
Anal, calcd for C i3H7F2NS; C, 63.15; H, 2.85; N, 5.66; found C, 63.01; H, 2.82; N,
5.59.
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7.9 Synthesis of 6-Ethoxy Substituted Benzothiazoles
Synthesis o f  6-E thoxy-2-(3-m ethoxyphenyl)benzothiazole [70 a]
OMe
C i6H15N 0 2S 
Mol. Wt.: 285.36
Etcr v  w
Prepared according to Standard Procedure D, from bis(2-amino-5- 
ethoxyphenyl)disulfide (0.29 g, 0.86 mmol), m-anisaldehyde (0.1 mL, 0.88 mmol), 
sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The reaction 
mixture was stirred at 120 °C for 40 min, water was then added and the resulting 
precipitate collected. This precipitate was washed with excess water, followed by a 
brine wash and finally dried to give 70 a as a black solid in 92% yield (230 mg).
Mp=94-97 °C
‘H-NMR (500MHz, CDC13) 5 (ppm) 8.07 (s, 1H, H-7), 7.96 (d, J=9Hz, 1H, H-4), 
7.90 (td, J=1.5, 7Hz, 1H, H-5’), 7.45-7.39 (m, 2H, H-5, H-6’), 7.35 (d, J=2.5Hz, 
1H, H-2’), 7.11 (dd, J=2.5, 9.0Hz, 1H, H-4’), 4.13 (q, J=7Hz, 2H, OCH2), 2.19 (s, 
3H, OCH3), 1.48 (t, J=7Hz, 3H, CH3)
13C-NMR (126MHz, CDC13) 6 (ppm) 165.39, 157.42, 148.47, 136.50, 135.48, 
135.09, 130.35, 130.19 127.06, 125.35, 123.93, 116.39, 104.80, 64.15, 30.90,
14.82.
MS (El positive ion) m/z 285.03 (M+)
Synthesis o f  6-Ethoxy-2-(4-m ethoxyphenyl)benzothiazole [70 b]
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mL). The reaction mixture was refluxed for 60 min, cooled, filtered through 
Celite® washed with methanol followed by subsequent extraction with water and 
brine. The resulting product was evaporated to dryness to give 70 i as a white solid 
in 80% Yield (39 mg).
Mp=130-133 °C
!H-NMR (500MHz, CDC13) 5 (ppm) 7.92 (d, J=9Hz, 1H, H-4), 7.91 (d, J=8.5Hz, 
2H, H-3’, H-5’), 7.61 (d, J=8.5Hz, 2H, H-2\ H-6’), 7.34 (d, J=2.5Hz, 1H, H-7), 
7.10 (dd, J= 2.5, 8.5Hz, 1H, H-5), 4.13 (q, J=7Hz, 2H, OCH2), 1.49 (t, J=7Hz, 3H, 
CH3)
13C-NMR (126MHz, CDC13) 6 (ppm) 164.03, 157.34, 148.56, 136.44, 132.76, 
132.16, 128.59, 124.83, 123.80, 116.30, 104.87, 64.15, 14.82 
MS (El positive ion) m/z 334.98 (M+)
HRMS (El positive ion) m/z = 332.9822, calcd for Ci5Hi2BrNOS m/z = 332.9823
Synthesis o f  3-(6-Ethoxybenzothiazol-2-yl)-phenol [70 j]
C i5Hi3N 02S 
Mol. Wt.: 271.33
EtO'
Prepared according to Standard Procedure D, from bis(2-amino-5- 
ethoxyphenyl)disulfide (0.29 g, 0.86 mmol), 3-hydroxybenzaldehyde (0.11 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 80 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash. The sample was then dissolved in dichloromethane and 
washed through a plug of silica and reduced to dryness to give 70 j as a yellow 
solid in 93% yield (220 mg).
Mp=138-142 °C
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‘H-NMR (500MHz, CDC13) 8 (ppm) 9.82 (bs, 1H, OH), 7.90 (d, J=9Hz, 1H, H-4), 
7.59 (s, 1H, H-7), 7.49 (d, J=7.5Hz, 1H, H-6’), 7.30-7.28 (m, 2H, H-2’, H-5’), 7.05 
(d, J=9Hz, 1H, H-5), 6.97 (d, J=8Hz, 1H, H-4’), 4.08 (q, J=7Hz, 2H, OCH2), 1.46 
(t, J=7Hz, 3H, CH3).
13C-NMR (126MHz, CDC13) 8 (ppm) 165.75, 157.13, 157.11, 148.21, 136.26, 
134.71, 130.17, 123.49, 119.16, 118.16, 116.11, 113.93, 104.83,64.12, 14.31.
Synthesis o f 4-(6-Ethoxybenzothiazol-2-yl)phenol45 [70 k]
)  o h  C15Hi3N 02S
/  Mol. Wt.: 271.33
Prepared according to Standard Procedure D, from bis(2-amino-5- 
ethoxyphenyl)disulfide (0.29 g, 0.86 mmol), 4-hydroxybenzaldehyde (0.11 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 80 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash. The sample was then dissolved in dichloromethane and 
washed through a plug of silica and reduced to dryness to give 70 k as a black 
solid in 91% yield (215 mg).
Prepared according to Standard Procedure E, from 4-hydroxybenzaldehyde (0.09 
mg, 0.73 mmol), /?-tolunesulfonic acid (0.03 g, 0.14 mmol), polymer-bound 
triphenylphosphine (0.25 g, 0.74 mmol), and bis(2-amino-5- 
ethoxyphenyl)disulfide (0.25 g, 0.74 mmol), in toluene (1.5 mL) and DMF (7.5 
mL). The reaction mixture was refluxed for 60 min, cooled, filtered through 
Celite® and washed with methanol followed by subsequent extraction with water 
and brine. The resulting product was evaporated to dryness to give 70 k as a 
yellow solid in 94% yield (37 mg).
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‘H-NMR (500MHz, d6-DMSO) 8 (ppm) 10.11 (bs, 1H, OH), 7.87-7.83 (m, 3H, H- 
4,H-2\ H-6’), 7.63 (d, J=2.5Hz, 1H, H-7), 7.07 (dd, J=3, 8.5Hz, 1H, H-5), 6.91 (d, 
J=9Hz, 2H, H-3’, H-5’) 4.11 (q, J=7Hz, 2H, OCH2), 1.37 (t, J=7Hz, 3H, Me) 
13C-NMR (126M Hz, d6-DMSO) 8 (ppm) 164.80, 160.03, 156.30, 148.02, 135.51, 
128.58, 124.27, 122.78, 115.98, 115.75, 105.47, 63.67, 14.62.
Synthesis o f  2-(3-Fluorophenyl)-6-ethoxybenzothiazole [70 1]
C15H12CINOS 
Mol. W t: 289.78
EtO
Prepared according to Standard Procedure D, from bis(2-amino-5- 
ethoxyphenyl)disulfide (0.29 g, 0.86 mmol), 3-fluorobenzaldehyde (0.10 mL, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash. The sample was then dissolved in dichloromethane and 
washed through a plug of silica and reduced to dryness to give 70 1 as a grey solid 
in 67% yield (170 mg).
Mp=70-72 °C
1 H-NMR (500MHz, CDC13) 6 (ppm) 7.96 (d, J=8.5Hz, 1H, H-4), 7.65 (s, 1H, H- 
7), 7.61 (d, J=8Hz, 1H, H-6’), 7.39 (t, J=8Hz, 1H, H-5’), 7.35 (d, J=2.5Hz, 1H, H- 
2’), 7.11 (dd, J=2.5, 8.5Hz, 1H, H-4’), 7.03 (dd, J=2.5, 8.5Hz, 1H, H-5), 4.08 (q, 
J=7Hz, 2H, OCH2), 1.46 (t, J=7Hz, 3H, CH3)
13C-NMR (126MHz, CDC13) 5 (ppm) 165.30, 160.06, 157.18, 148.56, 136.46,
135.12, 129.97, 123.73, 119.93, 116.89, 116.09, 111.77, 104.86, 64.12, 14.94.
MS (El positive ion) m/z 289.02 MS (M+)
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Synthesis o f 4-(6-Ethoxybenzothiazol-2-yl)benzonitriIe [70 g]
EtO'
Cl6Hl2N2OS 
Mol. Wt.: 280.34
Prepared according to Standard Procedure D, from bis(2-amino-5- 
ethoxyphenyl)disulflde (0.29 g, 0.86 mmol), 4-cyanobenzaldehyde (0.11 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 50 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 70 g as a black solid in 82% 
yield (200 mg).
‘H-NMR (500MHz, d6-DMSO) 6 (ppm) 8.20 (d, J= 8.5Hz 2H, H-2’, H-6’), 8.00- 
7.98 (m, 3H, H -3\ H-5’, H-4), 7.73 (d, J=2.5Hz, 1H, H-7), 7.16 (dd, J=2.5, 8.5Hz, 
1H, H-5), 4.13 (q, J=7Hz, 2H, OCH2), 1.37 (t, J=7Hz, 3H, Me)
13C-NMR (126MHz, d6-DMSO) 5 (ppm) 167.63, 162.48, 153.05, 142.11, 141.80,
138.44, 132.61, 129.19, 123.60, 122.07, 117.97, 110.56, 69.04, 19.80
Synthesis o f  2-(3-Fluorophenyl)-6-ethoxybenzothiazole [70 h]
Ci5H12FNOS 
Mol. Wt.: 273.33
EtO'
Prepared according to Standard Procedure D, from bis(2-amino-5- 
ethoxyphenyl)disulfide (0.29 g, 0.86 mmol), 3-fluorobenzaldehyde (0.09 mL, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 30 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water,
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13C-NMR (126MHz, CDC13) 6 (ppm) 162.12, 157.74, 148.73, 148.39, 136.65,
135.45, 132.61, 129.99, 124.64, 124.22, 121.91, 116.76, 104.75, 64.19, 14.79.
MS (El positive ion) m/z 300.04 (M+)
Synthesis o f  6-Ethoxy-2-(4-nitrophenyl)benzothiazole [70 f]
n o 2 C 15H 12N 2O 3S  
Mol. Wt.: 300.33
EtO'
Prepared according to Standard Procedure D, from bis(2-amino-5- 
ethoxyphenyl)disulfide (0.29 g, 0.86 mmol), 4-nitrobenzaldehyde (0.13 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
precipitate collected. This precipitate was washed with excess water, followed by a 
brine wash and finally dried to give 70 f as a black solid in 86% yield (225 mg).
Prepared according to Standard Procedure E, from 4-nitrobenzaldehyde (0.11 g, 
0.73 mmol), /?-tolunesulfonic acid (0.03 g, 0.14 mmol), polymer-bound 
triphenylphosphine (0.25 g, 0.74 mmol), and bis(2-amino-5- 
ethoxyphenyl)disulfide (0.25 g, 0.74 mmol), in toluene (1.5 mL) and DMF (7.5 
mL). The reaction mixture was refluxed for 70 min, cooled, filtered through 
Celite® washed with methanol followed by subsequent extraction with water and 
brine. The resulting product was evaporated to dryness to give 70 f as a purple 
solid in 87% Yield (38 mg).
'H NMR (500MHz, CDC13) 5 (ppm) 8.35 (d, J=9Hz, 2H, H-3’, H-5’), 8.22 (d, 
J=9Hz, 2H, H-2’, H-6’), 8.01 (d, J=9Hz, 1H, H-4), 7.39 (d, J=2.5Hz, 1H, H-7), 
7.16 (dd, J=2.5, 8.5Hz, 1H, H-5), 4.15 (q, J=7Hz, 2H, OCH2), 1.50 (t, J=7Hz, 3H, 
Me)
MS (El positive ion) m/z 300.05 (M+)
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7.10 Synthesis of 6-Chloro Substituted Benzothiazoles
Synthesis o f 2-(3-M ethoxyphenyl)-6-chlorobenzothiazole [71 a]
OMe
C14H10CINOS 
Mol. Wt.: 275.75
Prepared according to Standard Procedure D, from bis (2-amino-5- 
chlorophenyl)disulfide (0.27 g, 0.86 mmol), wz-anisaldehyde (0.1 mL, 0.88 mmol), 
sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The reaction 
mixture was stirred at 120 °C for 30 min, water was then added and the resulting 
precipitate collected. This precipitate was washed with excess water, followed by a 
brine wash and finally dried to give 71 a as a white solid in 89% yield (215 mg).
Mp=76-79 °C Lit=75-78 °C170
'H-NMR (500MHz, CDC13) 8 (ppm) 8.00 (d, J=8.5Hz, 1H, H-4), 7.90 (s, 1H, H- 
7), 7.68 (s, 1H, H-2’), 7.64 (d, J=8.5Hz, 1H, H-5), 7.48 (d, J=8.5Hz, 1H, H-6’), 
7.42 (t, J=8Hz, 1H, H-5’), 7.08 (d, J=8.5Hz, 1H, H-4’), 3.94 (s, 3H, OCH3) 
l3C-NMR (126MHz, CDC13) 5 (ppm) 168.44, 160.11, 152.61, 136.25, 134.49,
131.14, 130.12, 127.14, 123.95, 121.22, 120.21, 117.59, 112.09, 55.53.
MS (El positive ion) m/z 275.01 (M+)
Synthesis o f  2-(4-M ethoxyphenyl)-6-chlorobenzothiazole [71 b]
0Me c 14h 10c in o s
Mol. Wt.: 275.75
Prepared according to Standard Procedure D, from bis (2-amino-5-
chlorophenyl)disulfide (0.27 g, 0.86 mmol),/7-anisaldehyde (0.1 mL, 0.88 mmol),
sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The reaction
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Synthesis o f  6-Chloro-2-(3,4,5-trim ethoxyphenyl)benzothiazole[71 g]
OMe
Cl
0Me C i6H14C1N03S 
Mol. Wt.: 335.81
OMe
Prepared according to Standard Procedure D, from bis (2-amino-5-chlorophenyl) 
disulfide (0.27 g, 0.86 mmol), 3,4,5-trimethoxybenzaldehyde (0.17 g, 0.88 mmol), 
sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The reaction 
mixture was stirred at 120 °C for 60 min, water was then added and the resulting 
precipitate collected. This precipitate was washed with excess water followed by a 
brine wash. The sample was then dissolved in dichloromethane and washed 
through a plug of silica and reduced to dryness to give 71 g as a green solid in 84% 
yield (245 mg).
Mp=150-152 °C
'H-NMR (500MHz, d6-DMSO) 6 (ppm) 8.03 (d, J=8.5Hz, 1H, H-4), 7.97 (d, 
J=1.5Hz, 1H, H-7), 7.49 (dd, J=2, 8.5Hz, 1H, H-5), 7.28 (s, 2H, H -2\ H-6’), 4.01 
(s, 6H, OCH3, OCH3), 3.96 (s, 3H, OCH3)
13C-NMR (126MHz, d6-DMSO) 5 (ppm) 168.11, 153.39, 152.22, 140.36, 136.09, 
129.80, 127.91, 127.10, 123.86, 121.93, 104.46, 60.20, 56.10.
MS (El positive ion) m/z 335.04 MS (M+)
Synthesis o f  3-(6-Chlorobenzothiazol-2-yl)phenol [71 h]
OH
Prepared according to Standard Procedure D, from bis (2-amino-5-
chlorophenyl)disulfide (0.27 g, 0.86 mmol), 3-hydroxybenzaldehyde (0.11 g, 0.88
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The
ci
Ci3H8C1NOS 
Mol. Wt.: 261.73
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followed by a brine wash and finally dried to give 71 e as a green solid in 85% 
yield (240 mg).
Mp= 196-200 °C
1 H-NMR (500MHz, d6-DMSO) 5 (ppm) 8.43-8.41 (m, 3H, H-7, H-3’, H-5’), 8.38 
(d, J=9Hz, 2H, H -2 \ H-6’), 8.16 (d, J=8.5Hz, 1H, H-4), 7.66 (dd, J=2.5, 8.5Hz, 
1H, H-5)
13C-NMR (126MHz, d6-DMSO) 6 (ppm) 165.87, 152.20, 148.87, 137.91, 136.56,
130.86, 128.45, 127.63, 124.63, 124.59, 123.32.
Synthesis o f 6-Chloro-2-(3,4-dim ethoxyphenyl)benzothiazole[71 f|
OMe
0Me Ci5H12C1N02S
Mol. Wt.: 305.78
c r  v
Prepared according to Standard Procedure D, from bis (2-amino-5-chlorophenyl) 
disulfide (0.27 g, 0.86 mmol), 3,4-dimethoxybenzaldehyde (0.14 g, 0.88 mmol), 
sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The reaction 
mixture was stirred at 120 °C for 60 min, water was then added and the resulting 
precipitate collected. This precipitate was washed with excess water, followed by a 
brine wash. The sample was then dissolved in dichloromethane and washed 
through a plug of silica and reduced to dryness to give 71 f as a brown solid in 
88% yield (235 mg).
*H-NMR (500MHz, CDC13) 5 (ppm) 7.94 (d, J=8.5Hz, 1H, H-4), 7.85 (d, J=2Hz, 
1H, H-7), 7.70 (d, J=2Hz, 1H, H-2’), 7.58( dd, J=2, 8.5Hz, 1H, H-5), 7.44(dd, J=2, 
8.5Hz, 1H, H-5’), 6.96 (d, J=8.5Hz, 1H, H-6’) 4.03 (s, 3H, OCH3), 3.97 (s, 3H, 
OCH3)
13C-NMR (126MHz, CDC13) 5 (ppm) 168.35, 152.73, 151.84, 149.51, 136.12, 
130.69, 127.06, 126.28, 123.51, 122.21, 121.12, 111.08, 109.78, 56.15
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Synthesis o f 6-E thoxy-2-(3,4-dim ethoxy-phenyl)benzothiazole [70 c]
OMe
EtO
OMe C17H17NO3S 
Mol. Wt.: 315.39
Prepared according to Standard Procedure D, from bis(2-amino-5- 
ethoxyphenyl)disulfide (0.29 g, 0.86 mmol), 3,4-dimethoxybenzaldehyde (0.1 mL, 
0.88 mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 70 c as a yellow solid in 91% 
yield (250 mg).
Mp=l 12-115 °C
!H-NMR (500MHz, CDCL3) 5 (ppm) 7.91 (d, J=9Hz, 1H, H-4), 7.67 (d, J=2.5Hz, 
1H, H-7), 7.50 (dd, J= 2.5, 8.5Hz, 1H, H-5), 7.29 (d, J=2.5Hz, 1H, H-2’), 7.05 (dd, 
J= 2.5, 8.5Hz, 1H, H-5’), 6.89 (d, J= 8.5Hz, 1H, H-6’), 4.07 (q, J=7Hz, 2H, 
OCH2), 4.00 (s, 3H, OMe), 3.92 (s, 3H, OMe), 1.47 (t, J=6.5Hz, 3H, Me)
13C-NMR (126MHz, CDC13) 5 (ppm) 165.34, 156.91, 151.22, 149.32, 148.59, 
136.22, 126.89, 123.59, 120.72, 115.77, 111.35, 109.54, 104.94, 64.07, 56.09, 
14.84.
Synthesis o f  6-E thoxy-2-(3,4,5-trim ethoxyphenyl)benzothiazole [70 d]
OMe
EtO
OMe
OMe
Mol. Wt.: 345.41
Prepared according to Standard Procedure D, from bis(2-amino-5-
ethoxyphenyl)disulfide (0.29 g, 0.86 mmol), 3,4,5-trimethoxybenzaldehyde (0.17
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followed by a brine wash and finally dried to give 70 h as a purple solid in 84% 
yield (230 mg).
Mp=89-92 °C
*H-NMR (500MHz, CDC13) 5 (ppm) 7.96 (d, J=9Hz, 1H, H-4), 7.81-7.77 (m, 2H, 
H-7, H-5’), 7.47-7.43 (m, 1H, H-6’), 7.35 (d, J=2.5Hz, 1H, H-2’), 7.17 (dt, J=2.5, 
9Hz, H-4’), 7.11 (dd, J=2.5, 8.5Hz, 1H, H-5), 4.13 (q, J=7Hz, 2H, CH2), 1.48 (t, 
J=7Hz, 3H, CH3).
19F-NMR (471MHz, CDC13) 5 (ppm) 122.10
13C-NMR (126MHz, CDC13) 5 (ppm) 164.05, 162.08, 157.40, 148.46, 136.50, 
135.92, 130.57, 123.93, 122.97, 117.39, 116.36, 114.06, 104.80, 64.19, 14.81.
MS (El positive ion) m/z 273.06 (M+)
Synthesis o f  2-(4-Brom ophenyl)-6-ethoxybenzothiazole [70 i]
EtO'
Ci5H12BrNOS 
Mol. Wt.: 334.23
Prepared according to Standard Procedure D, from bis(2-amino-5- 
ethoxyphenyl)disulfide (0.29 g, 0.86 mmol), 4-bromobenzaldehyde (0.16 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 30 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 70 i as a purple solid in 93% 
yield (270 mg).
Prepared according to Standard Procedure E, from 4-bromobenzaldehyde (0.13 g, 
0.73 mmol), /?-tolunesulfonic acid (0.03 g, 0.14 mmol), polymer-bound 
triphenylphosphine (0.25 g, 0.74 mmol), and bis(2-amino-5- 
ethoxyphenyl)disulfide (0.25 g, 0.74 mmol), in toluene (1.5 mL) and DMF (7.5
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g, 0.88 mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 70 d as a purple solid in 82% 
yield (245 mg).
‘H-NMR (500M Hz, CDC13) 5 (ppm) 7.92 (d, J=8.5Hz, 1H, H-4), 7.33 (d, J=2.5Hz, 
1H, H-7), 7.28 (s, 2H, H-2’, H-6’), 7.08 (dd, J= 2.5, 8.5Hz, 1H, H-5), 4.12(q, 7Hz, 
2H, OCH2), 3.98 (s, 6H, OCH3, OCH3), 3.92 (s, 3H, OCH3), 1.47 (t, J= 7Hz, CH3) 
13C-NMR (126M Hz, CDC13) 5 (ppm) 165.17, 157.09, 153.57, 148.53, 140.32, 
136.29, 129.29, 123.70, 115.99, 104.93, 104.52, 64.14, 60.98, 56.36, 14.83
Synthesis o f  6-Ethoxy-2-(3-nitrophenyl)benzothiazole [70 e]
Ci5H i2N20 3S 
Mol. Wt.: 300.33
/  \  / /  '  5  v _______ : /
EtO
Prepared according to Standard Procedure D, from bis(2-amino-5- 
ethoxyphenyl)disulfide (0.29 g, 0.86 mmol), 3-nitrobenzaldehyde (0.13 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 70 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 70 e as a purple solid in 80% 
yield (210 mg).
Mp=138-141 °C
1 H-NMR (500MHz, CDC13) 5 (ppm) 8.87 (s, 1H, H-2’), 8.37 (d, J= 8.5Hz, 1H, H- 
4 ’), 8.30 (d, J=8.5Hz, 1H, H-4), 7.98(d, J=9Hz, 1H, H-6’), 7.67 (t, J=8Hz, 1H, H- 
5’), 7.36 (d, J=2.5Hz, 1H, H-7), 7.13 (dd, J=2.5, 9Hz, 1H, H-5), 4.15 (q, J=7Hz, 
2H, OCH2), 1.49 (t, J=7Hz, 3H, Me)
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mixture was stirred at 120 °C for 20 min, water was then added and the resulting 
precipitate collected. This precipitate was washed with excess water, followed by a 
brine wash and finally dried to give 71 b as a white solid in 83% yield (200 mg).
Mp=134-137 °C Lit=135-137 °C170
*H-NMR (500MHz, CDC13) 5 (ppm) 8.04 (d, J=8.5Hz, 2H, H-2’, H-6 ’), 7.95 (d, 
J=8.5Hz, 1H, H-4), 7.87 (d, J=2Hz, 1H, H-7), 7.45 (dd, J=2, 8.5Hz, 1H, H-5), 7.03 
(d, J=8.5Hz, 2H, H-3’, H-5’), 3.91 (s, 3H, OCH3)
13C-NMR (126MHz, CDC13) 6 (ppm) 168.36, 162.15, 152.79, 136.03, 130.59,
129.14, 126.97, 126.03, 123.49, 121.12, 114.46, 55.48.
Synthesis o f 2-(4-Nitrophenyl)-6-chlorobenzothiazoIe171 [71 cj
Prepared according to Standard Procedure D, from bis (2-amino-5- 
chlorophenyl)disulfide (0.27 g, 0.86 mmol), 4-nitrobenzaldehyde (0.13 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 50 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 71 c as a brown solid in 90% 
yield (228 mg).
Mp=216-220 °C
‘H-NMR (500MHz, d6-DMSO) 5 (ppm) 8.40 (d, J=2Hz, 1H, H-7), 8.29 (d, J-
Cl
Ci3H7C1N20 2S 
Mol. Wt.: 290.72
8.5Hz, 2H, H-3’, H-5’), 8.13 (d, J=9Hz, 1H, H-4), 8.06 (d, J=8.5Hz, 2H, H-2’, H- 
6 ’), 7.63 (dd, J=2, 8.5Hz, 1H, H-5)
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l3C-NMR (126MHz, d6-DMSO) 8  (ppm) 165.87, 152.01, 148.36, 136.24, 133.79, 
133.51, 131.28, 130.63, 127.54, 125.80, 124.46, 122.31, 121.19.
MS (El positive ion) m/z 289.98 MS (M+)
Chapter 7 Experimental
Synthesis o f  4-(6-Chlorobenzothiazol-2-yl)benzonitrile [71 d]
CN C14H7C1N2S 
Mol. Wt.: 270.74
Prepared according to Standard Procedure D, from bis (2-amino-5- 
chlorophenyl)disulfide (0.27 g, 0.86 mmol), 4-cyanobenzaldehyde (0.11 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 30 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 71 d as a brown solid in 95% 
yield (225 mg).
Mp=168-171 °C
‘H-NMR (500MHz, CDCI3) 6  (ppm) 8.12 (s, 1H, H-7), 8.01 (d, J=8.5Hz, 1H, H- 
4), 7.95-7.92 (m, 2H, H-2’, H-6 ’), 7.51-7.44 (m, 3H, H-5, H-3’, H-5’)
13C-NMR (126MHz, CDCI3) 5 (ppm) 166.74, 152.55, 136.25, 135.27, 134.90, 
131.54, 131.13, 130.33, 127.41, 125.67, 124.18, 121.31.
Synthesis o f  2-(4-Brom ophenyl)-6-chlorobenzothiazole [71 e]
Br Ci3H7BrClNS 
Mol. Wt.: 324.62
Prepared according to Standard Procedure D, from bis (2-amino-5- 
chlorophenyl)disulfide (0.27 g, 0.86 mmol), 4-bromobenzaldehyde (0.16 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water,
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7.11 Synthesis of 6-Methyl Substituted Benzothiazoles
Synthesis o f 2-(4-M ethoxyphenyl)-6-m ethylbenzothiazole [72 a]
Prepared according to Standard Procedure D, from bis(2-amino-5- 
methylphenyl)disulfide (0.24 g, 0.86 mmol),/?-anisaldehyde (0.1 mL, 0.88 mmol), 
sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The reaction 
mixture was stirred at 120 °C for 60 min, water was then added and the resulting 
precipitate collected. This precipitate was washed with excess water, followed by a 
brine wash and finally dried to give 72 a as a yellow solid in 94% yield (210 mg).
Mp=174-177 °C, Lit =176-177 °Cm
'H-NMR (500MHz, d6-DMSO) 8  (ppm) 8.00 (d, J=8.5Hz, 2H, H-2’, H-6 ’), 7.88-
8.87 (m, 2H, H-4, H-7), 7.33(d, J=8.5Hz, 1H, H-5), 7.1 l(d, J=8.5Hz, 2H, H-3’, H- 
5’), 3.85 (s, 3H, O CH3), 2.44 (s, 3H, CH3)
13C-NMR (126MHz, d6-DMSO) 5 (ppm) 165.98, 161.60, 151.72, 134.87, 134.31, 
128.68, 127.94, 125.57, 121.97, 121.66, 114.70, 55.44, 20.96 
MS (El positive ion) m/z 255.07 (M+)
Synthesis o f  4-(6-M ethylbenzothiazol-2-yl)phenol173 [72 h|
Prepared according to Standard Procedure D, from bis(2-amino-5-
methylphenyl)disulfide (0.24 g, 0.86 mmol), 4-hydroxybenzaldehyde (0.12 g, 0.88
Mol. Wt.: 255.33
o h  C m H u N O S  
Mol. Wt.: 241.31
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reaction mixture was stirred at 120 °C for 70 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 71 h as a yellow solid in 90% 
yield (205 mg).
Mp=176-180 °C
1 H-NMR (500MHz, d6-DMSO) 6 (ppm) 9.09 (bs, 1H, OH), 8.31 (s, 1H, H-7), 8.05 
(d, J=8.5Hz, 1H, H-4), 7.58 (dd, J=2, 8.5Hz, 1H, H-5), 7.53-7.51 (m, 2H, H-2’, H- 
4 ’), 7.38 (t, J=8 Hz, 1H, H-5’), 6.99 (d, J=9Hz, 1H, H-6 ’)
MS (El positive ion) m/z 261.00 (M+)
Synthesis o f  2-(3-Nitrophenyl)-6-chlorobenzothiazole [71 i]
C13H7CIN2O2S 
Mol. Wt.: 290.72
Prepared according to Standard Procedure D, from bis (2-amino-5- 
chlorophenyl)disulfide (0.27 g, 0.86 mmol), 3-nitrobenzaldehyde (0.13 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 71 i as a green solid in 91% 
yield (230 mg).
Mp=163-165 °C
1 H-NMR (500MHz, d6-DMSO) 5 (ppm) 8.83 (s, 1H, H-2’), 8.51 (d, J= 8.5Hz, 1H, 
H-4), 8.44-8.40 (m, 2H, H-7, H-4’), 8.16 (d, J=8.5Hz, 1H, H-6 ’), 7.89 (t, J=8.5Hz, 
1H, H-5’), 7.65 (dd, J=2.5, 8.5Hz, 1H, H-5)
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Synthesis o f  2-(3, 4, 5-Trim ethoxy-phenyl)-6-m ethyl-benzothiazoIe [72 e]
OMe
OMe C17H17NO3S
Mol. Wt.: 315.39
OMe
Prepared according to Standard Procedure D, from bis(2-amino-5- 
methylphenyl)disulflde (0.24 g, 0.86 mmol), 3,4,5-trimethoxybenzaldehyde (0.18 
g, 0.88 mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 30 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 72 e as a yellow solid in 84% 
yield (230 mg).
Mp=102-105 °C
’H-NMR (500MHz, d6-DMSO) 5 (ppm) 7.92 (d, J= 8.5Hz, 1H, H-4), 7.87 (s, 1H, 
H-7), 7.35 (dd, J= 1, 8.5Hz, 1H, H-5), 7.30 (s, 2H, H-2’, H-6 ’), 3.91 (s, 6 H, 
OCH3), 3.57 (s, 3H, OCH3), 2.46 (s, 3H, CH 3)
13C-NMR (126MHz, d6-DMSO) 5 (ppm) 165.97, 153.32, 151.55, 140.05, 135.22, 
134.66, 128.38, 128.08, 122.24, 121.66, 104.28, 60.19, 56.08, 20.97.
MS (El positive ion) m/z 315.09 (M+)
Synthesis o f  3-(6-M ethylbenzothiazol-2-yl)phenol [72 f[
OH
Prepared according to Standard Procedure D, from bis(2-amino-5-
methylphenyl)disulfide (0.24 g, 0.86 mmol), 3-hydroxybenzaldehyde (0.11 g, 0.88
C14H11NOS 
Mol. Wt.: 241.31
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mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 25 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 72 b as a yellow solid in 90% 
yield (190 mg).
Mp=242-245 °C
'H-NMR (500MHz, d6-DMSO) 8 (ppm) 10.19 (bs, 1H, OH), 7.88 (d, J=8.5Hz, 2H, 
H-2’, H-6 ’), 7.87-7.85 (m, 2H, H-4, H-7), 7.32 (d, J=8 Hz, 1H, H-5), 6.92 (d, 
J=8.5Hz, 2H, H-3’, H-5’), 2.41 (s, 3H, CH3)
13C-NMR (126MHz, d6-DMSO) 5 (ppm) 166.29, 160.23, 151.73, 134.65, 134.17,
128.82, 127.83, 124.13, 121.79, 121.58, 116.03,20.92 
MS (El positive ion) m/z 241.05 (M+)
Synthesis o f  2-(4-Brom o-phenyl)-6-m ethyl-benzothiazole174 [72 c]
Prepared according to Standard Procedure D, from bis(2-amino-5- 
methylphenyl)disulfide (0.24 g, 0.86 mmol), 4-bromobenzaldehyde (0.17 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 72 c as a yellow solid in 83% 
yield ( 2 2 0  mg).
Ci4HioBrNS
Mol. Wt.: 304.20
Mp=175-178 °C
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13C-NMR (126MHz, CDC13) 5 (ppm) 164.39, 151.50, 135.77, 134.85, 134.77, 
134.06, 131.31, 130.84, 128.32,126.20, 125.85, 122.66, 121.90,21.06
Chapter 7 Experimental
'H-NMR (500MHz, CDCI3) 5 (ppm) 7.97-7.95 (m, 3H, H-4, H-3’, H-5’), 7.77 (s, 
1H, H-7), 7.64 (d, J=8.5Hz, 2H, H-2’, H-6 ’), 7.33 (d, J=8.5Hz, 1H, H-5), 2.50 (s, 
3H, Me)
13C-NMR (126MHz, CDCI3) 5 (ppm) 165.61, 152.24, 135.63, 135.23, 132.73, 
132.18, 129.10, 128.23, 125.13, 123.27, 121.39,21.57.
MS (El positive ion) m/z 302.97 (M+)
Synthesis o f 2-(3,4-D im ethoxyphenyl)-6-m ethyIbenzothiazole [72 d]
OMe
OMe C 1 6 H 1 5 N O 2 S
Mol. Wt.: 285.36
Prepared according to Standard Procedure D, from bis(2-amino-5- 
methylphenyl)disulfide (0.24 g, 0.86 mmol), 3,4-dimethoxybenzaldehyde (0.14 g, 
0.88 mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 20 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 72 d as a brown solid in 81% 
yield ( 2 0 0  mg).
Mp=104-107 °C
'H-NMR (500M H z, d6-DMSO) 8  (ppm) 7.90 (d, J=8 Hz, 1H, H-4), 7.88 (s, 1H, H- 
7), 7.62 (d, J=2Hz, 1H, H-2’), 7.59 (dd, J=2, 8 Hz, 1H, H-6 ’), 7.34-7,32 (m, 1H, H- 
5’), 7.12 (d, J=8 Hz, 1H, H-5), 3.89 (s, 3H, OMe), 3.85 (s, 3H, OMe), 2.45 (s, 3H, 
Me)
13C-NMR (126M Hz, d6-DMSO) 8 (ppm) 166.07, 151.72, 151.44, 149.10, 134.83,
134.42, 127.91, 125.72, 122.02, 121.66, 120.65, 111.91, 109.35, 55.69, 20.98 
MS (El positive ion) m/z 285.09 (M+)
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mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 20 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 72 f as a yellow solid in 8 6 % 
yield (180 mg).
Mp=180-185 °C
!H-NMR (500MHz, d6-DMSO) 5 (ppm) 9.85 (bs, 1H, OH), 7.93-7.91 (m, 2H, H- 
4, H-7), 7.49-7.47 (m, 2H, H-5, H-5’), 7.37-7.34 (m, 2H, H-2’, H-6 ’), 6.97-6.94 
(m, 1H, H-4’), 2.46 (s, 3H, CH3)
13C-NMR (125MHz, d6-DMSO) 5 (ppm) 166.17, 157.94, 151.65, 135.26, 134.49,
134.13, 130.46, 128.04, 122.39, 121.77, 118.30, 117.92, 113.27,21.03.
MS (El positive ion) m/z 241.05 (M+)
Synthesis o f  2-(3-Chlorophenyl)-6-m ethylbenzothiazole [72 g]
ci
-Nv / =  C14H10CINS
Mol. Wt.: 259.75
Prepared according to Standard Procedure D, from bis(2-amino-5- 
methylphenyl)disulfide (0.24 g, 0.86 mmol), 3-chlorobenzaldehyde (0.1 mL, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 72 g as a brown solid in 90% 
yield (205 mg).
'H-NMR (500MHz, CDC13) 8 (ppm) 8.09-8.08 (m 1H, Ar-H), 8.02-8.00 (m, 1H, 
Ar-H), 7.97-7.96 (m, 2H, Ar-H), 7.65-7.58 (m, 2H, Ar-H), 7.40-7.38 (m 1H, Ar- 
H), 2.47 (s, 3H, CH3)
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7.12 Synthesis of 6-Methoxy Substituted Benzothiazoles
Synthesis o f  2-(3, 4-Dim ethoxyphenyl)-6-m ethoxybenzothiazole165[73]
Prepared according to Standard Procedure D, from bis(2-amino-5- 
methoxyphenyl)disulfide (0.27 g, 0.86 mmol), 3,4-dimethoxybenzaldehyde (0.14 
g, 0.88 mmol), sodium metabisulflte (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash and finally dried to give 73 as a purple solid in 93% 
yield (245 mg).
Mp=l 13-116 °C
!H-NMR (500MHz, d6-DMSO) 5 (ppm) 7.90 (d, J=9Hz, 1H, H-4), 7.65 (s, 1H, H- 
7), 7.59 (s, 1H, H-2’), 7.53 (d, J=8.5Hz, 1H, H-5), 7.11-7.08 (m, 2H, H-5’, H-6 ’),
3.88 (s, 3H, OCH3), 3.84 (s, 6 H, OCH3, OCH3)
13C-NMR (126MHz, d6-DMSO) 6 (ppm) 164.58, 157.21, 151.19, 149.07, 147.98, 
135.74, 125.81, 122.96, 120.41, 115.56, 111.87, 109.12, 104.83, 55.68.
MS (El positive ion) m/z 301.08 (M+)
OMe
MeO
Ci6H15N 0 3S 
Mol. Wt.: 301.36
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7.13 Synthesis of 5-Fluoro Substituted Benzothiazoles
Synthesis o f 2-(3,4-D im ethoxyphenyl)-5-fluorobenzothiazole44 [231
OMe
OMe
C15H12FNO2S 
Mol. Wt.: 289.32
Prepared according to Standard Procedure D, from bis(2-amino-4- 
fluorophenyl)disulfide (0.24 g, 0.86 mmol), 3,4-dimethoxybenzaldehyde (0.14 g, 
0.88 mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash. The sample was then dissolved in dichloromethane and 
washed through a plug of silica and reduced to dryness to give 23 as a yellow solid 
in 87% yield (220 mg).
1 H-NMR (500MHz, d6-DMSO) 6 (ppm) 8.14 (dd, J=5.5, 9Hz, 1H, H-7), 7.86 (dd, 
J=2, 9Hz, 1H, H-4), 7.63-7.62 (m, 2H, H-2’, H-6 ’), 7.33 (dt, J=2.5, 9Hz, 1H, H-5), 
7.13 (d, J=9Hz, 1H, H-5’), 3.89 (s, 3H, OCH3), 3.86 (s, 3H, OCH3)
19F-NMR (471MHz, d6-DMSO) 5 (ppm) 115.92
13C-NMR (126MHz, d6-DMSO) 6 (ppm) 170.00, 162.33, 160.41, 154.53, 151.83, 
149.11, 125.33, 123.47, 121.00, 113.41, 111.94, 109.40, 108.56, 55.73.
MS (El positive ion) m/z 289.06 (M+)
Synthesis o f  5-FIuoro-2-(4-nitrophenyl)benzothiazole [74 a]
N02 C 13H 7FN 2 0 2 S 
Mol. Wt.: 274.27
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Prepared according to Standard Procedure D, from bis(2-amino-4- 
fluorophenyl)disulfide (0.24 g, 0.86 mmol), 4-nitrobenzaldehyde (0.13 g, 0.88 
mmol), sodium metabisulfite (0.17 g, 0.88 mmol), and DMSO (5 mL). The 
reaction mixture was stirred at 120 °C for 60 min, water was then added and the 
resulting precipitate collected. This precipitate was washed with excess water, 
followed by a brine wash. The sample was then dissolved in dichloromethane and 
washed through a plug of silica and reduced to dryness to give 74 a as a yellow 
solid in 90% yield (215 mg).
'H-NMR (500MHz, d6-DMSO) 5 (ppm) 8.40 (d, J=9Hz, 2H, H-3’, H-5’), 8.35 (d, 
J=9Hz, 2H, H-2’, H-6’), 8.28 ( dd, J=5, 8.5Hz, 1H, H-7), 8.00 (dd, J=2.5, 9Hz, 1H, 
H-4), 7.46 (dt, J=2.5, 9Hz, 1H, H-6).
I9F-NMR (471M H z, d6-DMSO) 6 (ppm) 115.35
i3C-NMR (126MHz, d6-DMSO) 8 (ppm) 167.62, 162.69, 160.74, 154.43, 149.01, 
138.01, 128.38, 124.59, 124.02, 115.20, 109.53 
MS (El positive ion) m/z 274.02 (M+)
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